data_1wiu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wiu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 12' ' ' ILE . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' CD2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.574 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.622 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CG ' HG22 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.636 ' CE2' HD12 ' A' ' 75' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.327 0.584 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.8 pp . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.608 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' O ' ' CG1' ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.672 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.471 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 26' ' ' PHE . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' LEU . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.507 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CD2' ' CB ' ' A' ' 9' ' ' SER . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG21 ' A' ' 92' ' ' VAL . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 91' ' ' ILE . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.627 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.593 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.627 ' CE1' ' CG2' ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.726 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' HG21 ' A' ' 24' ' ' VAL . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 22' ' ' LEU . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.451 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.579 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.632 ' CH2' HD23 ' A' ' 22' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 14.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.583 0.706 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.743 0.783 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG12 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 54' ' ' LYS . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 22' ' ' LEU . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 61' ' ' PHE . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD1' ' OH ' ' A' ' 73' ' ' TYR . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 92' ' ' VAL . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.512 ' ND2' ' HG3' ' A' ' 89' ' ' GLU . 13.1 m120 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.632 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ASN . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 9' ' ' SER . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.512 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB3' ' CA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.581 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LEU . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.557 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.623 HG12 ' CE1' ' A' ' 20' ' ' HIS . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.632 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.632 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 43' ' ' ALA . 7.1 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' CG2' ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.571 ' HG ' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.55 0.69 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.591 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.641 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' HG22 ' A' ' 90' ' ' VAL . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' THR . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.616 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HG3' ' CB ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' C ' ' CD ' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.497 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.425 ' N ' ' HB2' ' A' ' 9' ' ' SER . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.512 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.608 ' CE1' HG12 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' CG ' HG23 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.476 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.642 ' O ' HD12 ' A' ' 45' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 2.7 p . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.605 0.716 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.591 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.6 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.647 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.62 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' LEU . 2.6 t-20 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.484 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.619 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' HG21 ' A' ' 92' ' ' VAL . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 91' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.588 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.6 HG12 ' CE1' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.609 ' NE2' ' CG2' ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 55' ' ' SER . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.509 ' CG ' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 10.7 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.61 0.719 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.647 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.1 pp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' C ' ' CG1' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' VAL . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.647 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.613 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.1 mtmp? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.528 ' CA ' ' O ' ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.614 HG22 ' CD2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.718 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 65' ' ' ALA . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.632 ' N ' ' CG ' ' A' ' 18' ' ' PHE . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.633 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 58' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.563 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 3.5 p . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.611 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.56 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.598 HG22 ' CG ' ' A' ' 36' ' ' TRP . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.454 ' N ' ' CG2' ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' VAL . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.627 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' O ' ' CA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 73' ' ' TYR . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.527 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' ' HB1' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' CD2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.643 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.526 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.643 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.866 0.841 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.59 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.503 ' N ' HG22 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' VAL . 11.4 m120 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 15.7 t-20 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.527 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 5' ' ' ILE . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 HD13 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.526 ' CG ' HD13 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.536 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' CD2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.541 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 14' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' OG ' ' A' ' 59' ' ' SER . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.625 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 3' ' ' PRO . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 4.0 p . . . . . 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.677 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 38' ' ' VAL . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.625 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' LEU . 4.9 t-20 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.56 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.539 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.528 ' CG2' ' HB1' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.597 HG22 ' CD2' ' A' ' 20' ' ' HIS . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.648 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.638 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.581 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 p . . . . . 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' CE2' ' A' ' 36' ' ' TRP . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' O ' ' OG1' ' A' ' 37' ' ' THR . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.529 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.541 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 2' ' ' LYS . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.499 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.53 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.539 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.634 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 7' ' ' THR . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.548 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.601 ' CE2' HD12 ' A' ' 75' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 72' ' ' ASN . 13.7 p . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD12 HD22 ' A' ' 45' ' ' LEU . 1.5 pp . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.31 0.576 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 52' ' ' ASP . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.592 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.634 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.454 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.535 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.601 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.5 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 10.7 t-20 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' O ' ' OD2' ' A' ' 84' ' ' ASP . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.719 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.636 ' N ' ' CD1' ' A' ' 18' ' ' PHE . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.604 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 77' ' ' VAL . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.492 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.513 ' HA ' ' HB3' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 43' ' ' ALA . 2.6 p . . . . . 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.68 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 52' ' ' ASP . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' HG11 ' A' ' 51' ' ' VAL . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.591 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 66' ' ' LYS . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.68 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 26' ' ' PHE . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.579 HG22 ' CG ' ' A' ' 73' ' ' TYR . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' C ' HG21 ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.561 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 6' ' ' LEU . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.592 HG22 ' CD2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.539 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.652 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 73' ' ' TYR . 1.6 p . . . . . 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.666 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.4 pp . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' CE2' ' A' ' 36' ' ' TRP . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.653 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.513 ' N ' HG22 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.666 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.525 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 82' ' ' GLY . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' OD1' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG3' ' CG ' ' A' ' 76' ' ' LYS . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG1' HD13 ' A' ' 14' ' ' ILE . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 70' ' ' SER . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.557 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.669 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.531 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.616 HG22 ' CD2' ' A' ' 20' ' ' HIS . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.632 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.48 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 13.2 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.45 0.643 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 73' ' ' TYR . 2.0 mp . . . . . 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 122.245 1.021 . . . . 0.0 110.691 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.54 HG12 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' O ' ' A' ' 54' ' ' LYS . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.609 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.619 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' VAL . 1.8 m-80 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.614 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.545 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' LEU . 20.7 t-20 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.529 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG1' HD13 ' A' ' 14' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OXT' ' HB1' ' A' ' 16' ' ' ALA . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.57 ' CD1' ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.503 ' CG2' HG11 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.547 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.61 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.645 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.667 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.526 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 43' ' ' ALA . 3.9 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.546 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG12 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.588 HG22 ' CE2' ' A' ' 36' ' ' TRP . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 72' ' ' ASN . 1.0 OUTLIER -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.649 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.49 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.667 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 73' ' ' TYR . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.488 ' OXT' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.548 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.555 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 12' ' ' ILE . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.597 HG22 ' CD2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HA ' ' OG ' ' A' ' 59' ' ' SER . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.642 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.624 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.553 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.8 p . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.672 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG12 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.535 HG23 ' CG ' ' A' ' 54' ' ' LYS . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.591 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.672 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 82' ' ' GLY . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.578 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.642 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.539 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 7.0 mtmm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.56 0.219 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.652 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.535 ' HB3' ' CG1' ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 35' ' ' THR . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.652 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.592 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.633 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.65 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.645 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.633 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.595 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG22 ' CD2' ' A' ' 26' ' ' PHE . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.508 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 73' ' ' TYR . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 26' ' ' PHE . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.589 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.642 HG12 ' CE1' ' A' ' 20' ' ' HIS . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.611 HD23 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HD22 ' A' ' 22' ' ' LEU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.619 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 9.5 p . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.443 0.639 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 73' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 62' ' ' PHE . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' HG23 ' A' ' 14' ' ' ILE . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.504 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 38' ' ' VAL . 2.9 m120 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.67 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.619 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.49 ' CG ' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 7' ' ' THR . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 73' ' ' TYR . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.646 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' HG21 ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.501 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.585 HG22 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.593 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.668 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.583 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.452 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 38' ' ' VAL . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.534 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.63 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.419 ' C ' HG21 ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.549 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 20' ' ' HIS . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.628 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.624 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.549 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.624 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.21 0.529 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.531 HG12 ' CG2' ' A' ' 60' ' ' ILE . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.596 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.624 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.628 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' ALA . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.655 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG22 ' CG ' ' A' ' 73' ' ' TYR . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 ' C ' HG21 ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.602 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.669 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HA ' ' CB ' ' A' ' 59' ' ' SER . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.654 ' HB3' HG12 ' A' ' 5' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.529 ' N ' HD11 ' A' ' 27' ' ' ILE . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.526 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.655 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.584 HG11 ' CB ' ' A' ' 43' ' ' ALA . 4.8 p . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.69 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.59 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.7 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' O ' ' OG1' ' A' ' 37' ' ' THR . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.649 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.574 HG22 ' CG ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 22.1 t-20 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.501 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 87' ' ' ILE . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.533 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 1.4 mttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.57 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.583 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.594 HG22 ' CD2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HA ' HG21 ' A' ' 91' ' ' ILE . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.689 HG12 ' CE1' ' A' ' 20' ' ' HIS . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.689 ' CE1' HG12 ' A' ' 14' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CG ' ' O ' ' A' ' 56' ' ' SER . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.535 ' N ' HD11 ' A' ' 27' ' ' ILE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 1.4 p . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.53 0.681 . . . . 0.0 109.172 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' O ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CZ ' ' CE2' ' A' ' 73' ' ' TYR . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HA ' HG13 ' A' ' 92' ' ' VAL . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.601 HD12 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 8.4 t-20 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' CD1' ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.576 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.8 pttm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.601 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 86' ' ' ALA . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' HG21 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HA ' ' CB ' ' A' ' 89' ' ' GLU . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.65 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 20' ' ' HIS . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.668 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.653 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' HG21 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.601 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG13 ' CB ' ' A' ' 43' ' ' ALA . 4.0 p . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.594 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 73' ' ' TYR . 1.7 pp . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HD2' ' CA ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 92' ' ' VAL . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' HG21 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 38' ' ' VAL . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.626 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HB ' ' CE1' ' A' ' 73' ' ' TYR . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.0 mttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.58 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.576 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.648 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.633 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.645 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.599 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.54 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.607 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 5.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.607 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.548 ' N ' ' CD ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.6 HG22 ' CE2' ' A' ' 36' ' ' TRP . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.669 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.62 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD1' ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.539 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 5' ' ' ILE . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB3' ' CG2' ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 2.0 ptpp? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.606 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.574 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.63 ' CE1' HG12 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.606 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 3.8 p . . . . . 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 49' ' ' LEU . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 14' ' ' ILE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' VAL . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.548 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 86' ' ' ALA . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.55 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.587 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.596 HG22 ' CD2' ' A' ' 20' ' ' HIS . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.647 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.617 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.58 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.519 ' N ' HD11 ' A' ' 27' ' ' ILE . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.486 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' ' CA ' ' A' ' 28' ' ' GLY . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.2 p . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.599 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.576 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.606 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.51 ' N ' HG22 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.618 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HG3' ' A' ' 78' ' ' LYS . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.522 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 9' ' ' SER . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.563 HG22 ' CG ' ' A' ' 73' ' ' TYR . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.545 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' CD ' ' HG3' ' A' ' 2' ' ' LYS . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' PHE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.507 HG23 ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.532 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.54 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.635 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.643 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' N ' HG11 ' A' ' 24' ' ' VAL . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.612 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.643 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 73' ' ' TYR . 3.8 p . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.438 0.637 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' HG11 ' A' ' 51' ' ' VAL . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' HB3' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' CE2' ' A' ' 36' ' ' TRP . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.676 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' HD11 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.545 HG22 HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HG3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.539 ' CD1' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG22 ' CD2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.664 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.664 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG11 ' CB ' ' A' ' 43' ' ' ALA . 2.1 p . . . . . 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.595 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.546 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 58' ' ' THR . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.546 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.518 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.611 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.666 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.62 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.513 ' N ' HG22 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.629 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' CB ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 30' ' ' PRO . 6.8 t-20 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 73' ' ' TYR . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.475 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.521 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' PHE . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' CD2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.6 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.665 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.629 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.629 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.561 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.557 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.582 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' VAL . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' CA ' ' HD2' ' A' ' 2' ' ' LYS . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.522 ' O ' ' CG2' ' A' ' 92' ' ' VAL . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.516 ' HB2' ' N ' ' A' ' 87' ' ' ILE . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HD3' ' HB3' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD12 ' CG ' ' A' ' 20' ' ' HIS . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 65' ' ' ALA . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.644 ' N ' ' CD1' ' A' ' 18' ' ' PHE . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.58 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.5 ' N ' HG11 ' A' ' 24' ' ' VAL . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.637 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 4.7 p . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.528 HD13 ' CG2' ' A' ' 51' ' ' VAL . 1.1 pp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.627 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.485 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 90' ' ' VAL . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 3' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' OE2' ' A' ' 83' ' ' GLU . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.462 ' O ' HG21 ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 16' ' ' ALA . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.596 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.525 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.506 ' HB2' ' N ' ' A' ' 87' ' ' ILE . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.618 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.618 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.613 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.625 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.587 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.615 ' CG ' ' O ' ' A' ' 56' ' ' SER . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' HD11 ' A' ' 27' ' ' ILE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.58 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.625 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 43' ' ' ALA . 9.8 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.46 0.648 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD2' HD11 ' A' ' 60' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' CD1' ' A' ' 36' ' ' TRP . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 36' ' ' TRP . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 37' ' ' THR . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.474 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt -82.99 149.12 58.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 12' ' ' ILE . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' CD2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.574 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.649 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.622 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.595 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CG ' HG22 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.636 ' CE2' HD12 ' A' ' 75' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -96.26 39.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 39.32 87.13 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -179.18 62.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.111 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.4 52.36 1.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.0 109.341 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.15 4.82 74.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -43.26 147.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.35 -1.088 . . . . 0.0 109.703 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -111.56 38.21 2.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . -80.25 -55.15 0.79 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.664 . . . . 0.0 110.9 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.32 1.26 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.125 1.884 . . . . 0.0 111.34 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.9 mm-40 -114.38 12.72 17.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 108.611 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.8 pp 167.63 -171.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.608 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' O ' ' CG1' ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' GLY . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.672 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HG3' ' CA ' ' A' ' 39' ' ' GLY . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 26' ' ' PHE . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' LEU . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.507 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CD2' ' CB ' ' A' ' 9' ' ' SER . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' O ' HG21 ' A' ' 92' ' ' VAL . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 91' ' ' ILE . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 27' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.277 0.56 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? -95.42 152.25 39.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.413 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.624 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 6' ' ' LEU . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.585 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.627 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.593 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.627 ' CE1' ' CG2' ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.726 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' HG21 ' A' ' 24' ' ' VAL . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG22 ' CD2' ' A' ' 22' ' ' LEU . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.624 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.579 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.632 ' CH2' HD23 ' A' ' 22' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 14.1 p -115.92 50.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' O ' ' HB1' ' A' ' 43' ' ' ALA . . . 61.3 -144.57 48.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 0.7 OUTLIER 65.57 6.66 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.836 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.03 47.34 4.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.832 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 138.8 -27.54 2.69 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -44.65 141.57 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.288 . . . . 0.0 109.791 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -95.96 140.21 31.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 155.51 -59.77 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.805 -0.559 . . . . 0.0 110.46 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 46' ' ' ALA . 30.8 Cg_endo -70.02 79.98 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.402 2.068 . . . . 0.0 110.308 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 3.9 mt-10 157.83 -15.65 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -165.28 -168.26 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.796 -1.19 . . . . 0.0 111.402 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG12 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 54' ' ' LYS . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 22' ' ' LEU . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 61' ' ' PHE . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD1' ' OH ' ' A' ' 73' ' ' TYR . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 92' ' ' VAL . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.512 ' ND2' ' HG3' ' A' ' 89' ' ' GLU . 13.1 m120 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.632 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ASN . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 9' ' ' SER . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.512 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB3' ' CA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 50.39 167.18 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.581 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' LEU . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.557 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.623 HG12 ' CE1' ' A' ' 20' ' ' HIS . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.632 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.581 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.632 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 43' ' ' ALA . 7.1 p -109.07 179.13 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 72' ' ' ASN . . . 84.44 -141.89 20.01 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.1 p-10 -115.69 -21.25 9.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -1.122 . . . . 0.0 109.642 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.9 t 165.71 71.73 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.154 -0.967 . . . . 0.0 109.84 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.48 -34.07 0.27 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 37' ' ' THR . . . -81.02 150.17 28.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' CG2' ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.571 ' HG ' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -50.33 165.62 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 49' ' ' LEU . . . -82.56 132.11 53.16 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.52 -5.14 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.124 1.883 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -73.71 -17.74 61.09 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -104.24 -167.44 1.36 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.591 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.641 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD1' HG22 ' A' ' 90' ' ' VAL . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.616 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HG3' ' CB ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' C ' ' CD ' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.497 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.425 ' N ' ' HB2' ' A' ' 9' ' ' SER . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.581 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.579 0.704 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt -45.7 140.12 4.63 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.581 -0.699 . . . . 0.0 109.608 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.608 ' CE1' HG12 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' CG ' HG23 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.476 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' O ' HD12 ' A' ' 45' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 2.7 p -111.79 -168.15 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -64.56 -140.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER 63.02 9.48 3.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -1.095 . . . . 0.0 109.859 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER 44.34 50.46 7.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.307 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.6 -13.58 1.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -71.11 170.46 12.87 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.193 -1.18 . . . . 0.0 108.95 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.647 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -134.36 151.94 51.51 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 168.35 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -70.61 -0.83 8.22 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.296 1.997 . . . . 0.0 111.404 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 2.4 mt-10 -114.9 14.11 17.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -162.7 -164.02 0.95 Allowed 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.463 -0.773 . . . . 0.0 109.448 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.591 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.6 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 39' ' ' GLY . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.647 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.62 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' LEU . 2.6 t-20 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.484 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.619 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' HG21 ' A' ' 92' ' ' VAL . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 91' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.314 0.578 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt -34.51 131.54 0.43 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 122.143 -0.348 . . . . 0.0 110.447 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.537 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.588 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.6 HG12 ' CE1' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.609 ' NE2' ' CG2' ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 55' ' ' SER . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.509 ' CG ' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 HG21 ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 10.7 p -113.46 49.87 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.29 -142.39 48.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 1.1 t70 66.21 6.48 4.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -1.064 . . . . 0.0 109.748 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 64.85 40.56 5.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.74 -24.46 2.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -47.3 142.34 4.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.956 -1.32 . . . . 0.0 109.556 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -88.29 164.24 15.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.695 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 120.96 -45.87 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.17 1.32 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.834 1.689 . . . . 0.0 111.568 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 43.3 mt-10 -134.36 22.54 3.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.1 pp 164.58 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.537 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.607 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' C ' ' CG1' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.647 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.613 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 2' ' ' LYS . 2.2 pp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.664 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 1' ' ' LEU . 4.1 mtmp? -54.05 141.91 48.09 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.554 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.523 HG22 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.528 ' CA ' ' O ' ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.614 HG22 ' CD2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.718 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 65' ' ' ALA . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.632 ' N ' ' CG ' ' A' ' 18' ' ' PHE . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.633 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 58' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.563 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 3.5 p -127.75 52.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 72' ' ' ASN . . . 167.69 -141.29 6.75 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 41' ' ' SER . 3.7 p30 -89.09 47.5 1.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -1.11 . . . . 0.0 109.648 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER 83.1 -28.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.648 -0.657 . . . . 0.0 110.506 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.23 -56.22 4.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 37' ' ' THR . . . -60.82 153.61 24.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.609 -0.936 . . . . 0.0 108.593 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -138.51 148.55 44.41 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 167.85 -54.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.716 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -71.18 -1.2 9.21 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.293 1.995 . . . . 0.0 111.105 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 13.9 mt-10 -117.78 12.14 13.79 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.611 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.69 -163.98 1.05 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.56 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.598 HG22 ' CG ' ' A' ' 36' ' ' TRP . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.454 ' N ' ' CG2' ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.627 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.645 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' O ' ' CA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 73' ' ' TYR . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.455 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 145.14 98.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' ' HB1' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.579 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' CD2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.643 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.526 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.643 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.563 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -99.15 41.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 38.47 88.36 0.01 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.537 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . 4.7 m-20 179.13 62.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 65.61 52.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.55 3.75 73.04 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -42.32 146.45 0.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -1.055 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.61 36.4 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' HD3' ' A' ' 47' ' ' PRO . . . -75.06 -58.37 1.57 Allowed Pre-proline 0 C--N 1.298 -1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.556 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -70.6 80.14 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.465 2.11 . . . . 0.0 110.723 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' PRO . 1.4 tt0 161.11 -22.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -137.27 -165.61 1.79 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.329 -0.857 . . . . 0.0 109.787 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.59 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.606 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.503 ' N ' HG22 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' GLY . 11.4 m120 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.589 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 15.7 t-20 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.527 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 5' ' ' ILE . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 HD13 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' CG ' HD13 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.5 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 5.8 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER -44.02 132.81 4.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.536 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' CD2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.541 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 14' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' OG ' ' A' ' 59' ' ' SER . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.625 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 4.0 p -133.71 77.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 37.57 -152.97 0.02 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 2.0 t0 70.15 1.8 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 t 53.89 46.61 25.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.325 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.67 -21.16 0.91 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -69.43 164.89 22.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.38 -1.07 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.677 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -139.56 144.99 38.08 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 172.57 -57.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.734 -0.603 . . . . 0.0 109.441 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.5 Cg_endo -71.58 82.05 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.309 2.006 . . . . 0.0 110.025 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 9.6 tt0 159.34 -25.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -142.25 -166.29 2.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.611 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.625 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' LEU . 4.9 t-20 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.56 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.524 ' CD1' ' HG2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.524 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.539 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 1.5 mm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -135.9 139.86 31.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.391 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.528 ' CG2' ' HB1' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.597 HG22 ' CD2' ' A' ' 20' ' ' HIS . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.561 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.648 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.638 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.638 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.581 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 p -128.03 63.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.61 -154.44 0.39 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER 74.37 -1.89 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -1.053 . . . . 0.0 109.94 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 41' ' ' SER . 4.4 p 57.94 47.26 15.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.082 -1.011 . . . . 0.0 109.27 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.58 -14.55 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -79.71 160.9 26.09 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.27 -1.135 . . . . 0.0 109.099 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -140.51 146.04 37.64 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 163.97 -52.38 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.845 . . . . 0.0 110.373 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.48 -14.46 33.83 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.953 1.769 . . . . 0.0 110.897 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.524 ' CG ' HD21 ' A' ' 49' ' ' LEU . 3.3 pt-20 -100.95 14.58 31.43 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -171.62 -164.13 0.31 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' CE2' ' A' ' 36' ' ' TRP . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' O ' HG22 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' O ' ' OG1' ' A' ' 37' ' ' THR . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.529 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.541 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.572 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.533 ' CG1' HG23 ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -114.46 155.62 45.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.343 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 2' ' ' LYS . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.499 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.548 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.53 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.539 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.634 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 7' ' ' THR . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.548 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.601 ' CE2' HD12 ' A' ' 75' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 72' ' ' ASN . 13.7 p -128.17 107.06 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -24.55 89.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -168.03 43.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.0 109.149 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.5 t 72.05 54.94 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.4 4.3 73.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 37' ' ' THR . . . -44.3 146.71 0.63 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.26 -1.141 . . . . 0.0 109.297 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -80.03 -172.79 3.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' N ' ' CD ' ' A' ' 47' ' ' PRO . . . 82.37 24.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.813 -0.554 . . . . 0.0 112.132 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -67.21 87.71 0.32 Allowed 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.181 1.254 . . . . 0.0 109.968 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.0 OUTLIER 77.58 21.36 1.0 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 46' ' ' ALA . 1.5 pp -138.57 -172.43 3.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.083 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 52' ' ' ASP . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.62 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.634 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.454 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.535 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.601 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.5 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 10.7 t-20 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 7.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -42.13 142.15 1.25 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.455 -0.778 . . . . 0.0 109.608 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' O ' ' OD2' ' A' ' 84' ' ' ASP . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.612 HG22 ' CD2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.719 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.719 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.636 ' N ' ' CD1' ' A' ' 18' ' ' PHE . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.604 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CD2' HG22 ' A' ' 77' ' ' VAL . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' HA ' ' HB3' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 43' ' ' ALA . 2.6 p -136.95 -169.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -59.81 -142.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER 60.07 12.5 3.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t 44.79 50.98 8.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.76 -9.79 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -68.79 179.45 1.77 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.097 -1.237 . . . . 0.0 108.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.68 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -136.94 147.8 46.59 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 163.88 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.1 Cg_endo -69.3 -4.44 13.73 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.764 1.643 . . . . 0.0 110.89 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 6.8 mm-40 -108.0 22.09 16.45 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 173.98 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 52' ' ' ASP . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' HG11 ' A' ' 51' ' ' VAL . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.591 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.698 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.476 ' C ' ' CG ' ' A' ' 66' ' ' LYS . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 39' ' ' GLY . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.68 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' CD2' ' A' ' 26' ' ' PHE . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 81' ' ' LEU . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.579 HG22 ' CG ' ' A' ' 73' ' ' TYR . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' C ' HG21 ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.513 ' CG2' ' OG ' ' A' ' 70' ' ' SER . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.299 0.571 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt -38.89 136.15 0.96 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.776 -0.577 . . . . 0.0 110.059 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.561 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 6' ' ' LEU . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.592 HG22 ' CD2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.539 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.652 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.567 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.666 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 73' ' ' TYR . 1.6 p -137.5 -167.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 47.48 -142.97 6.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -156.83 27.68 0.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -1.115 . . . . 0.0 109.374 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 41' ' ' SER . 1.0 OUTLIER -141.83 6.01 1.78 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.53 -9.57 5.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -51.68 167.61 0.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.271 -1.135 . . . . 0.0 108.812 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.666 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -135.19 148.05 49.56 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.59 -53.88 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 110.36 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.0 Cg_endo -70.48 -3.31 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.052 1.835 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -112.92 21.44 15.45 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.4 pp 174.33 -167.78 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' CE2' ' A' ' 36' ' ' TRP . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.653 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' N ' HG22 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.666 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.525 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 82' ' ' GLY . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' OD1' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG3' ' CG ' ' A' ' 76' ' ' LYS . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG1' HD13 ' A' ' 14' ' ' ILE . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 70' ' ' SER . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -48.74 162.72 0.35 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.289 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.557 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.669 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.531 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.616 HG22 ' CD2' ' A' ' 20' ' ' HIS . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' A' ' 20' ' ' HIS . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.632 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 3' ' ' PRO . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.48 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 13.2 p -97.9 49.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 60.44 -135.63 49.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER 60.37 12.7 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -1.048 . . . . 0.0 109.673 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t 66.53 45.95 1.96 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.061 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 130.47 -23.62 4.51 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -45.68 144.27 1.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.002 -1.293 . . . . 0.0 109.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 73' ' ' TYR . 2.0 mp -50.39 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -100.27 142.55 24.84 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.278 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -70.17 -2.88 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.147 1.898 . . . . 0.0 109.949 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -14.58 60.04 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.363 -0.835 . . . . 0.0 109.075 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -100.58 -173.46 2.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.691 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.54 HG12 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' O ' ' A' ' 54' ' ' LYS . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.609 ' CG2' ' NE1' ' A' ' 36' ' ' TRP . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.619 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.433 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.8 m-80 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.445 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.614 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.545 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' LEU . 20.7 t-20 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.529 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.524 ' CG1' HD13 ' A' ' 14' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OXT' ' HB1' ' A' ' 16' ' ' ALA . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.511 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -46.3 147.55 1.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.57 ' CD1' ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.503 ' CG2' HG11 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.547 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.61 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.645 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.667 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 77' ' ' VAL . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.542 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 43' ' ' ALA . 3.9 p -128.61 53.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' LYS . . . 177.48 -115.71 0.52 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' SER . 13.1 p-10 -118.43 -19.16 8.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 2.0 t 168.84 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.249 -0.907 . . . . 0.0 109.739 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.56 -58.05 1.68 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.546 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -58.09 152.79 15.98 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.237 -1.154 . . . . 0.0 108.872 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -140.4 148.48 41.3 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.01 -52.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.013 -1.055 . . . . 0.0 111.169 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.47 -1.8 9.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.024 1.816 . . . . 0.0 111.101 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -115.76 17.45 16.12 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -161.88 -163.92 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG12 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.588 HG22 ' CE2' ' A' ' 36' ' ' TRP . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 72' ' ' ASN . 1.0 OUTLIER -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.649 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.667 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 73' ' ' TYR . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' OXT' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.302 0.572 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -51.66 143.95 19.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.548 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.555 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 12' ' ' ILE . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.597 HG22 ' CD2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.549 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' HA ' ' OG ' ' A' ' 59' ' ' SER . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.642 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.624 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.553 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.8 p -147.69 179.98 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.5 7.11 9.63 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.866 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.9 t0 37.08 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.125 . . . . 0.0 110.23 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -145.54 8.85 1.18 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.028 -1.045 . . . . 0.0 110.43 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . 123.91 -24.88 6.26 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.588 -1.291 . . . . 0.0 109.917 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -50.63 178.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.18 -1.188 . . . . 0.0 108.609 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.672 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -136.76 143.67 43.37 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.56 -52.48 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.891 -1.131 . . . . 0.0 111.49 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.9 Cg_endo -69.76 -1.52 8.61 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.803 . . . . 0.0 111.336 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -118.12 19.69 13.47 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -162.91 -164.53 0.99 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG12 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' CG ' HG23 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.535 HG23 ' CG ' ' A' ' 54' ' ' LYS . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.591 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.672 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 82' ' ' GLY . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.578 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.642 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.539 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.595 ' CD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.595 ' N ' ' CD2' ' A' ' 1' ' ' LEU . 7.0 mtmm -35.0 149.0 0.11 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.761 -0.587 . . . . 0.0 110.504 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.525 ' CG2' HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.607 HG22 ' CD2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.645 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.652 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.535 ' HB3' ' CG1' ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 35' ' ' THR . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.652 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.592 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.6 p -103.3 -163.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -106.71 103.82 2.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -176.78 31.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.338 179.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 3.5 t 71.82 47.91 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.342 -0.849 . . . . 0.0 110.375 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.21 -2.69 37.67 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.218 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -56.23 164.92 1.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.031 -1.276 . . . . 0.0 108.849 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.633 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -115.8 147.38 41.05 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 168.78 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.539 -0.726 . . . . 0.0 110.247 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.06 -3.94 13.21 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.936 1.757 . . . . 0.0 110.713 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 3.7 mm-40 -114.61 23.32 12.81 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER 171.62 -162.66 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.65 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.645 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.633 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.595 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.51 HG22 ' CD2' ' A' ' 26' ' ' PHE . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 76' ' ' LYS . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.508 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.543 HG22 ' CG ' ' A' ' 73' ' ' TYR . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 2' ' ' LYS . 3.1 pp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.528 ' O ' ' CD1' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -52.32 141.1 33.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.423 -0.798 . . . . 0.0 109.65 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 26' ' ' PHE . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 86' ' ' ALA . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.589 HG22 ' CD2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.642 HG12 ' CE1' ' A' ' 20' ' ' HIS . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.611 HD23 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HD22 ' A' ' 22' ' ' LEU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.477 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.619 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 9.5 p -109.35 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 62.95 -143.55 48.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 1.4 t70 67.18 5.21 4.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -1.028 . . . . 0.0 109.735 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.97 37.17 7.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.203 -0.935 . . . . 0.0 109.785 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.54 -20.91 1.33 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -53.52 142.4 22.5 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.049 -1.265 . . . . 0.0 109.426 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.3 mp -78.72 142.81 36.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 157.24 -60.45 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -69.47 1.0 4.63 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.439 2.093 . . . . 0.0 111.598 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -127.07 9.89 6.86 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 108.958 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER 167.01 -162.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.516 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 62' ' ' PHE . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' CB ' HG23 ' A' ' 14' ' ' ILE . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.504 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.9 m120 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.67 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.619 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.49 ' CG ' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 7' ' ' THR . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 73' ' ' TYR . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.646 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' C ' HG21 ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' A' ' 27' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' N ' HD21 ' A' ' 1' ' ' LEU . 0.1 OUTLIER -116.23 137.72 23.69 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.501 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' CB ' ' HB2' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.585 HG22 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.593 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.668 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.581 ' CG2' ' CD1' ' A' ' 1' ' ' LEU . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.6 p -96.61 -160.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 72' ' ' ASN . . . -111.71 101.97 1.35 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -172.5 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -1.04 . . . . 0.0 109.091 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.469 ' O ' ' OG ' ' A' ' 41' ' ' SER . 2.5 p 68.63 47.26 0.89 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.384 -0.823 . . . . 0.0 110.51 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.65 22.32 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.133 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -60.71 157.5 14.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.048 -1.266 . . . . 0.0 108.951 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.645 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -116.42 147.69 41.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 168.4 -54.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.153 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.21 -3.21 11.85 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.009 1.806 . . . . 0.0 110.801 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 7.9 mp0 -118.45 23.78 11.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER 173.72 -162.8 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.583 HG22 ' CE2' ' A' ' 36' ' ' TRP . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.452 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.523 ' N ' HG22 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.534 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.63 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.419 ' C ' HG21 ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.574 ' CB ' ' N ' ' A' ' 29' ' ' ALA . 4.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt -121.32 128.24 25.77 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.549 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 20' ' ' HIS . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.529 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.628 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.624 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.584 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.549 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.624 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' HD11 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 12.1 p -127.77 83.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.67 -163.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 9.8 t0 71.8 -0.64 3.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -1.111 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t 60.35 45.44 11.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 109.874 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 146.53 -24.79 1.68 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 40' ' ' ASP . . . -43.51 145.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -1.204 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt -98.28 144.89 27.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' N ' ' CD ' ' A' ' 47' ' ' PRO . . . 80.74 37.84 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -68.31 -5.71 15.65 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.608 1.539 . . . . 0.0 109.978 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' C ' HD22 ' A' ' 49' ' ' LEU . 3.9 tt0 -141.47 29.29 1.78 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -159.36 -159.65 0.77 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.17 -0.956 . . . . 0.0 110.18 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 46' ' ' ALA . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.596 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.624 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.628 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' ALA . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 39' ' ' GLY . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.655 ' CD2' ' CD1' ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG22 ' CG ' ' A' ' 73' ' ' TYR . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' C ' HG21 ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.541 ' CD2' HG21 ' A' ' 27' ' ' ILE . 17.8 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.81 143.73 28.84 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.654 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.602 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.669 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' HA ' ' CB ' ' A' ' 59' ' ' SER . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.654 ' HB3' HG12 ' A' ' 5' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 1' ' ' LEU . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.601 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.526 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.655 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.584 HG11 ' CB ' ' A' ' 43' ' ' ALA . 4.8 p -128.53 67.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 136.93 -161.86 25.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -121.41 -17.35 7.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.525 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 t -71.74 -16.06 62.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.277 -0.889 . . . . 0.0 109.75 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.3 -8.59 7.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -48.61 165.19 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.277 -1.131 . . . . 0.0 108.59 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.69 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -140.84 146.55 37.7 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.557 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.9 -53.65 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 110.3 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.51 -11.11 29.34 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.802 . . . . 0.0 110.677 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 8.8 tp10 -102.63 18.27 21.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER 179.32 -159.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.59 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.553 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.7 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' O ' ' OG1' ' A' ' 37' ' ' THR . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.649 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.566 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.574 HG22 ' CG ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 22.1 t-20 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.501 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 87' ' ' ILE . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.533 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 2' ' ' LYS . 2.5 pp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.341 0.591 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 1.4 mttm -61.06 143.78 91.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.512 -0.742 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.57 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.583 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.594 HG22 ' CD2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HA ' HG21 ' A' ' 91' ' ' ILE . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.689 HG12 ' CE1' ' A' ' 20' ' ' HIS . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.689 ' CE1' HG12 ' A' ' 14' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' CG ' ' O ' ' A' ' 56' ' ' SER . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.535 ' N ' HD11 ' A' ' 27' ' ' ILE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.503 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 1.4 p -137.33 -169.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 51.38 -134.03 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.13 25.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -1.116 . . . . 0.0 109.315 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 4.72 1.95 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.294 -0.879 . . . . 0.0 110.057 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.39 -10.08 4.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -50.73 167.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -1.146 . . . . 0.0 108.901 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -134.29 145.16 48.82 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 171.52 -57.06 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.132 -0.98 . . . . 0.0 110.043 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.01 -5.59 17.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.16 1.907 . . . . 0.0 110.274 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.59 15.62 25.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -178.34 -165.37 0.09 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.504 -0.748 . . . . 0.0 109.172 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' O ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.61 ' CZ ' ' CE2' ' A' ' 73' ' ' TYR . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HA ' HG13 ' A' ' 92' ' ' VAL . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.601 HD12 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 8.4 t-20 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.588 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' CD1' ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 73' ' ' TYR . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.576 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.462 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' N ' HD11 ' A' ' 1' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 1' ' ' LEU . 14.8 pttm -42.87 135.06 2.87 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.613 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.601 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 86' ' ' ALA . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' HG21 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HA ' ' CB ' ' A' ' 89' ' ' GLU . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.65 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 20' ' ' HIS . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.668 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.653 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' HG21 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.601 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG13 ' CB ' ' A' ' 43' ' ' ALA . 4.0 p -96.63 -170.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -57.78 -150.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 1.9 t0 71.81 -0.28 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -1.217 . . . . 0.0 110.115 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER 57.71 45.72 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.682 179.792 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.1 -26.66 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -52.58 156.7 1.77 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -1.097 . . . . 0.0 109.396 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.663 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -111.2 -170.68 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 127.62 -48.25 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 31.2 Cg_endo -71.73 -2.68 11.78 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.784 1.656 . . . . 0.0 110.538 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.8 tp10 -123.45 20.58 9.57 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 73' ' ' TYR . 1.7 pp 173.58 -166.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.56 -0.712 . . . . 0.0 109.214 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' CD2' ' A' ' 36' ' ' TRP . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.668 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HD2' ' CA ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB3' HG22 ' A' ' 92' ' ' VAL . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' HG21 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.581 ' CE1' ' HB ' ' A' ' 90' ' ' VAL . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.626 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.553 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HB ' ' CE1' ' A' ' 73' ' ' TYR . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.096 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.59 ' N ' ' CD2' ' A' ' 1' ' ' LEU . 10.0 mttm -45.04 118.61 3.7 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' CD ' ' HA3' ' A' ' 82' ' ' GLY . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.58 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.576 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.648 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.633 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.645 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.56 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.599 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.54 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.548 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.645 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.607 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 5.1 p -101.12 34.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 36.31 94.77 0.01 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . 1.6 m-20 176.44 57.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -1.196 . . . . 0.0 109.417 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 66.13 53.02 1.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.785 . . . . 0.0 109.721 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.9 -4.43 82.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -46.55 148.99 0.85 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.139 -1.212 . . . . 0.0 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -130.73 154.84 47.54 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 166.56 -54.21 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 110.207 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.91 -5.33 16.68 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.053 1.835 . . . . 0.0 110.674 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 16.9 tp10 -107.21 16.68 23.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER 178.26 -161.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.548 ' N ' ' CD ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.6 HG22 ' CE2' ' A' ' 36' ' ' TRP . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.669 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' GLY . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.62 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' CD1' ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.539 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 5' ' ' ILE . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB3' ' CG2' ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.491 ' CD1' HG23 ' A' ' 27' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.329 0.585 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 2.0 ptpp? -43.89 144.22 1.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 0.0 109.417 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' O ' HD11 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.606 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.574 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 20' ' ' HIS . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.63 ' CE1' HG12 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.716 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.606 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.593 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.621 ' CE3' ' HB2' ' A' ' 75' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 3.8 p -129.61 51.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 39.89 -143.42 0.5 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 2.1 t0 78.51 -73.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.676 -0.896 . . . . 0.0 109.751 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 174.76 39.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.22 -0.925 . . . . 0.0 108.872 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.99 25.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -65.58 162.61 17.85 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 109.149 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -128.49 143.46 50.98 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 172.0 -57.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.62 -0.675 . . . . 0.0 109.507 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -71.66 80.98 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.309 2.006 . . . . 0.0 109.814 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.4 mm-40 160.25 -25.17 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -134.59 -167.49 1.98 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 49' ' ' LEU . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 14' ' ' ILE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 86' ' ' ALA . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.55 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -45.27 159.67 0.27 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.692 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.587 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.596 HG22 ' CD2' ' A' ' 20' ' ' HIS . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.647 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.617 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.519 ' N ' HD11 ' A' ' 27' ' ' ILE . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' ' CA ' ' A' ' 28' ' ' GLY . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.646 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' A' ' 43' ' ' ALA . 1.2 p -140.42 -179.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 75.49 -7.7 23.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 76.49 -11.02 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -1.234 . . . . 0.0 110.505 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.7 t 163.79 80.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.026 -1.046 . . . . 0.0 109.615 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.05 31.76 0.43 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -169.57 176.14 5.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.212 -1.169 . . . . 0.0 108.885 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.653 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -137.96 150.98 47.5 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.91 -53.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 111.233 -179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.37 -1.39 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.165 1.91 . . . . 0.0 111.394 -178.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -116.61 15.93 15.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.325 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.599 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -164.17 -164.67 0.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.576 HG22 ' CE2' ' A' ' 36' ' ' TRP . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.606 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.591 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.51 ' N ' HG22 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 37' ' ' THR . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.618 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HG3' ' A' ' 78' ' ' LYS . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.522 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 9' ' ' SER . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.563 HG22 ' CG ' ' A' ' 73' ' ' TYR . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.545 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 1.2 mp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.375 0.607 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp -103.08 122.65 44.71 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.585 -0.697 . . . . 0.0 109.128 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' CD ' ' HG3' ' A' ' 2' ' ' LYS . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' PHE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.507 HG23 ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.57 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.532 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.635 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.635 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.54 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.635 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.643 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' N ' HG11 ' A' ' 24' ' ' VAL . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.643 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 73' ' ' TYR . 3.8 p -132.76 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 156.59 -31.41 0.57 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.542 ' HB2' ' CG ' ' A' ' 74' ' ' LYS . 6.2 t0 62.28 30.78 17.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.14 . . . . 0.0 109.531 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -160.45 20.35 0.15 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.202 -0.936 . . . . 0.0 109.924 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.75 40.93 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.549 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -168.09 148.97 5.05 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.119 -1.224 . . . . 0.0 109.84 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -138.99 149.89 45.22 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 165.13 -53.17 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.326 -179.01 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -70.61 -12.95 32.08 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.966 1.777 . . . . 0.0 110.827 -179.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -99.04 14.32 29.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -174.66 -163.09 0.13 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' HG11 ' A' ' 51' ' ' VAL . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' HB3' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' CE2' ' A' ' 36' ' ' TRP . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.676 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.542 ' CG ' ' HB2' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' HD11 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 5' ' ' ILE . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.545 HG22 HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' HD11 ' A' ' 1' ' ' LEU . 0.1 OUTLIER -42.68 158.14 0.22 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 109.667 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.522 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' CD1' ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 86' ' ' ALA . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG22 ' CD2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 20' ' ' HIS . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.62 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.664 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.664 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG11 ' CB ' ' A' ' 43' ' ' ALA . 2.1 p -135.99 -165.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -58.86 -145.36 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.246 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 2.2 t0 59.05 12.6 2.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 109.84 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 40' ' ' ASP . 10.5 p 43.33 48.22 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.55 -17.46 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.595 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.259 -1.142 . . . . 0.0 108.968 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -130.94 149.98 52.31 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 164.12 -52.71 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.534 -178.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.1 Cg_endo -70.58 -12.33 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.979 1.786 . . . . 0.0 110.748 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.17 15.12 28.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -176.4 -160.96 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.443 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.546 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.532 ' CB ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' A' ' 58' ' ' THR . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.546 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.518 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.666 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.62 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 17' ' ' GLY . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' N ' HG22 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 39' ' ' GLY . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.629 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' CE3' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' CB ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 30' ' ' PRO . 6.8 t-20 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 73' ' ' TYR . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.475 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -69.39 143.96 94.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' PHE . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.587 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' CD2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.6 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.665 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.629 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.518 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.629 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 3.8 p -132.48 56.94 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 133.15 133.56 3.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -12.35 41.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -1.19 . . . . 0.0 109.549 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.12 -7.4 22.93 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.6 -7.21 28.08 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -59.83 164.54 3.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.401 -1.058 . . . . 0.0 108.845 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -138.81 146.48 41.37 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 47' ' ' PRO . . . 169.23 -56.73 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.709 . . . . 0.0 109.978 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.58 -4.41 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.251 1.967 . . . . 0.0 110.625 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.523 ' HG3' ' CD2' ' A' ' 49' ' ' LEU . 9.0 pt-20 -113.22 21.67 15.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER 175.36 -165.43 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.38 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.561 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.557 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.582 HG22 ' CE2' ' A' ' 36' ' ' TRP . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.677 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.539 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' CA ' ' HD2' ' A' ' 2' ' ' LYS . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' C ' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG22 ' CG ' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.522 ' O ' ' CG2' ' A' ' 92' ' ' VAL . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 1' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt -63.68 135.14 96.15 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.37 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 8' ' ' ALA . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.516 ' HB2' ' N ' ' A' ' 87' ' ' ILE . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HD3' ' HB3' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD12 ' CG ' ' A' ' 20' ' ' HIS . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 65' ' ' ALA . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.644 ' N ' ' CD1' ' A' ' 18' ' ' PHE . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.643 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.5 ' N ' HG11 ' A' ' 24' ' ' VAL . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.607 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.533 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.637 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 43' ' ' ALA . 4.7 p -100.92 -174.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -60.67 -139.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . 2.7 t0 66.71 4.87 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -1.221 . . . . 0.0 110.214 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.27 46.52 23.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.111 -0.993 . . . . 0.0 110.096 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.28 -17.92 2.09 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' CB ' ' CG1' ' A' ' 38' ' ' VAL . . . -58.21 154.45 13.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.235 -1.156 . . . . 0.0 109.184 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.629 ' CD2' ' CD1' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -44.99 148.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' A' ' 49' ' ' LEU . . . -52.56 125.48 36.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 110.027 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -2.55 11.25 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.035 1.823 . . . . 0.0 110.28 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 46' ' ' ALA . 2.4 pt-20 -83.06 -12.08 57.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 46' ' ' ALA . 1.1 pp -102.45 -169.88 1.73 Allowed 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.226 -0.922 . . . . 0.0 110.036 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 45' ' ' LEU . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.627 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.485 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 90' ' ' VAL . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.596 HG23 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 3' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' N ' ' OE2' ' A' ' 83' ' ' GLU . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 ' N ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.582 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' O ' HG21 ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 16' ' ' ALA . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.546 ' C ' ' CD2' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.348 0.594 . . . . 0.0 109.575 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' N ' HD21 ' A' ' 1' ' ' LEU . 34.0 mtpt -48.65 137.65 12.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.95 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.596 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.525 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.506 ' HB2' ' N ' ' A' ' 87' ' ' ILE . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.618 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.618 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.613 ' CE1' HG12 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.625 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.587 HG23 ' CZ ' ' A' ' 88' ' ' PHE . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.615 ' CG ' ' O ' ' A' ' 56' ' ' SER . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' HD11 ' A' ' 27' ' ' ILE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.58 ' CB ' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' GLY . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.625 ' CH2' ' CD2' ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 43' ' ' ALA . 9.8 p -105.76 51.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 144.07 154.54 6.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -81.27 -13.85 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.354 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 p -67.0 -8.35 29.31 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.04 25.23 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -48.15 143.85 4.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.256 -1.143 . . . . 0.0 109.656 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD2' HD11 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -45.33 161.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 49' ' ' LEU . . . -84.46 136.8 39.57 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.411 -178.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -10.89 28.39 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.186 1.924 . . . . 0.0 109.669 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' A' ' 46' ' ' ALA . 6.8 pt-20 -68.48 -19.62 64.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -110.16 -167.92 1.25 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.492 -0.755 . . . . 0.0 109.016 179.416 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' CD1' ' A' ' 36' ' ' TRP . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 36' ' ' TRP . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.657 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 10.5 t-20 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.596 HD11 ' CD2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' ' HB3' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 73' ' ' TYR . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.638 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 7' ' ' THR . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 89' ' ' GLU . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.887 HG23 ' NE2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.776 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.761 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.887 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' GLU . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CG ' HG21 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.002 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.927 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.925 ' CH2' HD21 ' A' ' 22' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 43' ' ' ALA . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.327 0.584 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.779 HD11 HD23 ' A' ' 45' ' ' LEU . 1.8 pp . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 60' ' ' ILE . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.761 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.97 ' O ' HG11 ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 74' ' ' LYS . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.714 ' CG ' HG21 ' A' ' 90' ' ' VAL . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.921 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.714 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 13' ' ' LYS . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.97 HG11 ' O ' ' A' ' 66' ' ' LYS . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.869 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.697 HD13 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 63' ' ' PRO . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.869 ' NE2' HG21 ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.773 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.671 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG21 ' CH2' ' A' ' 36' ' ' TRP . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.642 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.662 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.938 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.938 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.768 ' CE2' HD13 ' A' ' 75' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.583 0.706 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.743 0.783 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.979 HG13 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.642 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.979 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.768 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 19' ' ' THR . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.799 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 70' ' ' SER . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.891 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 80' ' ' GLU . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.955 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.955 ' N ' HD13 ' A' ' 87' ' ' ILE . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' OE1' HD11 ' A' ' 91' ' ' ILE . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.645 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 66' ' ' LYS . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 2' ' ' LYS . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.762 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.588 ' HB ' HG13 ' A' ' 24' ' ' VAL . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.896 HG22 ' CG1' ' A' ' 14' ' ' ILE . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.896 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.774 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.875 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 23' ' ' GLU . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.762 ' CB ' HD12 ' A' ' 5' ' ' ILE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.773 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.875 ' CH2' HD21 ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.945 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.1 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.945 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 36' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.55 0.69 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.768 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.864 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' HG21 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 45' ' ' LEU . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' THR . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.77 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.508 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.864 HG11 ' C ' ' A' ' 66' ' ' LYS . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HE3' HG21 ' A' ' 27' ' ' ILE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.627 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.596 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.888 ' O ' HG22 ' A' ' 91' ' ' ILE . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HD1' HG23 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.942 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.721 ' CG ' HG21 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.716 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.942 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.691 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.7 p . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.108 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.108 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.605 0.716 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.563 HG22 ' CG ' ' A' ' 54' ' ' LYS . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.742 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.668 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.721 HG21 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 39.8 t30 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.619 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.604 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.784 ' N ' HD13 ' A' ' 87' ' ' ILE . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.888 HG22 ' O ' ' A' ' 12' ' ' ILE . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' A' ' 14' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.66 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.697 ' CG2' HG13 ' A' ' 24' ' ' VAL . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.959 HG21 ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.691 HD13 ' CG ' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 66' ' ' LYS . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.959 ' NE2' HG21 ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.913 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 ' CG2' ' A' ' 7' ' ' THR . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.02 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.02 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.671 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.913 ' CH2' HD21 ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 38' ' ' VAL . 10.7 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.61 0.719 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.083 HD21 ' CE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.08 HD11 HD23 ' A' ' 45' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.837 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.889 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.889 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.615 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.866 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.517 ' CA ' HG23 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' VAL . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.083 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.671 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.66 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.866 HG11 ' C ' ' A' ' 66' ' ' LYS . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.1 mtmp? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' H ' HG23 ' A' ' 7' ' ' THR . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.578 ' HB2' HG22 ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' O ' HD13 ' A' ' 12' ' ' ILE . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.926 HG23 ' NE2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.875 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.734 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.786 ' HE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.926 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.89 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CD2' HD12 ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 34' ' ' ALA . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.966 ' CE2' HD13 ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.5 p . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.75 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.155 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.155 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.861 HG13 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.861 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.735 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.743 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.515 ' O ' HG11 ' A' ' 92' ' ' VAL . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.526 ' N ' HG23 ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' VAL . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.966 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.649 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 12' ' ' ILE . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 69' ' ' ASP . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.759 HG22 ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.861 HG23 ' NE2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.771 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.665 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.902 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.902 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.724 HG22 HG23 ' A' ' 37' ' ' THR . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.927 ' CH2' HD21 ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.724 HG23 HG22 ' A' ' 35' ' ' THR . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.641 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.866 0.841 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.907 ' O ' HD13 ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.911 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.869 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.453 ' CA ' HG23 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' VAL . 10.4 m-80 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.898 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 50.8 t30 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' HA3' ' HD2' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB2' HG22 ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.576 ' CG ' HD11 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.807 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 66' ' ' LYS . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 2.3 pt20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.79 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.69 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.572 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.894 HG23 ' NE2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.894 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.947 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.873 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.405 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.947 ' CH2' HD21 ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.0 p . . . . . 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.803 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.931 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.887 HG13 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.887 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.912 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.931 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.691 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.439 ' N ' HG23 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 51.4 t30 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.69 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.699 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 12' ' ' ILE . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.691 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.651 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.87 ' HB ' HG22 ' A' ' 90' ' ' VAL . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.772 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.847 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.63 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.533 ' N ' HD13 ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.004 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.004 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.618 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.2 p . . . . . 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.607 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.6 HD23 ' CG ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.823 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.895 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HD3' HG23 ' A' ' 87' ' ' ILE . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.784 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.531 ' CB ' ' HA ' ' A' ' 2' ' ' LYS . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.789 HG23 ' HD3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HD11 ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.87 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' HG2' ' A' ' 89' ' ' GLU . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.895 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.867 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD1' ' HE3' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.877 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.793 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.877 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.887 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.855 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.887 ' CH2' HD21 ' A' ' 22' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.046 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.046 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.025 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 62' ' ' PHE . 1.5 pp . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.31 0.576 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.932 HD12 HD22 ' A' ' 45' ' ' LEU . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.694 ' O ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.684 ' C ' HG11 ' A' ' 92' ' ' VAL . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.025 ' CD2' HD11 ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 30.0 t30 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.867 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.019 ' N ' HD13 ' A' ' 87' ' ' ILE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.684 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.838 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.603 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.924 HG23 ' NE2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.874 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.774 ' CE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.924 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.962 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 23' ' ' GLU . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.962 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.6 p . . . . . 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' A' ' 59' ' ' SER . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.752 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 19' ' ' THR . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.706 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.843 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.523 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.848 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.838 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.737 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.889 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.592 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.884 HG23 ' NE2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.884 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.858 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.931 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.6 p . . . . . 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.804 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 45' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 51' ' ' VAL . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.703 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.851 ' C ' HG11 ' A' ' 92' ' ' VAL . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.743 ' CD1' HG23 ' A' ' 38' ' ' VAL . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' CE ' ' OE2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.859 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.889 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.641 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 73' ' ' TYR . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 91' ' ' ILE . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.851 HG11 ' C ' ' A' ' 66' ' ' LYS . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.864 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.865 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.879 HG22 ' CG1' ' A' ' 14' ' ' ILE . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.879 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.945 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 7' ' ' THR . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.71 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.977 ' CD2' HG21 ' A' ' 77' ' ' VAL . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.688 HG22 ' H ' ' A' ' 28' ' ' GLY . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.015 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.945 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 38' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.45 0.643 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.852 HD22 ' HB3' ' A' ' 36' ' ' TRP . 2.0 mp . . . . . 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.691 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 122.245 1.021 . . . . 0.0 110.691 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.906 HG13 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.71 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.906 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.647 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.924 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.708 ' O ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.924 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.599 ' CA ' HG23 ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' VAL . 3.3 m120 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.618 ' CD2' HD21 ' A' ' 45' ' ' LEU . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.977 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 41.8 t30 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 9' ' ' SER . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' N ' HD13 ' A' ' 87' ' ' ILE . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' CD ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.625 ' N ' HG22 ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.852 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.914 HG21 HG13 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.66 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 93' ' ' GLN . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.667 ' HB2' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.66 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.935 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG21 ' A' ' 7' ' ' THR . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.852 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.552 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.935 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.9 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.763 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.074 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.074 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.892 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.892 ' CG2' HG13 ' A' ' 51' ' ' VAL . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.66 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.621 ' CA ' HG23 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 1.9 m-20 -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 38' ' ' VAL . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.821 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 83' ' ' GLU . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.734 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.499 HG23 ' HG2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' HA ' ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.66 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.667 ' OXT' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.737 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.679 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 89' ' ' GLU . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.839 HG23 ' NE2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.78 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.839 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.952 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.719 ' OD1' HD11 ' A' ' 6' ' ' LEU . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.952 ' CH2' HD21 ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.8 p . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.947 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.003 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.003 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.919 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.619 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.919 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.746 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.814 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.866 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.679 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.645 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 12' ' ' ILE . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.814 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 7.0 mtmm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.56 0.219 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.628 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.79 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.876 HG23 ' NE2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.847 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.876 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.628 HG13 ' CG2' ' A' ' 7' ' ' THR . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.625 ' HB3' HD12 ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.964 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 76' ' ' LYS . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.987 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.73 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.987 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.915 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.915 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.971 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG13 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.708 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.971 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.72 ' C ' HG11 ' A' ' 92' ' ' VAL . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.767 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 35' ' ' THR . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.566 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.517 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.723 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.631 HG22 ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.72 HG11 ' C ' ' A' ' 66' ' ' LYS . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.839 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.604 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.843 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.801 ' CG1' HG22 ' A' ' 12' ' ' ILE . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.843 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.599 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.893 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 45' ' ' LEU . 9.5 p . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.443 0.639 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.079 HD21 ' CD2' ' A' ' 73' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.96 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.96 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' CB ' ' OD2' ' A' ' 69' ' ' ASP . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.853 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 38' ' ' VAL . 9.2 m-80 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.079 ' CD2' HD21 ' A' ' 45' ' ' LEU . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.839 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.728 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.853 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.913 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.007 HG21 ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.784 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 1.007 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG21 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.58 ' HB3' HD12 ' A' ' 5' ' ' ILE . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.986 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.986 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.029 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.715 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 1.029 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.694 ' C ' HG11 ' A' ' 92' ' ' VAL . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.619 ' CA ' HG23 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.681 ' OD1' HD11 ' A' ' 87' ' ' ILE . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CG ' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.791 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.913 ' CG ' HG22 ' A' ' 5' ' ' ILE . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.031 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.031 ' N ' HD13 ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.687 HG21 ' CG ' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.584 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.82 HG22 ' CG1' ' A' ' 14' ' ' ILE . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.82 ' CG1' HG22 ' A' ' 12' ' ' ILE . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.771 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.698 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 34' ' ' ALA . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.995 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.939 ' CH2' HD21 ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.873 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.21 0.529 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.872 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 60' ' ' ILE . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.882 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.872 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.67 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 92' ' ' VAL . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.966 ' CD2' HD11 ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.878 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.032 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.032 ' N ' HD13 ' A' ' 87' ' ' ILE . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 12' ' ' ILE . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' C ' HG23 ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.6 HG21 ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.7 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.617 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.759 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.7 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.926 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG13 ' CG2' ' A' ' 7' ' ' THR . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.582 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.944 ' C ' HD12 ' A' ' 27' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.944 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.983 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.983 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 75' ' ' LEU . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.926 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.8 p . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.745 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.582 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.795 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.742 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HA ' HG22 ' A' ' 19' ' ' THR . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.595 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.717 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.83 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.83 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 6.9 t30 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD12 ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 5' ' ' ILE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.623 ' N ' HG22 ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.549 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 1.4 mttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.044 HG23 ' NE2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 92' ' ' VAL . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 93' ' ' GLN . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 1.044 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.888 HD21 ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 ' HH2' ' A' ' 36' ' ' TRP . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.925 ' C ' HD12 ' A' ' 27' ' ' ILE . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.925 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.888 ' CH2' HD21 ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.701 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.883 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.816 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.53 0.681 . . . . 0.0 109.172 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.911 HD23 ' HG3' ' A' ' 63' ' ' PRO . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CG2' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.981 ' CG2' HG13 ' A' ' 51' ' ' VAL . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.911 ' HG3' HD23 ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.791 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.821 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.708 ' CD1' HG21 ' A' ' 90' ' ' VAL . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.682 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.512 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 53.3 t30 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 5' ' ' ILE . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.668 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.932 HD11 ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.932 ' HG3' HD11 ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CG2' ' A' ' 12' ' ' ILE . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 1.096 HD13 ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.096 ' N ' HD13 ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.8 pttm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.741 HG21 HG13 ' A' ' 24' ' ' VAL . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.78 ' HA ' HG23 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.73 ' O ' HD13 ' A' ' 12' ' ' ILE . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.76 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.636 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.76 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' C ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.862 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.637 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' HB3' HD12 ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.719 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.977 ' CH2' HD21 ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 4.0 p . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.608 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.816 HG13 ' CG2' ' A' ' 60' ' ' ILE . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.816 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.729 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 90' ' ' VAL . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.887 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.618 ' CG ' ' HH ' ' A' ' 73' ' ' TYR . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 38' ' ' VAL . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.619 ' HE2' HD21 ' A' ' 49' ' ' LEU . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 81' ' ' LEU . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.612 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.78 HG23 ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.862 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 62' ' ' PHE . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.887 HG11 ' C ' ' A' ' 66' ' ' LYS . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.0 mttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.774 ' N ' HD22 ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.794 ' HB ' HG13 ' A' ' 90' ' ' VAL . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.681 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.67 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.67 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CD1' HG21 ' A' ' 77' ' ' VAL . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.506 ' HG2' ' HA ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.943 ' CE2' HD13 ' A' ' 75' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 5.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.901 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.82 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.75 HD21 HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.049 HD13 ' N ' ' A' ' 51' ' ' VAL . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.049 ' N ' HD13 ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.551 HG22 ' CG ' ' A' ' 54' ' ' LYS . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.651 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.79 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.641 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 87' ' ' ILE . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.943 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.899 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.59 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.565 ' CB ' HG21 ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 12' ' ' ILE . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.79 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 2.0 ptpp? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.584 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.831 ' O ' HG13 ' A' ' 92' ' ' VAL . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HG3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.683 ' HD1' HG23 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.759 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.739 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.547 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.946 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.946 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.739 ' CH2' HD21 ' A' ' 22' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.986 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.986 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.759 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.773 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.439 ' CA ' HG23 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' VAL . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.733 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' THR . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.615 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.999 ' N ' HD13 ' A' ' 87' ' ' ILE . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.466 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.676 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 7' ' ' THR . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.606 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.854 ' HB ' HG22 ' A' ' 90' ' ' VAL . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.849 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.924 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 7' ' ' THR . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 28' ' ' GLY . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.707 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.948 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.924 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.2 p . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.101 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.101 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.931 HG13 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.931 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.655 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.605 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.811 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.481 ' CA ' HG23 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.747 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.643 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.081 ' N ' HD13 ' A' ' 87' ' ' ILE . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' HB ' ' A' ' 12' ' ' ILE . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.811 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 5' ' ' ILE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.599 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 HG23 ' HE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.695 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.695 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 24' ' ' VAL . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 7' ' ' THR . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 77' ' ' VAL . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.812 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.059 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.059 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.438 0.637 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.663 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.794 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 51' ' ' VAL . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HB2' HG22 ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.828 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' HG12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.969 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.969 ' OD1' HG22 ' A' ' 77' ' ' VAL . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.731 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.732 ' N ' HD13 ' A' ' 87' ' ' ILE . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.878 HG23 ' NE2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.789 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.878 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.814 ' CB ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.877 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.877 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.1 p . . . . . 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.822 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.674 ' CA ' HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.82 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.652 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.952 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.486 ' CA ' HG23 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.652 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 6.4 t30 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.071 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 1.071 ' N ' HD13 ' A' ' 87' ' ' ILE . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 12' ' ' ILE . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.952 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.472 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.837 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.865 HG23 ' NE2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.934 ' HA ' HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.777 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.865 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 23' ' ' GLU . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.862 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.903 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.903 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.821 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.74 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.876 ' C ' HG11 ' A' ' 92' ' ' VAL . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 92' ' ' VAL . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' OD1' ' HG3' ' A' ' 89' ' ' GLU . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.716 ' HB2' HG23 ' A' ' 90' ' ' VAL . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.79 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.872 HD12 ' N ' ' A' ' 82' ' ' GLY . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.837 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.526 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.934 HG22 ' HA ' ' A' ' 13' ' ' LYS . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.876 HG11 ' C ' ' A' ' 66' ' ' LYS . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.773 HG22 ' HB3' ' A' ' 84' ' ' ASP . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.712 HG21 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . 1.012 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HD3' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.911 ' HB ' HG13 ' A' ' 90' ' ' VAL . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.841 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.814 HG22 ' HA ' ' A' ' 63' ' ' PRO . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.905 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.859 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG21 ' A' ' 7' ' ' THR . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.963 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.805 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.962 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.962 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.699 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.682 HG21 ' NZ ' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.859 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.71 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 4.7 p . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.759 HD21 ' HD2' ' A' ' 73' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 49' ' ' LEU . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HB2' HG22 ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.852 ' CG2' HG13 ' A' ' 51' ' ' VAL . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.692 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.676 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.814 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.759 ' HD2' HD21 ' A' ' 45' ' ' LEU . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' NZ ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.773 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.752 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.911 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.715 ' H ' HG22 ' A' ' 91' ' ' ILE . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.659 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.774 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.566 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' H ' HG23 ' A' ' 7' ' ' THR . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.706 ' CB ' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' HB ' HG13 ' A' ' 90' ' ' VAL . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.705 HG23 ' HD1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.696 HG22 ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.705 ' HD1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.902 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG21 ' HH2' ' A' ' 36' ' ' TRP . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.884 ' C ' HD12 ' A' ' 27' ' ' ILE . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.998 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.902 ' CH2' HD21 ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.46 0.648 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.039 HD23 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD11 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.98 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.903 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB2' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.903 ' CG2' HG13 ' A' ' 51' ' ' VAL . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.709 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.98 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' O ' HG21 ' A' ' 92' ' ' VAL . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.533 ' ND2' ' HB2' ' A' ' 74' ' ' LYS . 2.3 t30 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.533 ' HB2' ' ND2' ' A' ' 72' ' ' ASN . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.624 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.705 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.815 ' N ' HD22 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.991 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 66' ' ' LYS . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.719 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt -82.99 149.12 58.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.638 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 7' ' ' THR . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 89' ' ' GLU . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.887 HG23 ' NE2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.776 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.761 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.887 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' GLU . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CG ' HG21 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.002 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.927 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.925 ' CH2' HD21 ' A' ' 22' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 43' ' ' ALA . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -96.26 39.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 39.32 87.13 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -179.18 62.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.111 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.4 52.36 1.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.0 109.341 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.15 4.82 74.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 37' ' ' THR . . . -43.26 147.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.35 -1.088 . . . . 0.0 109.703 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.56 38.21 2.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.915 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . -80.25 -55.15 0.79 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.664 . . . . 0.0 110.9 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.32 1.26 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.125 1.884 . . . . 0.0 111.34 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -114.38 12.72 17.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 108.611 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.779 HD11 HD23 ' A' ' 45' ' ' LEU . 1.8 pp 167.63 -171.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 60' ' ' ILE . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.761 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.97 ' O ' HG11 ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' GLY . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.714 ' CG ' HG21 ' A' ' 90' ' ' VAL . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.507 ' HG3' ' CA ' ' A' ' 39' ' ' GLY . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.921 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.77 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.714 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 13' ' ' LYS . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.97 HG11 ' O ' ' A' ' 66' ' ' LYS . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.631 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mm? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.277 0.56 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? -95.42 152.25 39.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.413 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.869 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.697 HD13 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 63' ' ' PRO . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.869 ' NE2' HG21 ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.773 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.671 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG21 ' CH2' ' A' ' 36' ' ' TRP . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.642 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.662 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.938 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.938 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.768 ' CE2' HD13 ' A' ' 75' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.1 p -115.92 50.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . 61.3 -144.57 48.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.67 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER 65.57 6.66 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.836 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.03 47.34 4.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.832 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 138.8 -27.54 2.69 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' O ' HG22 ' A' ' 37' ' ' THR . . . -44.65 141.57 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.288 . . . . 0.0 109.791 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -95.96 140.21 31.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 155.51 -59.77 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.805 -0.559 . . . . 0.0 110.46 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 1.025 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.8 Cg_endo -70.02 79.98 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.402 2.068 . . . . 0.0 110.308 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 3.9 mt-10 157.83 -15.65 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -165.28 -168.26 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.796 -1.19 . . . . 0.0 111.402 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.979 HG13 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.642 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.979 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.768 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 19' ' ' THR . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.799 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 70' ' ' SER . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.512 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 73.6 m-20 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.891 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 80' ' ' GLU . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.955 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.955 ' N ' HD13 ' A' ' 87' ' ' ILE . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' OE1' HD11 ' A' ' 91' ' ' ILE . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.645 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 66' ' ' LYS . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 50.39 167.18 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 2' ' ' LYS . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.762 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.588 ' HB ' HG13 ' A' ' 24' ' ' VAL . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.896 HG22 ' CG1' ' A' ' 14' ' ' ILE . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.896 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.774 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.875 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 23' ' ' GLU . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.762 ' CB ' HD12 ' A' ' 5' ' ' ILE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.773 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.954 ' H ' HD23 ' A' ' 1' ' ' LEU . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.875 ' CH2' HD21 ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.945 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' GLY . 7.1 p -109.07 179.13 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 84.44 -141.89 20.01 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.1 p-10 -115.69 -21.25 9.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -1.122 . . . . 0.0 109.642 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.9 t 165.71 71.73 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.154 -0.967 . . . . 0.0 109.84 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.48 -34.07 0.27 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . -81.02 150.17 28.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.945 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -50.33 165.62 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -82.56 132.11 53.16 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.52 -5.14 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.124 1.883 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -73.71 -17.74 61.09 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -104.24 -167.44 1.36 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.768 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.864 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' HG21 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 45' ' ' LEU . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.77 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.508 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.864 HG11 ' C ' ' A' ' 66' ' ' LYS . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.906 HD13 ' H1 ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.579 0.704 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt -45.7 140.12 4.63 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.581 -0.699 . . . . 0.0 109.608 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HE3' HG21 ' A' ' 27' ' ' ILE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.627 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.596 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.888 ' O ' HG22 ' A' ' 91' ' ' ILE . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HD1' HG23 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.942 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.721 ' CG ' HG21 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.716 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.942 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.7 p -111.79 -168.15 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -64.56 -140.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.76 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER 63.02 9.48 3.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -1.095 . . . . 0.0 109.859 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER 44.34 50.46 7.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.307 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.6 -13.58 1.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' THR . . . -71.11 170.46 12.87 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.193 -1.18 . . . . 0.0 108.95 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.108 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.36 151.94 51.51 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.35 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -70.61 -0.83 8.22 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.296 1.997 . . . . 0.0 111.404 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.031 ' O ' HD23 ' A' ' 49' ' ' LEU . 2.4 mt-10 -114.9 14.11 17.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.108 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -162.7 -164.02 0.95 Allowed 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.463 -0.773 . . . . 0.0 109.448 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.563 HG22 ' CG ' ' A' ' 54' ' ' LYS . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.742 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.668 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.721 HG21 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 39.8 t30 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.619 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.604 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.784 ' N ' HD13 ' A' ' 87' ' ' ILE . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.888 HG22 ' O ' ' A' ' 12' ' ' ILE . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' A' ' 14' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.76 ' N ' HD22 ' A' ' 1' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.314 0.578 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt -34.51 131.54 0.43 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 122.143 -0.348 . . . . 0.0 110.447 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.66 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.697 ' CG2' HG13 ' A' ' 24' ' ' VAL . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.959 HG21 ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.691 HD13 ' CG ' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 66' ' ' LYS . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.959 ' NE2' HG21 ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.913 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 ' CG2' ' A' ' 7' ' ' THR . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.02 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.02 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.671 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.913 ' CH2' HD21 ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 38' ' ' VAL . 10.7 p -113.46 49.87 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.29 -142.39 48.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.1 t70 66.21 6.48 4.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -1.064 . . . . 0.0 109.748 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 64.85 40.56 5.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.74 -24.46 2.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 37' ' ' THR . . . -47.3 142.34 4.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.956 -1.32 . . . . 0.0 109.556 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.083 HD21 ' CE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -88.29 164.24 15.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.695 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 120.96 -45.87 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.17 1.32 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.834 1.689 . . . . 0.0 111.568 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 43.3 mt-10 -134.36 22.54 3.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.08 HD11 HD23 ' A' ' 45' ' ' LEU . 1.1 pp 164.58 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.837 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.889 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.615 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.866 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.517 ' CA ' HG23 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.083 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.671 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.66 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.866 HG11 ' C ' ' A' ' 66' ' ' LYS . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.83 HD11 HG22 ' A' ' 27' ' ' ILE . 2.2 pp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.664 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 1' ' ' LEU . 4.1 mtmp? -54.05 141.91 48.09 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.554 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' H ' HG23 ' A' ' 7' ' ' THR . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.578 ' HB2' HG22 ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' O ' HD13 ' A' ' 12' ' ' ILE . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.926 HG23 ' NE2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.875 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.734 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.786 ' HE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.926 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.89 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CD2' HD12 ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 1' ' ' LEU . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 34' ' ' ALA . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.966 ' CE2' HD13 ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.5 p -127.75 52.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 72' ' ' ASN . . . 167.69 -141.29 6.75 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 41' ' ' SER . 3.7 p30 -89.09 47.5 1.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -1.11 . . . . 0.0 109.648 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER 83.1 -28.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.648 -0.657 . . . . 0.0 110.506 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.23 -56.22 4.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 37' ' ' THR . . . -60.82 153.61 24.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.609 -0.936 . . . . 0.0 108.593 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.75 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.155 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -138.51 148.55 44.41 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.87 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 167.85 -54.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.716 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.87 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -71.18 -1.2 9.21 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.293 1.995 . . . . 0.0 111.105 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.03 ' O ' HD23 ' A' ' 49' ' ' LEU . 13.9 mt-10 -117.78 12.14 13.79 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.155 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.69 -163.98 1.05 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.861 HG13 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.861 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.735 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.743 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.515 ' O ' HG11 ' A' ' 92' ' ' VAL . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.526 ' N ' HG23 ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.966 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.649 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 12' ' ' ILE . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 69' ' ' ASP . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.46 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -64.71 145.14 98.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.759 HG22 ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.861 HG23 ' NE2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.771 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.665 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.902 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.902 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.724 HG22 HG23 ' A' ' 37' ' ' THR . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.927 ' CH2' HD21 ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.724 HG23 HG22 ' A' ' 35' ' ' THR . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.641 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -99.15 41.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 38.47 88.36 0.01 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.7 m-20 179.13 62.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 65.61 52.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.55 3.75 73.04 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' THR . . . -42.32 146.45 0.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -1.055 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.61 36.4 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . -75.06 -58.37 1.57 Allowed Pre-proline 0 C--N 1.298 -1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.556 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -70.6 80.14 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.465 2.11 . . . . 0.0 110.723 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 47' ' ' PRO . 1.4 tt0 161.11 -22.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -137.27 -165.61 1.79 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.329 -0.857 . . . . 0.0 109.787 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.907 ' O ' HD13 ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.911 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.869 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.453 ' CA ' HG23 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' GLY . 10.4 m-80 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.898 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 50.8 t30 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' HA3' ' HD2' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB2' HG22 ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.576 ' CG ' HD11 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.807 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 66' ' ' LYS . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 2.3 pt20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 5.8 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER -44.02 132.81 4.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.79 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.69 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.572 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.894 HG23 ' NE2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.894 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.947 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.873 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.405 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.947 ' CH2' HD21 ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.0 p -133.71 77.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 37.57 -152.97 0.02 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 t0 70.15 1.8 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 t 53.89 46.61 25.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.325 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.67 -21.16 0.91 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 37' ' ' THR . . . -69.43 164.89 22.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.38 -1.07 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.803 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -139.56 144.99 38.08 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.979 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 172.57 -57.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.734 -0.603 . . . . 0.0 109.441 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.5 Cg_endo -71.58 82.05 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.309 2.006 . . . . 0.0 110.025 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 9.6 tt0 159.34 -25.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -142.25 -166.29 2.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.931 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.887 HG13 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.887 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.912 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.931 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.691 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.439 ' N ' HG23 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.561 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 51.4 t30 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.69 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.699 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 12' ' ' ILE . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.691 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 1.5 mm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -135.9 139.86 31.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.391 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.651 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.87 ' HB ' HG22 ' A' ' 90' ' ' VAL . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.772 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.847 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.63 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.533 ' N ' HD13 ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.004 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.004 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.618 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.2 p -128.03 63.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.61 -154.44 0.39 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER 74.37 -1.89 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -1.053 . . . . 0.0 109.94 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 41' ' ' SER . 4.4 p 57.94 47.26 15.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.082 -1.011 . . . . 0.0 109.27 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.58 -14.55 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 37' ' ' THR . . . -79.71 160.9 26.09 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.27 -1.135 . . . . 0.0 109.099 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.607 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -140.51 146.04 37.64 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.799 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 163.97 -52.38 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.845 . . . . 0.0 110.373 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.48 -14.46 33.83 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.953 1.769 . . . . 0.0 110.897 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.859 ' HG2' HD23 ' A' ' 49' ' ' LEU . 3.3 pt-20 -100.95 14.58 31.43 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -171.62 -164.13 0.31 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.6 HD23 ' CG ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.823 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.895 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HD3' HG23 ' A' ' 87' ' ' ILE . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.784 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.531 ' CB ' ' HA ' ' A' ' 2' ' ' LYS . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.789 HG23 ' HD3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HD11 ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.87 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' HG2' ' A' ' 89' ' ' GLU . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.895 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.578 HD13 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -114.46 155.62 45.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.343 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.867 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD1' ' HE3' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.877 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.793 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.877 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.887 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.855 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.887 ' CH2' HD21 ' A' ' 22' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.046 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -128.17 107.06 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -24.55 89.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -168.03 43.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.0 109.149 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.5 t 72.05 54.94 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.4 4.3 73.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.046 ' O ' HG22 ' A' ' 37' ' ' THR . . . -44.3 146.71 0.63 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.26 -1.141 . . . . 0.0 109.297 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.025 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -80.03 -172.79 3.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' N ' ' CD ' ' A' ' 47' ' ' PRO . . . 82.37 24.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.813 -0.554 . . . . 0.0 112.132 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.87 ' HD2' HD21 ' A' ' 49' ' ' LEU . 30.4 Cg_endo -67.21 87.71 0.32 Allowed 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.181 1.254 . . . . 0.0 109.968 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.0 OUTLIER 77.58 21.36 1.0 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.87 HD21 ' HD2' ' A' ' 47' ' ' PRO . 1.5 pp -138.57 -172.43 3.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.083 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.932 HD12 HD22 ' A' ' 45' ' ' LEU . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' O ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.684 ' C ' HG11 ' A' ' 92' ' ' VAL . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.025 ' CD2' HD11 ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 30.0 t30 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.867 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.019 ' N ' HD13 ' A' ' 87' ' ' ILE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.684 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.642 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 7.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -42.13 142.15 1.25 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.455 -0.778 . . . . 0.0 109.608 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.838 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.603 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.924 HG23 ' NE2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.874 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.774 ' CE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.924 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.962 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 23' ' ' GLU . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.962 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.6 p -136.95 -169.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.721 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -59.81 -142.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.829 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER 60.07 12.5 3.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t 44.79 50.98 8.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.76 -9.79 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . -68.79 179.45 1.77 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.097 -1.237 . . . . 0.0 108.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.94 147.8 46.59 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 163.88 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.1 Cg_endo -69.3 -4.44 13.73 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.764 1.643 . . . . 0.0 110.89 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . 6.8 mm-40 -108.0 22.09 16.45 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 173.98 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' A' ' 59' ' ' SER . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.752 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 19' ' ' THR . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 39' ' ' GLY . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.706 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.843 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.523 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.848 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.838 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.737 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.299 0.571 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt -38.89 136.15 0.96 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.776 -0.577 . . . . 0.0 110.059 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.889 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.592 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.884 HG23 ' NE2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.884 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.858 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.931 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.6 p -137.5 -167.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.676 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 47.48 -142.97 6.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -156.83 27.68 0.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -1.115 . . . . 0.0 109.374 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 41' ' ' SER . 1.0 OUTLIER -141.83 6.01 1.78 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.53 -9.57 5.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 37' ' ' THR . . . -51.68 167.61 0.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.271 -1.135 . . . . 0.0 108.812 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.804 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.19 148.05 49.56 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.59 -53.88 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 110.36 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.0 Cg_endo -70.48 -3.31 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.052 1.835 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -112.92 21.44 15.45 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 45' ' ' LEU . 1.4 pp 174.33 -167.78 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 51' ' ' VAL . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.703 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.851 ' C ' HG11 ' A' ' 92' ' ' VAL . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.743 ' CD1' HG23 ' A' ' 38' ' ' VAL . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' CE ' ' OE2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.859 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.889 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.641 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 73' ' ' TYR . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 91' ' ' ILE . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.851 HG11 ' C ' ' A' ' 66' ' ' LYS . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 1' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -48.74 162.72 0.35 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.289 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.864 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.865 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.879 HG22 ' CG1' ' A' ' 14' ' ' ILE . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.879 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.945 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 7' ' ' THR . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.71 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.977 ' CD2' HG21 ' A' ' 77' ' ' VAL . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.688 HG22 ' H ' ' A' ' 28' ' ' GLY . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.015 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.945 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 38' ' ' VAL . 13.2 p -97.9 49.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 60.44 -135.63 49.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.736 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER 60.37 12.7 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -1.048 . . . . 0.0 109.673 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t 66.53 45.95 1.96 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.061 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 130.47 -23.62 4.51 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -45.68 144.27 1.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.002 -1.293 . . . . 0.0 109.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.852 HD22 ' HB3' ' A' ' 36' ' ' TRP . 2.0 mp -50.39 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 49' ' ' LEU . . . -100.27 142.55 24.84 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.278 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -70.17 -2.88 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.147 1.898 . . . . 0.0 109.949 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -14.58 60.04 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.363 -0.835 . . . . 0.0 109.075 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.691 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -100.58 -173.46 2.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.691 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.906 HG13 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.71 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.906 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.647 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.924 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.708 ' O ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.924 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.599 ' CA ' HG23 ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.3 m120 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.618 ' CD2' HD21 ' A' ' 45' ' ' LEU . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.977 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 41.8 t30 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 9' ' ' SER . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' N ' HD13 ' A' ' 87' ' ' ILE . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' CD ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.625 ' N ' HG22 ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.626 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -46.3 147.55 1.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.852 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.914 HG21 HG13 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.66 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 93' ' ' GLN . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.667 ' HB2' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.66 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.935 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG21 ' A' ' 7' ' ' THR . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.852 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.552 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.935 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.9 p -128.61 53.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . . . 177.48 -115.71 0.52 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' SER . 13.1 p-10 -118.43 -19.16 8.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 2.0 t 168.84 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.249 -0.907 . . . . 0.0 109.739 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.56 -58.05 1.68 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 37' ' ' THR . . . -58.09 152.79 15.98 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.237 -1.154 . . . . 0.0 108.872 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.763 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.074 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.4 148.48 41.3 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.01 -52.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.013 -1.055 . . . . 0.0 111.169 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.47 -1.8 9.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.024 1.816 . . . . 0.0 111.101 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.036 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -115.76 17.45 16.12 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.074 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.88 -163.92 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.892 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.892 ' CG2' HG13 ' A' ' 51' ' ' VAL . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.66 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.621 ' CA ' HG23 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 1.9 m-20 -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 38' ' ' VAL . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.821 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 83' ' ' GLU . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.734 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.499 HG23 ' HG2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' HA ' ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.66 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.667 ' OXT' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.302 0.572 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -51.66 143.95 19.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.737 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 89' ' ' GLU . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.839 HG23 ' NE2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.78 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.839 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.952 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.719 ' OD1' HD11 ' A' ' 6' ' ' LEU . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.952 ' CH2' HD21 ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.8 p -147.69 179.98 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.5 7.11 9.63 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.866 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.9 t0 37.08 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.125 . . . . 0.0 110.23 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -145.54 8.85 1.18 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.028 -1.045 . . . . 0.0 110.43 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . 123.91 -24.88 6.26 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.588 -1.291 . . . . 0.0 109.917 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.947 ' O ' HG22 ' A' ' 37' ' ' THR . . . -50.63 178.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.18 -1.188 . . . . 0.0 108.609 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.003 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -136.76 143.67 43.37 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.56 -52.48 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.891 -1.131 . . . . 0.0 111.49 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.9 Cg_endo -69.76 -1.52 8.61 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.803 . . . . 0.0 111.336 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.035 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -118.12 19.69 13.47 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -162.91 -164.53 0.99 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.919 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.619 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.919 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.746 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.814 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.866 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.679 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.645 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 12' ' ' ILE . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.814 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.975 ' N ' HD22 ' A' ' 1' ' ' LEU . 7.0 mtmm -35.0 149.0 0.11 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.761 -0.587 . . . . 0.0 110.504 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.628 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.79 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.876 HG23 ' NE2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.847 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.876 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.628 HG13 ' CG2' ' A' ' 7' ' ' THR . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.625 ' HB3' HD12 ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.964 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 76' ' ' LYS . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.987 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.73 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p -103.3 -163.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.672 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -106.71 103.82 2.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -176.78 31.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.338 179.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 3.5 t 71.82 47.91 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.342 -0.849 . . . . 0.0 110.375 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.21 -2.69 37.67 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.218 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.987 ' O ' HG22 ' A' ' 37' ' ' THR . . . -56.23 164.92 1.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.031 -1.276 . . . . 0.0 108.849 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.915 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.8 147.38 41.05 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.78 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.539 -0.726 . . . . 0.0 110.247 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.06 -3.94 13.21 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.936 1.757 . . . . 0.0 110.713 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 3.7 mm-40 -114.61 23.32 12.81 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.915 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER 171.62 -162.66 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.971 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG13 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.708 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.971 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.72 ' C ' HG11 ' A' ' 92' ' ' VAL . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.767 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 35' ' ' THR . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.566 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.517 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.723 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.631 HG22 ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.72 HG11 ' C ' ' A' ' 66' ' ' LYS . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.775 HD11 HG22 ' A' ' 27' ' ' ILE . 3.1 pp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.718 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -52.32 141.1 33.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.423 -0.798 . . . . 0.0 109.65 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.839 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.604 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.843 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.801 ' CG1' HG22 ' A' ' 12' ' ' ILE . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.843 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.599 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.775 HG22 HD11 ' A' ' 1' ' ' LEU . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.893 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 45' ' ' LEU . 9.5 p -109.35 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 62.95 -143.55 48.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.697 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t70 67.18 5.21 4.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -1.028 . . . . 0.0 109.735 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.97 37.17 7.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.203 -0.935 . . . . 0.0 109.785 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.54 -20.91 1.33 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 37' ' ' THR . . . -53.52 142.4 22.5 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.049 -1.265 . . . . 0.0 109.426 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.079 HD21 ' CD2' ' A' ' 73' ' ' TYR . 1.3 mp -78.72 142.81 36.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.018 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 157.24 -60.45 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 1.018 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -69.47 1.0 4.63 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.439 2.093 . . . . 0.0 111.598 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -127.07 9.89 6.86 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 108.958 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER 167.01 -162.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.96 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.96 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' CB ' ' OD2' ' A' ' 69' ' ' ASP . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.853 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' GLY . 9.2 m-80 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.079 ' CD2' HD21 ' A' ' 45' ' ' LEU . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.839 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.728 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.853 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -116.23 137.72 23.69 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.913 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.007 HG21 ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.784 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 1.007 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG21 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' HB3' HD12 ' A' ' 5' ' ' ILE . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.715 HG22 HD13 ' A' ' 1' ' ' LEU . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.986 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.986 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p -96.61 -160.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.661 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -111.71 101.97 1.35 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -172.5 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -1.04 . . . . 0.0 109.091 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 41' ' ' SER . 2.5 p 68.63 47.26 0.89 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.384 -0.823 . . . . 0.0 110.51 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.65 22.32 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.133 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 37' ' ' THR . . . -60.71 157.5 14.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.048 -1.266 . . . . 0.0 108.951 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.42 147.69 41.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.4 -54.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.153 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.21 -3.21 11.85 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.009 1.806 . . . . 0.0 110.801 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 7.9 mp0 -118.45 23.78 11.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER 173.72 -162.8 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.029 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.715 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 1.029 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.694 ' C ' HG11 ' A' ' 92' ' ' VAL . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.619 ' CA ' HG23 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.681 ' OD1' HD11 ' A' ' 87' ' ' ILE . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CG ' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.791 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.913 ' CG ' HG22 ' A' ' 5' ' ' ILE . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.031 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.031 ' N ' HD13 ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.687 HG21 ' CG ' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.76 HD12 ' CG2' ' A' ' 27' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt -121.32 128.24 25.77 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.584 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.82 HG22 ' CG1' ' A' ' 14' ' ' ILE . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.82 ' CG1' HG22 ' A' ' 12' ' ' ILE . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.771 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.698 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 34' ' ' ALA . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.76 ' CG2' HD12 ' A' ' 1' ' ' LEU . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.995 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.939 ' CH2' HD21 ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.873 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -127.77 83.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.67 -163.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 9.8 t0 71.8 -0.64 3.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -1.111 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t 60.35 45.44 11.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 109.874 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 146.53 -24.79 1.68 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -43.51 145.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -1.204 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt -98.28 144.89 27.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.702 ' N ' HD23 ' A' ' 45' ' ' LEU . . . 80.74 37.84 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -68.31 -5.71 15.65 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.608 1.539 . . . . 0.0 109.978 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.9 tt0 -141.47 29.29 1.78 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -159.36 -159.65 0.77 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.17 -0.956 . . . . 0.0 110.18 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.872 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 60' ' ' ILE . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.882 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.768 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.872 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.67 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 92' ' ' VAL . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 39' ' ' GLY . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.966 ' CD2' HD11 ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.878 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.032 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.032 ' N ' HD13 ' A' ' 87' ' ' ILE . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 12' ' ' ILE . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 17.8 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' H ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -110.81 143.73 28.84 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' C ' HG23 ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.6 HG21 ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.7 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.617 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.759 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.7 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.926 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG13 ' CG2' ' A' ' 7' ' ' THR . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.582 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.944 ' C ' HD12 ' A' ' 27' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.944 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.983 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.983 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 75' ' ' LEU . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.926 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.8 p -128.53 67.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 136.93 -161.86 25.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -121.41 -17.35 7.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.525 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 t -71.74 -16.06 62.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.277 -0.889 . . . . 0.0 109.75 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.3 -8.59 7.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 37' ' ' THR . . . -48.61 165.19 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.277 -1.131 . . . . 0.0 108.59 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.745 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.84 146.55 37.7 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.9 -53.65 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 110.3 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.838 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.51 -11.11 29.34 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.802 . . . . 0.0 110.677 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.665 ' C ' HD23 ' A' ' 49' ' ' LEU . 8.8 tp10 -102.63 18.27 21.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER 179.32 -159.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.582 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.795 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.742 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HA ' HG22 ' A' ' 19' ' ' THR . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.595 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.717 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.83 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.83 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 1' ' ' LEU . 6.9 t30 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD12 ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 5' ' ' ILE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.623 ' N ' HG22 ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 2' ' ' LYS . 2.5 pp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.341 0.591 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.755 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.4 mttm -61.06 143.78 91.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.512 -0.742 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.044 HG23 ' NE2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 92' ' ' VAL . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 93' ' ' GLN . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 1.044 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.888 HD21 ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 ' HH2' ' A' ' 36' ' ' TRP . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.925 ' C ' HD12 ' A' ' 27' ' ' ILE . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.925 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.888 ' CH2' HD21 ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.701 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -137.33 -169.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.627 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 51.38 -134.03 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.13 25.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -1.116 . . . . 0.0 109.315 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 4.72 1.95 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.294 -0.879 . . . . 0.0 110.057 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.39 -10.08 4.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.883 ' O ' HG22 ' A' ' 37' ' ' THR . . . -50.73 167.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -1.146 . . . . 0.0 108.901 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.816 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -134.29 145.16 48.82 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 171.52 -57.06 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.132 -0.98 . . . . 0.0 110.043 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.01 -5.59 17.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.16 1.907 . . . . 0.0 110.274 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.59 15.62 25.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -178.34 -165.37 0.09 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.504 -0.748 . . . . 0.0 109.172 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.911 HD23 ' HG3' ' A' ' 63' ' ' PRO . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CG2' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.981 ' CG2' HG13 ' A' ' 51' ' ' VAL . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.911 ' HG3' HD23 ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.791 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.821 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.708 ' CD1' HG21 ' A' ' 90' ' ' VAL . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.682 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.512 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 53.3 t30 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 5' ' ' ILE . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.668 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.932 HD11 ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.932 ' HG3' HD11 ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CG2' ' A' ' 12' ' ' ILE . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.096 HD13 ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.096 ' N ' HD13 ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.482 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.8 pttm -42.87 135.06 2.87 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.613 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.741 HG21 HG13 ' A' ' 24' ' ' VAL . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.78 ' HA ' HG23 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.73 ' O ' HD13 ' A' ' 12' ' ' ILE . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.76 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.636 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.76 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' C ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.862 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.637 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' HB3' HD12 ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.719 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.977 ' CH2' HD21 ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG22 ' H ' ' A' ' 39' ' ' GLY . 4.0 p -96.63 -170.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.772 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -57.78 -150.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.9 t0 71.81 -0.28 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -1.217 . . . . 0.0 110.115 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER 57.71 45.72 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.682 179.792 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.1 -26.66 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 37' ' ' THR . . . -52.58 156.7 1.77 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -1.097 . . . . 0.0 109.396 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.663 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -111.2 -170.68 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 127.62 -48.25 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 31.2 Cg_endo -71.73 -2.68 11.78 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.784 1.656 . . . . 0.0 110.538 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.8 tp10 -123.45 20.58 9.57 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.7 pp 173.58 -166.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.56 -0.712 . . . . 0.0 109.214 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.816 HG13 ' CG2' ' A' ' 60' ' ' ILE . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.816 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.729 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 90' ' ' VAL . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.887 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.618 ' CG ' ' HH ' ' A' ' 73' ' ' TYR . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' HE2' HD21 ' A' ' 49' ' ' LEU . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 81' ' ' LEU . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.612 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.78 HG23 ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.862 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 62' ' ' PHE . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.887 HG11 ' C ' ' A' ' 66' ' ' LYS . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.096 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.953 ' N ' HD22 ' A' ' 1' ' ' LEU . 10.0 mttm -45.04 118.61 3.7 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.774 ' N ' HD22 ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.794 ' HB ' HG13 ' A' ' 90' ' ' VAL . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.681 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.67 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.67 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CD1' HG21 ' A' ' 77' ' ' VAL . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.506 ' HG2' ' HA ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.943 ' CE2' HD13 ' A' ' 75' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 5.1 p -101.12 34.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 36.31 94.77 0.01 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 1.6 m-20 176.44 57.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -1.196 . . . . 0.0 109.417 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 66.13 53.02 1.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.785 . . . . 0.0 109.721 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.9 -4.43 82.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.901 ' O ' HG22 ' A' ' 37' ' ' THR . . . -46.55 148.99 0.85 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.139 -1.212 . . . . 0.0 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.82 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -130.73 154.84 47.54 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 166.56 -54.21 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 110.207 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.91 -5.33 16.68 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.053 1.835 . . . . 0.0 110.674 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 16.9 tp10 -107.21 16.68 23.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.75 HD21 HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER 178.26 -161.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.363 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.049 HD13 ' N ' ' A' ' 51' ' ' VAL . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.049 ' N ' HD13 ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.551 HG22 ' CG ' ' A' ' 54' ' ' LYS . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.651 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.79 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' GLY . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.641 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 87' ' ' ILE . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.899 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.59 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.565 ' CB ' HG21 ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 12' ' ' ILE . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.79 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.608 HD11 HG22 ' A' ' 27' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.329 0.585 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 1' ' ' LEU . 2.0 ptpp? -43.89 144.22 1.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 0.0 109.417 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.584 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.831 ' O ' HG13 ' A' ' 92' ' ' VAL . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HG3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.683 ' HD1' HG23 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.759 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.739 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.547 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.946 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.946 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.739 ' CH2' HD21 ' A' ' 22' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -129.61 51.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 39.89 -143.42 0.5 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 2.1 t0 78.51 -73.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.676 -0.896 . . . . 0.0 109.751 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 174.76 39.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.22 -0.925 . . . . 0.0 108.872 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.99 25.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' THR . . . -65.58 162.61 17.85 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 109.149 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -128.49 143.46 50.98 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 172.0 -57.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.62 -0.675 . . . . 0.0 109.507 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -71.66 80.98 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.309 2.006 . . . . 0.0 109.814 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.4 mm-40 160.25 -25.17 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -134.59 -167.49 1.98 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.986 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.986 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.759 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.773 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.439 ' CA ' HG23 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.733 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' THR . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.615 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.999 ' N ' HD13 ' A' ' 87' ' ' ILE . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.466 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -45.27 159.67 0.27 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.692 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.676 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.681 ' O ' HG23 ' A' ' 7' ' ' THR . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.606 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.854 ' HB ' HG22 ' A' ' 90' ' ' VAL . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.849 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.924 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 7' ' ' THR . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 28' ' ' GLY . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.707 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.948 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.924 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.2 p -140.42 -179.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 75.49 -7.7 23.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 76.49 -11.02 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -1.234 . . . . 0.0 110.505 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.7 t 163.79 80.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.026 -1.046 . . . . 0.0 109.615 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.05 31.76 0.43 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . -169.57 176.14 5.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.212 -1.169 . . . . 0.0 108.885 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.101 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.96 150.98 47.5 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.91 -53.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 111.233 -179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.37 -1.39 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.165 1.91 . . . . 0.0 111.394 -178.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.033 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -116.61 15.93 15.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.325 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.101 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -164.17 -164.67 0.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.931 HG13 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.931 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.655 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.605 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.811 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.481 ' CA ' HG23 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.747 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.643 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.081 ' N ' HD13 ' A' ' 87' ' ' ILE . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' HB ' ' A' ' 12' ' ' ILE . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.811 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.574 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 mp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.375 0.607 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp -103.08 122.65 44.71 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.585 -0.697 . . . . 0.0 109.128 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 5' ' ' ILE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.599 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 HG23 ' HE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.695 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.695 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 24' ' ' VAL . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 7' ' ' THR . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 77' ' ' VAL . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.812 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.059 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.059 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -132.76 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 156.59 -31.41 0.57 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HB2' ' CG ' ' A' ' 74' ' ' LYS . 6.2 t0 62.28 30.78 17.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.14 . . . . 0.0 109.531 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -160.45 20.35 0.15 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.202 -0.936 . . . . 0.0 109.924 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.75 40.93 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . -168.09 148.97 5.05 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.119 -1.224 . . . . 0.0 109.84 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.794 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -138.99 149.89 45.22 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.13 -53.17 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.326 -179.01 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -70.61 -12.95 32.08 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.966 1.777 . . . . 0.0 110.827 -179.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.429 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.3 mt-10 -99.04 14.32 29.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -174.66 -163.09 0.13 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 51' ' ' VAL . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HB2' HG22 ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.828 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.969 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.969 ' OD1' HG22 ' A' ' 77' ' ' VAL . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.731 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.732 ' N ' HD13 ' A' ' 87' ' ' ILE . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 1' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -42.68 158.14 0.22 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 109.667 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.878 HG23 ' NE2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.789 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.878 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.814 ' CB ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.877 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.877 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.1 p -135.99 -165.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.727 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -58.86 -145.36 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.246 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.784 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 t0 59.05 12.6 2.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 109.84 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 40' ' ' ASP . 10.5 p 43.33 48.22 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.55 -17.46 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.259 -1.142 . . . . 0.0 108.968 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.822 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -130.94 149.98 52.31 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 164.12 -52.71 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.534 -178.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.1 Cg_endo -70.58 -12.33 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.979 1.786 . . . . 0.0 110.748 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -100.17 15.12 28.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.201 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -176.4 -160.96 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.443 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.674 ' CA ' HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.82 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.652 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.952 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.486 ' CA ' HG23 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 39' ' ' GLY . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.652 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 29' ' ' ALA . 6.4 t30 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.071 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 1.071 ' N ' HD13 ' A' ' 87' ' ' ILE . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 12' ' ' ILE . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.952 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.472 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -69.39 143.96 94.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.837 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.865 HG23 ' NE2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.934 ' HA ' HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.777 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.865 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 23' ' ' GLU . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -132.48 56.94 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 133.15 133.56 3.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -12.35 41.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -1.19 . . . . 0.0 109.549 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.12 -7.4 22.93 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.6 -7.21 28.08 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.862 ' O ' HG22 ' A' ' 37' ' ' THR . . . -59.83 164.54 3.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.401 -1.058 . . . . 0.0 108.845 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.903 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -138.81 146.48 41.37 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 169.23 -56.73 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.709 . . . . 0.0 109.978 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.58 -4.41 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.251 1.967 . . . . 0.0 110.625 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HG3' HD23 ' A' ' 49' ' ' LEU . 9.0 pt-20 -113.22 21.67 15.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.356 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.903 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER 175.36 -165.43 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.38 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.821 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.74 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.876 ' C ' HG11 ' A' ' 92' ' ' VAL . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 92' ' ' VAL . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.716 ' HB2' HG23 ' A' ' 90' ' ' VAL . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.79 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.872 HD12 ' N ' ' A' ' 82' ' ' GLY . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.837 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.754 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.934 HG22 ' HA ' ' A' ' 13' ' ' LYS . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.876 HG11 ' C ' ' A' ' 66' ' ' LYS . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 6.6 mp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt -63.68 135.14 96.15 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.37 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.773 HG22 ' HB3' ' A' ' 84' ' ' ASP . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.712 HG21 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . 1.012 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HD3' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.911 ' HB ' HG13 ' A' ' 90' ' ' VAL . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.841 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.814 HG22 ' HA ' ' A' ' 63' ' ' PRO . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.905 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.859 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG21 ' A' ' 7' ' ' THR . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.963 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.805 ' N ' HD13 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.962 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.962 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.699 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.682 HG21 ' NZ ' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.859 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.71 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.768 HG22 ' H ' ' A' ' 39' ' ' GLY . 4.7 p -100.92 -174.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.768 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -60.67 -139.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t0 66.71 4.87 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -1.221 . . . . 0.0 110.214 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.27 46.52 23.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.111 -0.993 . . . . 0.0 110.096 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.28 -17.92 2.09 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -58.21 154.45 13.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.235 -1.156 . . . . 0.0 109.184 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.759 HD21 ' HD2' ' A' ' 73' ' ' TYR . 0.7 OUTLIER -44.99 148.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -52.56 125.48 36.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 110.027 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -2.55 11.25 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.035 1.823 . . . . 0.0 110.28 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' HB1' ' A' ' 46' ' ' ALA . 2.4 pt-20 -83.06 -12.08 57.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 46' ' ' ALA . 1.1 pp -102.45 -169.88 1.73 Allowed 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.226 -0.922 . . . . 0.0 110.036 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 49' ' ' LEU . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HB2' HG22 ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.852 ' CG2' HG13 ' A' ' 51' ' ' VAL . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.692 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.814 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.759 ' HD2' HD21 ' A' ' 45' ' ' LEU . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' NZ ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.773 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.752 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.911 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.715 ' H ' HG22 ' A' ' 91' ' ' ILE . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.808 ' N ' HD13 ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.348 0.594 . . . . 0.0 109.575 . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 1' ' ' LEU . 34.0 mtpt -48.65 137.65 12.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.95 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.659 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.774 ' N ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.566 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' H ' HG23 ' A' ' 7' ' ' THR . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.706 ' CB ' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' HB ' HG13 ' A' ' 90' ' ' VAL . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.705 HG23 ' HD1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.696 HG22 ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.705 ' HD1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.902 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG21 ' HH2' ' A' ' 36' ' ' TRP . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.884 ' C ' HD12 ' A' ' 27' ' ' ILE . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.998 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.902 ' CH2' HD21 ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -105.76 51.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 144.07 154.54 6.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -81.27 -13.85 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.354 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 p -67.0 -8.35 29.31 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.04 25.23 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' THR . . . -48.15 143.85 4.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.256 -1.143 . . . . 0.0 109.656 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.039 HD23 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -45.33 161.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -84.46 136.8 39.57 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.411 -178.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -10.89 28.39 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.186 1.924 . . . . 0.0 109.669 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.48 -19.62 64.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD11 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -110.16 -167.92 1.25 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.492 -0.755 . . . . 0.0 109.016 179.416 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.98 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.903 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB2' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.903 ' CG2' HG13 ' A' ' 51' ' ' VAL . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.709 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.98 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' O ' HG21 ' A' ' 92' ' ' VAL . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.634 ' ND2' HD11 ' A' ' 87' ' ' ILE . 10.5 t-20 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.624 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.705 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.815 ' N ' HD22 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.728 HD13 ' C ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.991 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 66' ' ' LYS . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.638 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 7' ' ' THR . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.887 HG23 ' NE2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.776 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.761 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.887 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' GLU . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CG ' HG21 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.002 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.927 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.925 ' CH2' HD21 ' A' ' 22' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 43' ' ' ALA . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.327 0.584 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.779 HD11 HD23 ' A' ' 45' ' ' LEU . 1.8 pp . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 60' ' ' ILE . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.761 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.97 ' O ' HG11 ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 74' ' ' LYS . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.714 ' CG ' HG21 ' A' ' 90' ' ' VAL . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' OG1' ' A' ' 37' ' ' THR . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.921 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HA ' HD13 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.77 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.714 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 13' ' ' LYS . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.97 HG11 ' O ' ' A' ' 66' ' ' LYS . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.869 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.697 HD13 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 63' ' ' PRO . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.869 ' NE2' HG21 ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.773 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.671 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG21 ' CH2' ' A' ' 36' ' ' TRP . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.642 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.662 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.938 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.938 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.768 ' CE2' HD13 ' A' ' 75' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.583 0.706 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.743 0.783 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.979 HG13 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.642 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.979 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.768 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 19' ' ' THR . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.799 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 70' ' ' SER . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 89' ' ' GLU . 13.1 m120 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.891 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 80' ' ' GLU . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.955 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.955 ' N ' HD13 ' A' ' 87' ' ' ILE . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.645 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 66' ' ' LYS . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 2' ' ' LYS . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.762 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.588 ' HB ' HG13 ' A' ' 24' ' ' VAL . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.896 HG22 ' CG1' ' A' ' 14' ' ' ILE . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.896 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.774 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.875 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 23' ' ' GLU . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.762 ' CB ' HD12 ' A' ' 5' ' ' ILE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.875 ' CH2' HD21 ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.945 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 7.1 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.945 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 36' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.55 0.69 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.768 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.864 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' HG21 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 45' ' ' LEU . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' THR . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.77 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.508 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.864 HG11 ' C ' ' A' ' 66' ' ' LYS . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HE3' HG21 ' A' ' 27' ' ' ILE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.627 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.596 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.888 ' O ' HG22 ' A' ' 91' ' ' ILE . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HD1' HG23 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.942 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.721 ' CG ' HG21 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.716 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.942 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.691 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.7 p . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.108 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.108 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.605 0.716 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.563 HG22 ' CG ' ' A' ' 54' ' ' LYS . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.742 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.668 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.721 HG21 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' LEU . 2.6 t-20 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.619 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.604 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.784 ' N ' HD13 ' A' ' 87' ' ' ILE . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.888 HG22 ' O ' ' A' ' 12' ' ' ILE . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' A' ' 14' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.66 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.697 ' CG2' HG13 ' A' ' 24' ' ' VAL . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.959 HG21 ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.691 HD13 ' CG ' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 66' ' ' LYS . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.959 ' NE2' HG21 ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.913 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 ' CG2' ' A' ' 7' ' ' THR . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.02 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.02 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.671 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.913 ' CH2' HD21 ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 38' ' ' VAL . 10.7 p . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.61 0.719 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.083 HD21 ' CE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.08 HD11 HD23 ' A' ' 45' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.837 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.889 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.889 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.615 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.866 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.517 ' CA ' HG23 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' VAL . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.083 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.671 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.66 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.866 HG11 ' C ' ' A' ' 66' ' ' LYS . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.1 mtmp? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.556 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' H ' HG23 ' A' ' 7' ' ' THR . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.578 ' HB2' HG22 ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' O ' HD13 ' A' ' 12' ' ' ILE . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.926 HG23 ' NE2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.875 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.734 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.786 ' HE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.926 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.89 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CD2' HD12 ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 34' ' ' ALA . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.966 ' CE2' HD13 ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.5 p . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.75 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.155 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.155 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.861 HG13 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.861 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.735 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.743 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.515 ' O ' HG11 ' A' ' 92' ' ' VAL . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.526 ' N ' HG23 ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' VAL . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.966 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.649 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 12' ' ' ILE . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 69' ' ' ASP . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.759 HG22 ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.861 HG23 ' NE2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.771 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.665 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.902 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.902 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.724 HG22 HG23 ' A' ' 37' ' ' THR . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.927 ' CH2' HD21 ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.724 HG23 HG22 ' A' ' 35' ' ' THR . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.641 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p . . . . . 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.866 0.841 . . . . 0.0 109.787 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.907 ' O ' HD13 ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.911 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.869 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.453 ' CA ' HG23 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 38' ' ' VAL . 11.4 m120 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.898 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 15.7 t-20 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' HA3' ' HD2' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB2' HG22 ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.576 ' CG ' HD11 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.807 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 66' ' ' LYS . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.79 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.69 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.572 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.894 HG23 ' NE2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.894 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.947 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.873 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.405 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.947 ' CH2' HD21 ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.0 p . . . . . 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.803 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.931 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.887 HG13 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.887 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.912 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.931 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.691 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.439 ' N ' HG23 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' LEU . 4.9 t-20 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.69 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.699 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 12' ' ' ILE . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.691 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.651 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.87 ' HB ' HG22 ' A' ' 90' ' ' VAL . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.772 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.847 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.63 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.004 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.004 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.618 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.2 p . . . . . 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.607 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.6 HD23 ' CG ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.823 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.895 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HD3' HG23 ' A' ' 87' ' ' ILE . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.784 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.531 ' CB ' ' HA ' ' A' ' 2' ' ' LYS . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.789 HG23 ' HD3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HD11 ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.87 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' HG2' ' A' ' 89' ' ' GLU . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.895 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.867 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD1' ' HE3' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.877 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.793 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.877 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.887 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.855 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.887 ' CH2' HD21 ' A' ' 22' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.046 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.046 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.381 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.025 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 62' ' ' PHE . 1.5 pp . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.31 0.576 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.853 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.932 HD12 HD22 ' A' ' 45' ' ' LEU . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.694 ' O ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.684 ' C ' HG11 ' A' ' 92' ' ' VAL . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.025 ' CD2' HD11 ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 10.7 t-20 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.867 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.019 ' N ' HD13 ' A' ' 87' ' ' ILE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.684 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.838 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.603 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.924 HG23 ' NE2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.874 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.774 ' CE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.924 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.962 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 23' ' ' GLU . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.962 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.6 p . . . . . 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' A' ' 59' ' ' SER . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.752 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 19' ' ' THR . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.737 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.706 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.843 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.523 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.848 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.838 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.737 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.889 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.592 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.884 HG23 ' NE2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.884 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.858 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.931 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.6 p . . . . . 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.804 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 45' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 51' ' ' VAL . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.703 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.851 ' C ' HG11 ' A' ' 92' ' ' VAL . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.743 ' CD1' HG23 ' A' ' 38' ' ' VAL . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' CE ' ' OE2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.859 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.889 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.641 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 73' ' ' TYR . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 91' ' ' ILE . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.851 HG11 ' C ' ' A' ' 66' ' ' LYS . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.865 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.879 HG22 ' CG1' ' A' ' 14' ' ' ILE . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.879 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.945 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 7' ' ' THR . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.71 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.977 ' CD2' HG21 ' A' ' 77' ' ' VAL . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.688 HG22 ' H ' ' A' ' 28' ' ' GLY . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.015 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.945 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 38' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.45 0.643 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.852 HD22 ' HB3' ' A' ' 36' ' ' TRP . 2.0 mp . . . . . 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.691 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 122.245 1.021 . . . . 0.0 110.691 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.906 HG13 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.71 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.906 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.647 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.924 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.708 ' O ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.924 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.599 ' CA ' HG23 ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 38' ' ' VAL . 1.8 m-80 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.618 ' CD2' HD21 ' A' ' 45' ' ' LEU . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.977 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' LEU . 20.7 t-20 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 9' ' ' SER . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.767 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' N ' HD13 ' A' ' 87' ' ' ILE . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' CD ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.625 ' N ' HG22 ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.852 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.914 HG21 HG13 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.66 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 93' ' ' GLN . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.667 ' HB2' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.66 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.935 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG21 ' A' ' 7' ' ' THR . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.852 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.552 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.935 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.9 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.763 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.074 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.074 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.892 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.892 ' CG2' HG13 ' A' ' 51' ' ' VAL . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.66 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.621 ' CA ' HG23 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 38' ' ' VAL . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.821 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 83' ' ' GLU . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.734 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.499 HG23 ' HG2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' HA ' ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.66 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.667 ' OXT' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.737 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.679 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 89' ' ' GLU . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.839 HG23 ' NE2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.78 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.839 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.952 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.719 ' OD1' HD11 ' A' ' 6' ' ' LEU . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.952 ' CH2' HD21 ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.8 p . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.947 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.003 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.003 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.919 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.619 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.919 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.746 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.814 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.866 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.679 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.645 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 12' ' ' ILE . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.814 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 7.0 mtmm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.56 0.219 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.628 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.79 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.876 HG23 ' NE2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.847 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.876 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.628 HG13 ' CG2' ' A' ' 7' ' ' THR . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.625 ' HB3' HD12 ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.964 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.566 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 76' ' ' LYS . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.987 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.73 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.987 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.915 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.915 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.971 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG13 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.708 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.971 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.72 ' C ' HG11 ' A' ' 92' ' ' VAL . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.767 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 35' ' ' THR . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.566 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.517 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.723 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.631 HG22 ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.72 HG11 ' C ' ' A' ' 66' ' ' LYS . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.839 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.604 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.843 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.801 ' CG1' HG22 ' A' ' 12' ' ' ILE . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.843 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.599 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.893 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 45' ' ' LEU . 9.5 p . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.443 0.639 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.079 HD21 ' CD2' ' A' ' 73' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.96 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.96 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' CB ' ' OD2' ' A' ' 69' ' ' ASP . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.853 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 38' ' ' VAL . 2.9 m120 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.079 ' CD2' HD21 ' A' ' 45' ' ' LEU . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.839 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.728 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.853 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.913 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.007 HG21 ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.784 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 1.007 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG21 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.58 ' HB3' HD12 ' A' ' 5' ' ' ILE . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.986 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.986 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.029 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.715 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 1.029 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.694 ' C ' HG11 ' A' ' 92' ' ' VAL . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.619 ' CA ' HG23 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.681 ' OD1' HD11 ' A' ' 87' ' ' ILE . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CG ' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.791 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.913 ' CG ' HG22 ' A' ' 5' ' ' ILE . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.031 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.031 ' N ' HD13 ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.687 HG21 ' CG ' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.584 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.82 HG22 ' CG1' ' A' ' 14' ' ' ILE . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.82 ' CG1' HG22 ' A' ' 12' ' ' ILE . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.771 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.698 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 34' ' ' ALA . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.995 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.939 ' CH2' HD21 ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.873 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt . . . . . 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.21 0.529 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.872 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 60' ' ' ILE . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.882 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.872 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.67 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 92' ' ' VAL . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.966 ' CD2' HD11 ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.878 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.032 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.032 ' N ' HD13 ' A' ' 87' ' ' ILE . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 12' ' ' ILE . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' C ' HG23 ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.6 HG21 ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG23 ' HE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.7 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.617 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.759 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.7 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.926 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG13 ' CG2' ' A' ' 7' ' ' THR . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.582 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.944 ' C ' HD12 ' A' ' 27' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.944 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.983 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.983 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 75' ' ' LEU . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.926 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.8 p . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.745 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.582 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.795 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.742 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HA ' HG22 ' A' ' 19' ' ' THR . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.595 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.717 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.83 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.83 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 22.1 t-20 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD12 ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 5' ' ' ILE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.623 ' N ' HG22 ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.549 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 1.4 mttm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.743 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.044 HG23 ' NE2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 92' ' ' VAL . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 93' ' ' GLN . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 1.044 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.888 HD21 ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 ' HH2' ' A' ' 36' ' ' TRP . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.925 ' C ' HD12 ' A' ' 27' ' ' ILE . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.925 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.888 ' CH2' HD21 ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.701 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.883 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.816 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.53 0.681 . . . . 0.0 109.172 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.911 HD23 ' HG3' ' A' ' 63' ' ' PRO . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CG2' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.981 ' CG2' HG13 ' A' ' 51' ' ' VAL . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.911 ' HG3' HD23 ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.791 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.821 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.708 ' CD1' HG21 ' A' ' 90' ' ' VAL . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.682 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.512 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 8.4 t-20 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 5' ' ' ILE . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.668 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.932 HD11 ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.932 ' HG3' HD11 ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CG2' ' A' ' 12' ' ' ILE . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 1.096 HD13 ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.096 ' N ' HD13 ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.8 pttm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.741 HG21 HG13 ' A' ' 24' ' ' VAL . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.78 ' HA ' HG23 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.73 ' O ' HD13 ' A' ' 12' ' ' ILE . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.76 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.636 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.76 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' C ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.862 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.637 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' HB3' HD12 ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.719 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.977 ' CH2' HD21 ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.606 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 4.0 p . . . . . 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.608 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.816 HG13 ' CG2' ' A' ' 60' ' ' ILE . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.816 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.729 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 90' ' ' VAL . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.887 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.618 ' CG ' ' HH ' ' A' ' 73' ' ' TYR . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 38' ' ' VAL . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.619 ' HE2' HD21 ' A' ' 49' ' ' LEU . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 81' ' ' LEU . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.612 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.78 HG23 ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.862 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 62' ' ' PHE . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.887 HG11 ' C ' ' A' ' 66' ' ' LYS . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HA ' ' OD1' ' A' ' 79' ' ' ASN . 10.0 mttm . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.794 ' HB ' HG13 ' A' ' 90' ' ' VAL . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.681 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.67 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.67 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CD1' HG21 ' A' ' 77' ' ' VAL . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.506 ' HG2' ' HA ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.943 ' CE2' HD13 ' A' ' 75' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 5.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.901 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.82 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.75 HD21 HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.049 HD13 ' N ' ' A' ' 51' ' ' VAL . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.049 ' N ' HD13 ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.551 HG22 ' CG ' ' A' ' 54' ' ' LYS . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.651 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.79 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.641 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 87' ' ' ILE . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.943 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.899 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.59 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.565 ' CB ' HG21 ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 12' ' ' ILE . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.79 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 2.0 ptpp? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.584 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.831 ' O ' HG13 ' A' ' 92' ' ' VAL . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HG3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.683 ' HD1' HG23 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.759 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.739 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.547 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.946 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.946 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.739 ' CH2' HD21 ' A' ' 22' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.986 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.986 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.759 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.773 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.439 ' CA ' HG23 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' VAL . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.733 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' THR . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.615 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.999 ' N ' HD13 ' A' ' 87' ' ' ILE . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.466 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.676 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 7' ' ' THR . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.606 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.854 ' HB ' HG22 ' A' ' 90' ' ' VAL . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.849 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.924 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 7' ' ' THR . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 28' ' ' GLY . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.707 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.948 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.924 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.2 p . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.101 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.101 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.931 HG13 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.931 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.655 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.605 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.811 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.481 ' CA ' HG23 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.747 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.517 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.643 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.081 ' N ' HD13 ' A' ' 87' ' ' ILE . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' HB ' ' A' ' 12' ' ' ILE . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.811 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 5' ' ' ILE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.599 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 HG23 ' HE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.695 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.695 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 24' ' ' VAL . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 7' ' ' THR . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 77' ' ' VAL . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.059 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.059 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.438 0.637 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.663 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.794 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 51' ' ' VAL . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HB2' HG22 ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.828 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD2' HG12 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.969 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.969 ' OD1' HG22 ' A' ' 77' ' ' VAL . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.731 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.732 ' N ' HD13 ' A' ' 87' ' ' ILE . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.878 HG23 ' NE2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.789 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.878 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.814 ' CB ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.877 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.877 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.697 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 2.1 p . . . . . 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.822 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.674 ' CA ' HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.82 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.652 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.952 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.486 ' CA ' HG23 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.652 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 30' ' ' PRO . 6.8 t-20 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.071 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 1.071 ' N ' HD13 ' A' ' 87' ' ' ILE . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 12' ' ' ILE . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.952 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.472 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.837 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.865 HG23 ' NE2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.934 ' HA ' HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.777 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.865 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 23' ' ' GLU . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.862 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.903 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.903 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.821 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.74 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.876 ' C ' HG11 ' A' ' 92' ' ' VAL . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 92' ' ' VAL . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' OD1' ' HG3' ' A' ' 89' ' ' GLU . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.716 ' HB2' HG23 ' A' ' 90' ' ' VAL . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.79 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.872 HD12 ' N ' ' A' ' 82' ' ' GLY . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.837 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.526 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.754 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.934 HG22 ' HA ' ' A' ' 13' ' ' LYS . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.876 HG11 ' C ' ' A' ' 66' ' ' LYS . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.773 HG22 ' HB3' ' A' ' 84' ' ' ASP . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.712 HG21 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 1.012 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HD3' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.911 ' HB ' HG13 ' A' ' 90' ' ' VAL . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.841 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.814 HG22 ' HA ' ' A' ' 63' ' ' PRO . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.905 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.859 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG21 ' A' ' 7' ' ' THR . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.963 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.805 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.962 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.962 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.699 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.682 HG21 ' NZ ' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.859 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.71 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 4.7 p . . . . . 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.759 HD21 ' HD2' ' A' ' 73' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 49' ' ' LEU . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HB2' HG22 ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.852 ' CG2' HG13 ' A' ' 51' ' ' VAL . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.692 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.676 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.814 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.759 ' HD2' HD21 ' A' ' 45' ' ' LEU . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' NZ ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.773 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.752 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.911 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.715 ' H ' HG22 ' A' ' 91' ' ' ILE . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.659 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.774 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.566 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' H ' HG23 ' A' ' 7' ' ' THR . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.706 ' CB ' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' HB ' HG13 ' A' ' 90' ' ' VAL . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.705 HG23 ' HD1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.696 HG22 ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.705 ' HD1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.902 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG21 ' HH2' ' A' ' 36' ' ' TRP . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.884 ' C ' HD12 ' A' ' 27' ' ' ILE . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.998 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.902 ' CH2' HD21 ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' THR . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.46 0.648 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.039 HD23 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.039 HD11 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.98 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.903 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB2' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.903 ' CG2' HG13 ' A' ' 51' ' ' VAL . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.709 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.98 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.645 ' O ' HG21 ' A' ' 92' ' ' VAL . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.634 ' ND2' HD11 ' A' ' 87' ' ' ILE . 10.5 t-20 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' HE2' ' HG3' ' A' ' 85' ' ' GLU . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.624 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.705 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.815 ' N ' HD22 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.728 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.991 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 66' ' ' LYS . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.719 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 27' ' ' ILE . 20.7 mttt -82.99 149.12 58.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -78.25 84.56 1.99 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.848 2.366 . . . . 0.0 110.449 -157.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 10.5 mttp -70.44 85.15 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 109.278 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.638 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -77.77 132.48 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.41 -0.806 . . . . 0.0 109.342 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.3 mp -121.5 -19.22 7.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.959 . . . . 0.0 110.358 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 7' ' ' THR . 8.8 t -40.61 114.47 0.47 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.076 -1.015 . . . . 0.0 109.841 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -75.53 -38.86 59.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.026 . . . . 0.0 108.595 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.653 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER 26.21 101.09 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.556 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -70.11 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.04 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 18.8 mttt -132.95 -176.05 3.99 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.887 HG23 ' NE2' ' A' ' 20' ' ' HIS . 9.7 mm -149.08 92.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 91' ' ' ILE . 40.3 tttt -75.66 99.08 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.79 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.776 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.2 mt -109.28 141.02 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.133 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 6.2 ttmm -83.36 130.37 35.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.809 -1.182 . . . . 0.0 108.431 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 67' ' ' ARG . . . -52.45 133.42 35.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.067 . . . . 0.0 110.336 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.07 48.6 9.56 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.5 m-85 -144.9 -169.85 3.27 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.079 -1.248 . . . . 0.0 111.208 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.761 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.8 p -121.36 129.44 53.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.695 -0.628 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.887 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -115.97 163.63 15.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.194 -0.941 . . . . 0.0 109.572 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.92 88.36 2.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 108.96 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -77.26 137.45 38.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.567 -0.708 . . . . 0.0 110.779 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.4 154.55 44.88 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.437 -0.789 . . . . 0.0 110.247 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' GLU . 23.1 t -159.82 162.3 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.2 p30 -150.52 145.16 25.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.04 . . . . 0.0 110.564 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CG ' HG21 ' A' ' 77' ' ' VAL . 55.0 p90 -164.93 131.44 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.64 89.78 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.268 -0.895 . . . . 0.0 110.496 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -124.03 152.97 17.35 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 174.27 172.74 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.152 -1.204 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.002 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.76 2.11 7.7 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.574 -1.427 . . . . 0.0 111.386 1.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 5.6 t70 -171.37 87.28 0.47 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.062 -1.024 . . . . 0.0 109.576 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.9 Cg_endo -80.61 161.55 21.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.82 2.347 . . . . 0.0 110.749 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 17.8 m -117.62 115.42 25.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.927 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -111.46 104.95 13.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.255 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 m -84.44 128.97 34.89 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.359 -0.838 . . . . 0.0 109.432 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.925 ' CH2' HD21 ' A' ' 22' ' ' LEU . 17.7 m95 -98.79 88.42 4.03 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.094 0.95 . . . . 0.0 108.752 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 43' ' ' ALA . 1.8 p -98.33 156.63 16.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 111.299 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -96.26 39.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.535 0.684 . . . . 0.0 110.027 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 39.32 87.13 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -179.18 62.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.111 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.4 52.36 1.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.0 109.341 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.15 4.82 74.29 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.68 ' O ' HG22 ' A' ' 37' ' ' THR . . . -43.26 147.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.35 -1.088 . . . . 0.0 109.703 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -117.12 148.69 41.34 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.779 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.56 38.21 2.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.522 -1.671 . . . . 0.0 110.637 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.915 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . -80.25 -55.15 0.79 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.664 . . . . 0.0 110.9 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.915 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.32 1.26 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.125 1.884 . . . . 0.0 111.34 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -114.38 12.72 17.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 108.611 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.779 HD11 HD23 ' A' ' 45' ' ' LEU . 1.8 pp 167.63 -171.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.252 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 25.3 tp -102.09 162.21 13.09 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 120.825 -1.172 . . . . 0.0 108.629 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 60' ' ' ILE . 67.1 t -152.96 137.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.901 -1.124 . . . . 0.0 110.784 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -135.01 156.12 49.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.68 147.16 18.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.325 -1.485 . . . . 0.0 111.133 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.8 mmtp -122.22 158.49 29.32 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.676 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -52.68 -47.88 66.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.083 -1.011 . . . . 0.0 111.61 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 57' ' ' THR . 46.7 m -98.91 20.38 13.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.6 -1.313 . . . . 0.0 111.059 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.9 t -179.63 -165.75 0.08 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.645 -1.285 . . . . 0.0 108.763 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 176.94 154.98 0.25 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 109.737 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 50.9 p -157.42 143.61 17.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.1 pt -128.71 159.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 117.775 -1.57 . . . . 0.0 110.893 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.5 m-85 -109.55 153.66 23.83 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.672 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -135.25 45.18 1.31 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.761 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.4 Cg_endo -63.76 -13.19 35.44 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.786 1.657 . . . . 0.0 109.812 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.09 42.87 2.72 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -74.74 139.01 43.11 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.874 -1.141 . . . . 0.0 109.687 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.97 ' O ' HG11 ' A' ' 92' ' ' VAL . 18.3 mtpt -134.92 -179.09 5.4 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 16' ' ' ALA . 8.5 mtm-85 -58.6 -44.6 89.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.985 -1.072 . . . . 0.0 109.728 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.6 -17.66 48.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 110.509 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -63.46 -10.58 18.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 109.77 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.01 98.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.342 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.39 -168.06 16.08 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' GLY . 34.7 t-20 -108.03 90.84 3.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 108.723 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.714 ' CG ' HG21 ' A' ' 90' ' ' VAL . 5.1 m-85 -65.83 91.55 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 110.021 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.507 ' HG3' ' CA ' ' A' ' 39' ' ' GLY . 4.9 mttt -96.43 126.67 41.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.921 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -118.8 144.18 46.47 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.032 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 23.9 ttpt -134.1 122.89 23.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -119.0 128.15 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.814 -1.179 . . . . 0.0 109.724 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -127.31 -175.38 3.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.025 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 4.5 t30 -172.43 101.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.501 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HA ' HD13 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -120.51 -17.19 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.906 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -77.34 152.26 39.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -152.54 145.78 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.235 . . . . 0.0 110.172 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -152.96 164.34 38.13 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 76' ' ' LYS . 2.3 mt-10 -155.26 141.67 18.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.011 -1.056 . . . . 0.0 110.346 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.686 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.17 133.42 54.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.77 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -96.11 129.07 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 9.3 m-85 -126.31 100.03 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.505 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tp10 -78.77 108.43 12.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.714 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -104.67 129.55 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.482 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 13' ' ' LYS . 15.2 tt -119.37 157.44 21.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.97 HG11 ' O ' ' A' ' 66' ' ' LYS . 43.7 t -140.95 122.61 14.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.212 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.631 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mm? . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.277 0.56 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 27' ' ' ILE . 4.4 ptpp? -95.42 152.25 39.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.413 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.1 Cg_endo -78.85 78.84 3.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.851 2.367 . . . . 0.0 110.258 -148.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -61.71 88.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.159 -0.963 . . . . 0.0 108.97 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -75.29 107.81 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 108.996 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.0 mp -85.6 -56.56 3.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.525 -0.735 . . . . 0.0 110.498 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 33.44 -89.79 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.866 -0.521 . . . . 0.0 110.493 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 80.61 -24.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 111.54 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.603 ' HB2' ' CD1' ' A' ' 88' ' ' PHE . 20.0 m -41.26 162.71 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -74.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.622 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -127.0 -173.55 2.92 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.542 -0.724 . . . . 0.0 109.359 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.869 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.7 mm -153.21 123.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.18 -0.95 . . . . 0.0 110.001 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -96.82 88.17 4.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.111 -0.993 . . . . 0.0 108.418 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.697 HD13 ' CG ' ' A' ' 20' ' ' HIS . 2.9 mt -95.43 151.9 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 0.0 109.925 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.28 169.63 10.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 108.937 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.11 147.42 40.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.65 29.0 17.28 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.605 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.9 m-30 -108.21 154.29 21.97 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.19 -1.183 . . . . 0.0 110.12 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 63' ' ' PRO . 3.0 p -82.22 165.75 20.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.376 -0.827 . . . . 0.0 109.399 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.869 ' NE2' HG21 ' A' ' 12' ' ' ILE . 10.2 t60 -154.86 166.51 33.28 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.773 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 12.0 p-10 -152.33 77.61 1.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.544 1.164 . . . . 0.0 111.083 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.671 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.3 tt -49.51 132.37 20.97 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.506 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -124.48 141.26 52.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 109.973 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG21 ' CH2' ' A' ' 36' ' ' TRP . 94.4 t -151.64 157.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 108.963 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.642 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 6.1 t70 -153.16 122.6 6.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.114 -0.991 . . . . 0.0 110.213 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 5' ' ' ILE . 42.2 p90 -134.9 134.42 40.66 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.139 -0.976 . . . . 0.0 110.597 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.662 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.88 89.41 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.826 . . . . 0.0 110.412 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -126.43 151.99 18.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.938 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.01 172.37 0.32 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.187 -1.184 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.938 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.6 Cg_endo -71.41 0.54 7.96 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.156 1.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 1.3 t70 -171.26 87.82 0.47 Allowed Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.113 -0.992 . . . . 0.0 109.349 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -80.2 -173.61 1.92 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.82 2.347 . . . . 0.0 110.468 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -133.45 149.93 51.76 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.41 132.3 24.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.958 -1.089 . . . . 0.0 109.233 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 55.3 m -115.77 121.45 42.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.772 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.768 ' CE2' HD13 ' A' ' 75' ' ' LEU . 21.6 m95 -95.78 97.25 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.26 167.52 9.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 0.0 108.923 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.1 p -115.92 50.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.117 -0.989 . . . . 0.0 109.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . 61.3 -144.57 48.73 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.67 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER 65.57 6.66 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -1.03 . . . . 0.0 109.836 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.03 47.34 4.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 109.832 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 138.8 -27.54 2.69 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' O ' HG22 ' A' ' 37' ' ' THR . . . -44.65 141.57 2.0 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.288 . . . . 0.0 109.791 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.42 147.72 26.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.707 . . . . 0.0 110.43 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -95.96 140.21 31.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.524 -0.735 . . . . 0.0 109.52 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 155.51 -59.77 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.805 -0.559 . . . . 0.0 110.46 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 1.025 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.8 Cg_endo -70.02 79.98 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.402 2.068 . . . . 0.0 110.308 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 3.9 mt-10 157.83 -15.65 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -165.28 -168.26 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.796 -1.19 . . . . 0.0 111.402 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 18.9 mt -109.06 122.89 48.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.979 HG13 ' CG2' ' A' ' 60' ' ' ILE . 72.7 t -114.3 124.28 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.405 -0.81 . . . . 0.0 110.749 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -123.62 162.08 23.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -153.18 -175.55 5.39 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.306 -1.496 . . . . 0.0 111.086 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -160.31 154.91 23.9 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.808 0.813 . . . . 0.0 109.993 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.531 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 6.4 m -45.54 -64.87 0.63 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' PHE . 1.5 p -94.68 21.36 7.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.701 -1.249 . . . . 0.0 111.105 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.642 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.9 t -172.93 -173.17 0.93 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.708 -1.245 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.579 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.0 t 179.88 158.23 0.71 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.804 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 89.3 p -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.979 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.2 pt -138.55 121.86 19.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.773 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -104.07 157.71 16.93 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 118.744 -1.182 . . . . 0.0 112.422 -177.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.768 ' CD1' HD22 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -109.2 88.91 6.27 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 19' ' ' THR . 36.4 Cg_endo -70.69 -12.33 30.98 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.234 1.956 . . . . 0.0 109.451 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -142.15 61.72 1.44 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -84.3 141.47 30.91 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.898 -1.126 . . . . 0.0 109.669 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.799 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.9 tttt -151.1 -175.72 5.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.8 ttt85 -44.99 -46.17 11.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.84 87.3 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.332 -0.855 . . . . 0.0 110.116 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 11.9 t0 -53.19 -21.28 4.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.72 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 70' ' ' SER . 31.7 p -56.65 95.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.252 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.98 -171.25 16.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' ND2' ' HG3' ' A' ' 89' ' ' GLU . 13.1 m120 -105.31 91.38 3.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.365 -1.08 . . . . 0.0 109.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 45' ' ' LEU . 30.8 m-85 -70.01 94.71 0.89 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.687 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -99.72 161.06 13.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -149.69 140.24 22.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -0.97 . . . . 0.0 109.627 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -129.78 108.99 10.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.41 -0.806 . . . . 0.0 109.145 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.891 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -115.02 130.95 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.962 -1.086 . . . . 0.0 109.567 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -127.65 -168.65 1.92 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.533 0.683 . . . . 0.0 110.421 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER 176.95 142.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.565 -0.709 . . . . 0.0 109.191 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER 40.77 -94.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.018 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 80' ' ' GLU . 5.7 mp -126.33 -10.57 6.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.21 152.41 26.76 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.1 pt-20 -143.18 156.85 44.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.079 -1.248 . . . . 0.0 109.738 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 5' ' ' ILE . 6.0 t0 -160.3 175.99 12.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 5.2 pt-20 -165.22 130.23 2.53 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.159 -0.963 . . . . 0.0 109.76 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -94.38 158.02 15.75 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.215 -0.928 . . . . 0.0 109.04 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.955 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -125.47 131.43 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.955 ' N ' HD13 ' A' ' 87' ' ' ILE . 32.0 m-85 -139.25 97.51 3.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 3.4 tt0 -79.08 106.26 10.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 14' ' ' ILE . 4.3 t -104.04 115.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.144 -0.973 . . . . 0.0 110.81 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.645 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.9 mp -109.67 163.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 66' ' ' LYS . 9.0 t -130.1 145.36 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.356 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 50.39 167.18 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 2' ' ' LYS . 39.6 Cg_endo -88.48 169.58 5.81 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.831 -1.321 . . . . 0.0 111.575 59.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -143.01 74.85 1.46 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.762 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -81.27 121.87 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.392 0.615 . . . . 0.0 109.922 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 7' ' ' THR . 3.9 mp -114.77 -10.22 12.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.888 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.588 ' HB ' HG13 ' A' ' 24' ' ' VAL . 5.2 t -37.88 130.99 1.08 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.16 -31.98 21.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.706 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 16.3 p 44.16 95.33 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.582 -0.699 . . . . 0.0 109.723 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.84 -79.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.742 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -150.65 -176.79 5.64 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.452 -0.78 . . . . 0.0 109.777 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.896 HG22 ' CG1' ' A' ' 14' ' ' ILE . 27.6 mm -155.35 87.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.53 84.74 0.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.896 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.1 mt -89.23 164.77 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.639 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 1.9 mmtt -95.92 167.94 10.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.88 147.71 40.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 0.0 109.869 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 44.42 31.47 2.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.51 -178.18 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.157 -1.202 . . . . 0.0 110.654 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.6 p -117.63 128.81 55.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.676 -0.64 . . . . 0.0 109.708 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.774 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.1 t60 -118.85 151.42 38.12 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.321 -0.862 . . . . 0.0 109.896 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -118.97 84.95 2.28 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.875 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -66.9 135.66 54.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.63 -0.669 . . . . 0.0 110.353 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -130.06 152.7 49.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 23' ' ' GLU . 9.6 t -160.27 142.12 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.224 -0.923 . . . . 0.0 109.086 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 1.1 m-20 -115.25 137.24 52.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.93 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.762 ' CB ' HD12 ' A' ' 5' ' ' ILE . 2.5 p90 -168.97 119.45 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -80.85 -169.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 135.6 105.74 0.82 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.954 ' H ' HD23 ' A' ' 1' ' ' LEU . . . -138.07 167.28 20.66 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.988 -1.301 . . . . 0.0 109.625 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 145.08 82.95 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.031 -1.654 . . . . 0.0 110.868 1.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.32 97.31 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 37.8 Cg_endo -80.23 -168.19 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.727 2.285 . . . . 0.0 109.938 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.5 m -148.15 112.57 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 109.652 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -106.16 137.28 44.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 44.8 m -118.68 118.2 30.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.875 ' CH2' HD21 ' A' ' 22' ' ' LEU . 56.0 m95 -86.77 91.51 8.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.945 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -111.14 159.86 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.959 -1.088 . . . . 0.0 109.874 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' GLY . 7.1 p -109.07 179.13 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 84.44 -141.89 20.01 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.1 p-10 -115.69 -21.25 9.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -1.122 . . . . 0.0 109.642 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.9 t 165.71 71.73 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.154 -0.967 . . . . 0.0 109.84 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.48 -34.07 0.27 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . -81.02 150.17 28.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.306 -1.114 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.945 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.61 152.39 21.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.935 . . . . 0.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD22 ' HB3' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -50.33 165.62 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.078 -1.014 . . . . 0.0 109.541 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -82.56 132.11 53.16 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 109.898 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.52 -5.14 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.124 1.883 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -73.71 -17.74 61.09 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -104.24 -167.44 1.36 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.325 -0.859 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.6 mt -120.54 167.97 11.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.8 t -155.99 140.06 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.641 -1.287 . . . . 0.0 111.111 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 3.0 m-20 -138.4 157.29 46.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -157.18 147.18 20.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.315 -1.491 . . . . 0.0 110.883 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.1 OUTLIER -121.35 159.0 27.0 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.771 0.796 . . . . 0.0 110.175 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 p -49.46 -58.41 5.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.444 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 6.3 m -94.67 20.13 9.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.735 -1.228 . . . . 0.0 110.862 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' THR . 6.2 t -173.33 -161.74 0.14 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.726 -1.234 . . . . 0.0 109.384 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 9.9 t 175.89 154.37 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.7 m -156.07 141.83 17.93 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.4 pt -128.64 164.74 29.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.794 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -109.12 158.03 18.17 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.42 1.266 . . . . 0.0 114.42 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.5 m-85 -143.96 47.31 0.75 Allowed Pre-proline 0 N--CA 1.492 1.645 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.93 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.768 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -63.67 -12.9 33.61 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.234 1.956 . . . . 0.0 110.507 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.6 m -128.39 48.9 2.24 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.642 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -88.97 141.68 28.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.054 -1.029 . . . . 0.0 110.023 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.864 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.81 178.17 8.71 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.42 -47.89 5.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.755 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.86 89.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.233 -0.917 . . . . 0.0 110.221 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' HB3' HG21 ' A' ' 92' ' ' VAL . 19.4 t70 -53.42 -21.67 6.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.155 -0.966 . . . . 0.0 109.754 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 70' ' ' SER . 6.3 p -57.38 108.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.461 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.46 -172.56 23.17 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 51.9 m-80 -98.0 89.96 4.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -1.09 . . . . 0.0 109.184 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.583 ' CE2' ' HG ' ' A' ' 45' ' ' LEU . 6.2 m-85 -73.03 86.96 1.34 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.254 -0.904 . . . . 0.0 109.717 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 14.2 tttt -89.44 124.88 34.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.033 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.77 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.28 133.23 53.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.197 -0.939 . . . . 0.0 108.753 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 7.3 pttt -128.9 114.39 16.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.107 -0.996 . . . . 0.0 109.581 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.1 m -109.37 159.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.278 -0.889 . . . . 0.0 109.181 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.85 170.24 22.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.158 -0.964 . . . . 0.0 109.487 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 81' ' ' LEU . 1.8 t30 -163.43 132.2 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' OE1' ' ND2' ' A' ' 79' ' ' ASN . 1.0 OUTLIER 41.41 -94.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -121.84 -15.58 7.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 109.854 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . -76.99 160.83 50.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.517 ' CB ' ' HG3' ' A' ' 78' ' ' LYS . 1.4 pm0 -152.8 140.41 19.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.244 . . . . 0.0 110.182 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -142.85 158.43 43.63 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 56.7 mt-10 -158.42 161.38 37.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.987 -1.071 . . . . 0.0 110.191 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -147.38 136.03 21.93 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.508 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -92.99 132.43 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.706 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 97.7 m-85 -126.51 96.31 4.64 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.207 -0.933 . . . . 0.0 109.301 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.13 106.47 11.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -98.39 126.21 51.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.61 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.7 mp -115.84 168.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.864 HG11 ' C ' ' A' ' 66' ' ' LYS . 17.3 t -143.89 127.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.113 -0.992 . . . . 0.0 110.238 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.459 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.906 HD13 ' H1 ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.579 0.704 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 21.9 ptmt -45.7 140.12 4.63 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.581 -0.699 . . . . 0.0 109.608 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.5 Cg_endo -79.27 117.32 3.77 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.777 2.318 . . . . 0.0 110.446 -155.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HE3' HG21 ' A' ' 27' ' ' ILE . 1.5 mtmp? -89.03 76.95 7.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.08 -1.013 . . . . 0.0 108.914 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.1 tt -74.43 118.52 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -116.49 -4.27 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 110.663 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.627 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -36.68 135.58 0.41 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.385 -0.822 . . . . 0.0 109.983 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.04 -57.01 4.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.262 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.596 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 68.59 125.99 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.606 -0.684 . . . . 0.0 109.587 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 4.4 ttt180 178.43 -88.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.393 -0.817 . . . . 0.0 109.356 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -155.87 -170.54 3.44 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.538 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.888 ' O ' HG22 ' A' ' 91' ' ' ILE . 31.9 mm -156.18 149.09 11.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.376 -0.827 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 91' ' ' ILE . 2.6 mtpt -117.01 76.22 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 92' ' ' VAL . 1.5 mt -90.3 160.67 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.136 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -108.0 165.87 11.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.774 -1.204 . . . . 0.0 108.941 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.52 147.88 51.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.086 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 50.92 34.78 30.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.76 -177.01 3.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.152 -1.204 . . . . 0.0 110.946 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 63' ' ' PRO . 65.4 p -123.89 124.79 43.4 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HD1' HG23 ' A' ' 14' ' ' ILE . 3.0 t60 -114.75 164.07 14.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 110.363 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 36.9 p30 -132.54 88.05 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.942 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -76.81 137.53 39.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.786 . . . . 0.0 110.465 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.1 mt-10 -128.48 152.93 47.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.435 -0.791 . . . . 0.0 110.011 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 18.5 t -160.04 160.02 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 10.8 t70 -148.75 146.96 28.3 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.122 . . . . 0.0 111.225 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.721 ' CG ' HG21 ' A' ' 77' ' ' VAL . 51.2 p90 -162.12 128.64 3.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.599 -0.688 . . . . 0.0 109.523 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.06 86.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -116.55 142.12 17.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.19 173.27 1.86 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.154 . . . . 0.0 109.322 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.7 Cg_endo -71.71 1.35 8.04 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.643 -1.399 . . . . 0.0 111.15 1.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 3.3 m-20 -174.56 89.19 0.33 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.195 -0.941 . . . . 0.0 109.282 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.504 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.4 Cg_endo -79.44 -165.85 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.747 2.298 . . . . 0.0 110.79 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 48.2 m -147.89 113.55 5.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.716 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -104.07 110.42 22.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.94 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 76' ' ' LYS . 8.7 t -98.78 123.46 43.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.424 -0.798 . . . . 0.0 109.231 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.942 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.1 m95 -87.69 107.42 18.62 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.315 1.055 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.1 165.57 11.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.883 -1.136 . . . . 0.0 109.662 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.7 p -111.79 -168.15 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -64.56 -140.31 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.76 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER 63.02 9.48 3.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -1.095 . . . . 0.0 109.859 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER 44.34 50.46 7.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.307 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.6 -13.58 1.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' O ' HG22 ' A' ' 37' ' ' THR . . . -71.11 170.46 12.87 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.193 -1.18 . . . . 0.0 108.95 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -135.25 161.29 35.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 109.644 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.108 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -134.36 151.94 51.51 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.77 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.35 -55.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -70.61 -0.83 8.22 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.296 1.997 . . . . 0.0 111.404 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.031 ' O ' HD23 ' A' ' 49' ' ' LEU . 2.4 mt-10 -114.9 14.11 17.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.108 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -162.7 -164.02 0.95 Allowed 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.463 -0.773 . . . . 0.0 109.448 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.2 76.01 1.05 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 60' ' ' ILE . 38.4 t -78.66 128.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.952 -1.093 . . . . 0.0 111.997 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' SER . 20.1 m-20 -130.25 155.22 46.65 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.53 148.48 19.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.394 -1.441 . . . . 0.0 110.867 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -125.25 161.72 26.29 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.127 0.965 . . . . 0.0 110.156 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.556 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 12.2 p -49.17 -51.86 29.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.839 -0.538 . . . . 0.0 112.445 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 67.2 m -98.56 19.86 13.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.422 -1.424 . . . . 0.0 111.315 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.563 HG22 ' CG ' ' A' ' 54' ' ' LYS . 7.4 t -178.8 -163.92 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.702 -1.249 . . . . 0.0 109.228 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.6 t 176.61 154.99 0.23 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.857 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -156.74 145.03 19.63 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -129.44 166.82 26.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.542 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -119.45 154.3 33.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.685 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -136.97 48.08 2.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.724 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.4 Cg_endo -63.74 -13.02 34.37 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.066 1.844 . . . . 0.0 109.496 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 m -123.92 46.83 2.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.84 142.98 31.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.025 -1.047 . . . . 0.0 110.164 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.742 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -149.93 166.44 29.59 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -43.83 -40.09 4.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.51 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.9 82.64 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.37 -22.48 42.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 8.9 p -47.05 108.9 0.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -163.83 -164.75 19.71 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 25.0 m-20 -107.36 94.13 4.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.194 -1.18 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.668 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 42.6 m-85 -70.86 100.36 1.92 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.623 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -111.31 121.95 46.57 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.755 . . . . 0.0 109.051 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -115.9 149.82 38.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 19.0 ttpt -137.0 122.72 19.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.721 HG21 ' CG ' ' A' ' 26' ' ' PHE . 2.8 m -110.67 114.93 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.74 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.4 mtpt -100.85 -174.02 2.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.183 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' LEU . 2.6 t-20 -174.77 123.58 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.562 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 40.99 -93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.088 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 79' ' ' ASN . 13.5 mt -120.0 -17.86 8.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -90.57 161.4 28.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 1.7 pt-20 -164.75 168.31 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.963 -1.316 . . . . 0.0 110.421 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.619 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.41 171.65 18.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 1.1 pm0 -159.2 143.44 15.28 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.884 -1.135 . . . . 0.0 110.444 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.604 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -118.8 135.71 54.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.502 -0.749 . . . . 0.0 109.096 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.83 145.25 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.784 ' N ' HD13 ' A' ' 87' ' ' ILE . 74.9 m-85 -146.17 95.19 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.847 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 2.2 tm-20 -78.37 111.92 14.85 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 73' ' ' TYR . 40.1 t -104.44 123.88 58.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.314 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.888 HG22 ' O ' ' A' ' 12' ' ' ILE . 4.4 tp -103.51 151.84 6.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' A' ' 14' ' ' ILE . 71.6 t -140.35 120.84 13.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.955 -1.09 . . . . 0.0 110.28 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.619 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.76 HD22 ' N ' ' A' ' 1' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.314 0.578 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG3' ' HD2' ' A' ' 3' ' ' PRO . 10.8 ttpt -34.51 131.54 0.43 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 122.143 -0.348 . . . . 0.0 110.447 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 2' ' ' LYS . 36.6 Cg_endo -79.15 103.83 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.632 2.221 . . . . 0.0 110.542 -171.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 28.9 mttp -78.7 78.64 5.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.66 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.04 116.94 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.5 mp -105.19 -18.75 14.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 111.057 -178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.697 ' CG2' HG13 ' A' ' 24' ' ' VAL . 6.9 t -40.35 134.69 1.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.052 -1.03 . . . . 0.0 109.588 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -108.14 -20.64 13.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.0 110.281 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.604 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . 15.2 m -24.89 141.66 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.227 0.537 . . . . 0.0 111.207 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.2 0.59 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.733 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER 174.21 160.15 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.724 -1.235 . . . . 0.0 109.031 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.959 HG21 ' NE2' ' A' ' 20' ' ' HIS . 20.3 mt -154.85 118.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 110.774 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -83.5 83.55 7.85 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.691 HD13 ' CG ' ' A' ' 20' ' ' HIS . 7.8 mt -86.59 125.76 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -59.69 152.05 23.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.693 -1.255 . . . . 0.0 109.657 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.48 147.46 47.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.175 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 66' ' ' LYS . . . 62.66 33.27 86.21 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.9 m-85 -119.78 -178.7 3.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.202 -1.175 . . . . 0.0 110.8 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.4 p -119.45 136.96 54.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.959 ' NE2' HG21 ' A' ' 12' ' ' ILE . 3.1 t60 -125.08 161.24 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.19 -0.944 . . . . 0.0 110.389 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.7 79.72 1.79 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.913 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.5 tt -64.0 135.3 56.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.632 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -124.66 148.57 47.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.601 -0.687 . . . . 0.0 109.6 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 ' CG2' ' A' ' 7' ' ' THR . 18.0 t -158.4 159.02 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.8 m-20 -146.08 146.34 30.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.855 -1.153 . . . . 0.0 111.166 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.4 p90 -161.42 127.8 3.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.548 -0.72 . . . . 0.0 109.583 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -79.93 83.31 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.344 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' C ' ' HG3' ' A' ' 32' ' ' PRO . . . -115.99 144.9 18.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.02 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -175.41 175.05 0.77 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.114 -1.227 . . . . 0.0 109.759 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.02 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 30.3 Cg_endo -69.23 -16.68 11.35 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.511 -1.454 . . . . 0.0 110.915 1.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 31' ' ' ASP . 7.7 p-10 -151.65 91.42 3.8 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.369 -0.832 . . . . 0.0 109.711 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 38.3 Cg_endo -81.57 -170.81 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.61 2.207 . . . . 0.0 110.465 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.9 m -149.64 112.2 4.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.671 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -97.33 129.18 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.747 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.479 ' HB ' ' CG ' ' A' ' 76' ' ' LYS . 35.8 m -105.09 119.68 39.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.88 . . . . 0.0 109.867 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.913 ' CH2' HD21 ' A' ' 22' ' ' LEU . 24.6 m95 -97.55 95.03 7.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.776 . . . . 0.0 108.936 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.822 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.27 164.33 12.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 109.818 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 38' ' ' VAL . 10.7 p -113.46 49.87 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.904 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.29 -142.39 48.37 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.1 t70 66.21 6.48 4.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -1.064 . . . . 0.0 109.748 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t 64.85 40.56 5.4 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.74 -24.46 2.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 37' ' ' THR . . . -47.3 142.34 4.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.956 -1.32 . . . . 0.0 109.556 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -108.84 148.01 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.0 110.024 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.083 HD21 ' CE2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -88.29 164.24 15.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.523 -0.736 . . . . 0.0 109.674 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.695 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 120.96 -45.87 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.17 1.32 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.834 1.689 . . . . 0.0 111.568 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' LEU . 43.3 mt-10 -134.36 22.54 3.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.08 HD11 HD23 ' A' ' 45' ' ' LEU . 1.1 pp 164.58 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.837 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -113.63 166.56 11.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.966 -1.084 . . . . 0.0 109.183 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.1 t -146.42 144.8 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.997 -1.065 . . . . 0.0 110.736 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 21.5 m-20 -138.06 157.78 45.64 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.4 147.21 14.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.178 -1.576 . . . . 0.0 111.094 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -123.09 158.03 31.56 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.578 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 57.5 p -51.54 -50.94 59.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.146 -0.971 . . . . 0.0 111.549 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 10.7 m -100.35 22.92 10.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.637 -1.289 . . . . 0.0 110.632 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.553 ' O ' ' HB ' ' A' ' 58' ' ' THR . 9.6 t -178.43 -164.21 0.07 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.84 -1.163 . . . . 0.0 108.682 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 175.76 157.32 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.267 -0.896 . . . . 0.0 109.801 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -160.13 146.83 15.95 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.889 ' CG2' HG13 ' A' ' 51' ' ' VAL . 13.6 pt -131.25 158.5 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 117.94 -1.504 . . . . 0.0 111.245 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.643 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.8 m-85 -105.69 154.29 20.66 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.615 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.8 48.85 1.09 Allowed Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.0 Cg_endo -64.09 -12.47 32.51 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.668 1.578 . . . . 0.0 109.52 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.76 44.84 2.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -78.88 140.05 38.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.928 -1.107 . . . . 0.0 109.547 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.866 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -153.4 175.99 12.52 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.19 -45.41 5.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.0 90.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.217 -0.927 . . . . 0.0 110.493 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.6 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -56.18 -19.21 12.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.955 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.517 ' CA ' HG23 ' A' ' 92' ' ' VAL . 54.2 p -56.85 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.122 -0.986 . . . . 0.0 109.566 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -138.65 176.71 20.67 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 8.0 t30 -87.76 89.54 8.03 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.374 -1.074 . . . . 0.0 108.177 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.083 ' CE2' HD21 ' A' ' 45' ' ' LEU . 4.3 m-85 -73.74 93.32 2.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.483 -0.761 . . . . 0.0 109.45 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -99.79 159.22 15.23 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -142.44 144.26 32.98 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.125 -0.984 . . . . 0.0 109.058 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.537 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.0 ptmm? -142.81 108.02 4.99 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.671 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.4 m -104.28 127.74 58.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.537 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -123.92 171.65 9.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.521 -0.737 . . . . 0.0 109.802 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -165.67 138.09 4.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.032 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 79' ' ' ASN . 3.8 tt0 34.02 -92.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.693 -0.629 . . . . 0.0 110.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -124.41 -11.01 7.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -0.885 . . . . 0.0 109.973 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 78' ' ' LYS . . . -83.3 151.79 28.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -148.12 145.44 28.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.002 -1.293 . . . . 0.0 110.488 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.66 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -157.49 151.31 24.24 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 84' ' ' ASP . 37.0 mp0 -151.39 160.16 43.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.082 . . . . 0.0 110.439 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -128.33 168.68 15.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' C ' ' CD1' ' A' ' 88' ' ' PHE . 2.0 tt -128.15 137.04 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.076 -1.015 . . . . 0.0 109.561 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 0.7 OUTLIER -141.74 95.03 2.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.16 -0.963 . . . . 0.0 109.838 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -78.74 95.35 5.3 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 73' ' ' TYR . 13.1 t -89.78 113.94 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.102 -0.999 . . . . 0.0 110.31 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 4.4 mt -105.16 165.29 3.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.866 HG11 ' C ' ' A' ' 66' ' ' LYS . 10.1 t -134.87 132.36 53.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.557 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.442 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.83 HD11 HG22 ' A' ' 27' ' ' ILE . 2.2 pp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.333 0.587 . . . . 0.0 109.664 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.651 ' O ' HD12 ' A' ' 1' ' ' LEU . 4.1 mtmp? -54.05 141.91 48.09 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.554 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.3 Cg_endo -78.23 96.2 1.09 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.653 2.235 . . . . 0.0 110.563 -170.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -79.01 83.98 5.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.058 -1.026 . . . . 0.0 109.007 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.2 tt -80.81 116.66 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.2 mp -121.18 10.68 10.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.853 . . . . 0.0 110.158 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.556 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -29.44 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.259 0.552 . . . . 0.0 110.828 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' H ' HG23 ' A' ' 7' ' ' THR . . . -177.44 -36.16 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.047 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.578 ' HB2' HG22 ' A' ' 87' ' ' ILE . 13.7 p 38.68 97.95 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.642 0.734 . . . . 0.0 110.612 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' C ' ' HG3' ' A' ' 11' ' ' LYS . 34.3 mtt180 -149.21 -85.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 109.026 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' O ' HD13 ' A' ' 12' ' ' ILE . 37.2 mtpt -153.77 -176.38 5.8 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.698 -0.626 . . . . 0.0 109.61 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.926 HG23 ' NE2' ' A' ' 20' ' ' HIS . 34.4 mm -155.8 89.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.341 -0.849 . . . . 0.0 109.386 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -72.13 84.42 1.02 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 108.619 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.875 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.9 mt -85.34 147.3 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.367 -0.833 . . . . 0.0 110.307 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.734 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 4.4 mtmm -84.61 129.22 34.87 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.522 -0.736 . . . . 0.0 109.101 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.64 143.95 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.188 -0.945 . . . . 0.0 110.843 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 41.45 70.5 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.786 ' HE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -159.57 -171.08 3.15 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.032 -1.276 . . . . 0.0 110.464 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.4 p -113.84 129.35 56.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 111.597 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.926 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.6 t60 -118.59 163.45 16.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.659 -0.65 . . . . 0.0 109.391 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.48 99.64 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.95 . . . . 0.0 109.175 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.89 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -86.48 130.71 34.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 110.118 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -119.95 147.32 44.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 10.9 t -154.51 158.96 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.6 t70 -151.62 145.13 24.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.885 -1.134 . . . . 0.0 111.139 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CD2' HD12 ' A' ' 5' ' ' ILE . 49.1 p90 -161.86 133.83 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.048 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 1' ' ' LEU . 1.5 mp -87.9 86.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.7 . . . . 0.0 110.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -121.77 156.22 16.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.48 170.94 0.22 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 109.625 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -75.17 145.79 84.64 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 123.328 -1.53 . . . . 0.0 110.492 0.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.6 m-20 33.34 79.93 0.27 Allowed Pre-proline 0 N--CA 1.493 1.693 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.484 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 55' ' ' SER . 37.5 Cg_endo -79.46 -162.33 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.73 2.286 . . . . 0.0 110.38 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 34' ' ' ALA . 87.8 m -143.54 160.06 41.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -158.31 102.02 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 35' ' ' THR . 10.6 t -88.88 124.84 34.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.373 -0.829 . . . . 0.0 109.603 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.966 ' CE2' HD13 ' A' ' 75' ' ' LEU . 26.2 m95 -84.54 108.5 17.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.224 1.012 . . . . 0.0 108.633 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.837 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -107.02 170.24 8.07 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.694 -1.253 . . . . 0.0 110.389 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.5 p -127.75 52.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.439 0.638 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 72' ' ' ASN . . . 167.69 -141.29 6.75 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 41' ' ' SER . 3.7 p30 -89.09 47.5 1.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -1.11 . . . . 0.0 109.648 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.568 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER 83.1 -28.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.648 -0.657 . . . . 0.0 110.506 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.23 -56.22 4.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 37' ' ' THR . . . -60.82 153.61 24.1 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.609 -0.936 . . . . 0.0 108.593 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.75 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -145.13 161.31 39.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.788 -1.195 . . . . 0.0 110.11 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.155 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -138.51 148.55 44.41 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.654 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.87 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 167.85 -54.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 110.716 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.87 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -71.18 -1.2 9.21 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.293 1.995 . . . . 0.0 111.105 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.03 ' O ' HD23 ' A' ' 49' ' ' LEU . 13.9 mt-10 -117.78 12.14 13.79 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.155 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.69 -163.98 1.05 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.682 0.753 . . . . 0.0 109.414 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 mp -118.12 78.58 1.27 Allowed 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.861 HG13 ' CG2' ' A' ' 60' ' ' ILE . 23.2 t -79.12 126.22 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 111.718 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -127.58 155.69 43.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -159.15 147.55 18.0 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.297 -1.502 . . . . 0.0 110.889 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -124.92 163.01 23.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.395 1.093 . . . . 0.0 110.503 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.558 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 3.6 p -51.97 -52.82 47.88 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -96.17 18.83 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.678 -1.264 . . . . 0.0 110.993 -178.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 7.1 t -177.45 -165.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.604 -1.31 . . . . 0.0 109.499 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.587 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.6 t 177.49 154.12 0.28 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.41 -0.806 . . . . 0.0 109.439 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.2 p -159.93 146.53 16.07 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.861 ' CG2' HG13 ' A' ' 51' ' ' VAL . 12.4 pt -129.3 171.58 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.59 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.735 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.8 m-85 -124.73 154.93 40.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.4 OUTLIER -136.93 48.19 2.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.743 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -64.2 -12.61 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.237 1.958 . . . . 0.0 109.695 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.77 60.14 1.65 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -96.81 140.43 31.38 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.848 -1.158 . . . . 0.0 109.858 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.515 ' O ' HG11 ' A' ' 92' ' ' VAL . 6.5 mmtt -118.61 176.34 5.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 1.6 ptt85 -54.83 -43.49 73.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.028 -1.045 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -59.09 -30.06 67.81 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.313 -0.867 . . . . 0.0 109.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -44.66 -25.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.233 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.526 ' N ' HG23 ' A' ' 92' ' ' VAL . 17.7 t -53.47 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -144.75 -172.92 15.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 86.7 m-20 -98.98 90.99 4.82 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.209 -1.171 . . . . 0.0 108.768 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.645 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 31.2 m-85 -72.33 94.84 1.65 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.343 -0.848 . . . . 0.0 108.802 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -109.63 121.51 45.36 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.966 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.23 147.23 37.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 9.0 ttmt -130.31 136.5 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -123.73 154.48 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.015 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -157.23 179.38 9.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 110.389 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 3' ' ' PRO . 8.4 p-10 -177.46 109.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 109.399 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' ' HG ' ' A' ' 81' ' ' LEU . 87.0 tt0 62.71 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.322 -0.861 . . . . 0.0 109.987 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.0 pp -129.15 -6.39 4.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.962 -1.086 . . . . 0.0 110.277 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.684 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -96.42 138.36 13.89 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -155.2 140.57 17.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.896 -1.355 . . . . 0.0 111.138 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 5' ' ' ILE . 3.6 m-20 -132.46 -174.28 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.8 tm-20 -166.57 143.04 4.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.899 -1.125 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.649 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -120.72 128.1 52.62 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.319 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -94.74 135.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.649 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 48.0 m-85 -134.47 102.8 5.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.859 . . . . 0.0 109.755 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 mt-10 -78.95 102.69 8.43 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.773 HG13 ' HB ' ' A' ' 12' ' ' ILE . 12.1 t -99.08 127.45 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 110.701 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.559 ' CG2' ' N ' ' A' ' 92' ' ' VAL . 1.2 mp -118.62 169.77 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 69' ' ' ASP . 2.5 t -139.33 135.28 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.482 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.46 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -64.71 145.14 98.84 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.6 Cg_endo -80.23 109.43 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.828 2.352 . . . . 0.0 109.905 -156.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 19.7 mttt -96.73 86.11 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.025 . . . . 0.0 109.189 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.759 HG22 ' HB2' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -75.67 117.45 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -109.52 -7.82 15.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 110.378 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -39.2 124.06 1.45 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.9 -54.44 6.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.6 p 66.0 130.61 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.563 -0.71 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mtp85 -175.36 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -0.83 . . . . 0.0 109.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -143.61 -177.64 5.5 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.589 -0.694 . . . . 0.0 109.312 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.861 HG23 ' NE2' ' A' ' 20' ' ' HIS . 21.4 mm -154.86 92.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -76.1 95.02 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.837 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.771 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.1 mt -104.18 151.71 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 5.1 tptt -92.73 158.33 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.157 . . . . 0.0 108.686 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.1 144.38 53.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.027 -1.045 . . . . 0.0 109.419 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.64 34.99 88.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.665 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.7 m-85 -119.51 -177.83 3.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.094 -1.239 . . . . 0.0 111.307 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.4 p -121.32 126.05 48.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -114.92 161.38 18.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 109.899 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.61 91.24 2.97 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -80.29 133.98 36.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.469 -0.769 . . . . 0.0 110.326 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.1 pt-20 -123.65 153.6 40.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.81 . . . . 0.0 109.963 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 13.5 t -158.4 160.89 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.9 m-20 -150.4 143.51 24.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.972 -1.08 . . . . 0.0 110.59 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 5' ' ' ILE . 54.2 p90 -161.18 126.96 3.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 0.0 109.456 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.17 85.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.82 . . . . 0.0 110.223 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -128.43 155.61 20.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.902 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.21 170.97 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.323 -1.104 . . . . 0.0 109.466 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.902 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -74.29 147.28 89.05 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 123.34 -1.525 . . . . 0.0 110.629 0.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 36.81 76.89 0.42 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 122.042 -0.411 . . . . 0.0 110.4 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.0 Cg_endo -79.06 177.46 8.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.711 2.274 . . . . 0.0 110.17 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 1.5 m -107.3 151.36 25.57 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -155.56 103.85 2.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 108.764 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.724 HG22 HG23 ' A' ' 37' ' ' THR . 88.0 m -94.56 125.8 39.44 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 110.449 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.927 ' CH2' HD21 ' A' ' 22' ' ' LEU . 15.9 m95 -96.95 85.97 3.89 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.724 HG23 HG22 ' A' ' 35' ' ' THR . 2.0 p -97.13 157.21 16.04 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.204 1.002 . . . . 0.0 111.546 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.641 HG12 ' CB ' ' A' ' 43' ' ' ALA . 8.3 p -99.15 41.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.107 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 38.47 88.36 0.01 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.7 m-20 179.13 62.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -1.159 . . . . 0.0 109.275 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 65.61 52.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.55 3.75 73.04 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' THR . . . -42.32 146.45 0.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -1.055 . . . . 0.0 109.818 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -118.92 147.77 43.66 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -113.61 36.4 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.726 -1.589 . . . . 0.0 110.647 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . -75.06 -58.37 1.57 Allowed Pre-proline 0 C--N 1.298 -1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.556 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -70.6 80.14 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.465 2.11 . . . . 0.0 110.723 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 47' ' ' PRO . 1.4 tt0 161.11 -22.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -137.27 -165.61 1.79 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.329 -0.857 . . . . 0.0 109.787 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.907 ' O ' HD13 ' A' ' 50' ' ' LEU . 1.8 tm? -123.48 82.55 2.02 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.911 HG13 ' CG2' ' A' ' 60' ' ' ILE . 33.7 t -78.79 126.45 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.192 -0.943 . . . . 0.0 111.824 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -122.09 155.5 35.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.42 146.83 18.63 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.147 -1.595 . . . . 0.0 111.281 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -117.51 157.95 25.4 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.713 0.768 . . . . 0.0 110.045 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 66.3 m -51.93 -50.91 60.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.117 -0.989 . . . . 0.0 111.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -99.87 24.18 8.79 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.625 -1.297 . . . . 0.0 110.687 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 10.3 t -178.57 -167.09 0.11 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 108.972 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.5 t 177.76 155.13 0.33 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.118 -0.989 . . . . 0.0 109.98 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.0 p -157.1 142.31 17.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.911 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.2 pt -125.94 166.03 22.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 118.144 -1.422 . . . . 0.0 110.482 -177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -119.95 151.83 38.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.777 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -135.28 46.65 1.86 Allowed Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.331 178.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.1 Cg_endo -63.55 -12.91 33.35 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.068 1.845 . . . . 0.0 109.736 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 m -126.09 49.47 1.97 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.36 143.32 26.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.98 -1.075 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.869 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.67 -178.01 5.95 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.298 0.571 . . . . 0.0 109.782 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttp85 -42.46 -46.65 4.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.16 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' ' HE3' ' A' ' 66' ' ' LYS . . . -57.69 -42.73 84.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.955 . . . . 0.0 110.209 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.6 OUTLIER -46.91 -23.6 0.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.0 109.989 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.453 ' CA ' HG23 ' A' ' 92' ' ' VAL . 4.5 t -53.84 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.53 -176.54 21.25 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' GLY . 11.4 m120 -99.46 91.07 4.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 108.659 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.592 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 22.1 m-85 -70.3 85.4 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.129 -0.982 . . . . 0.0 109.978 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 129.99 44.17 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.898 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -120.86 145.61 47.44 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.097 -1.002 . . . . 0.0 109.211 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.535 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.8 mttt -137.45 114.83 11.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 84' ' ' ASP . 1.1 m -109.79 147.86 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.405 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' C ' ' HG3' ' A' ' 3' ' ' PRO . 7.7 pttm -142.52 -170.36 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.092 -1.005 . . . . 0.0 109.782 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 15.7 t-20 -177.49 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.131 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.0 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -118.46 35.86 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.998 . . . . 0.0 109.859 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' HA3' ' HD2' ' A' ' 3' ' ' PRO . . . -135.21 134.42 7.29 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.83 139.26 44.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.034 -1.274 . . . . 0.0 110.529 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB2' HG22 ' A' ' 5' ' ' ILE . 22.2 p-10 -160.49 152.53 20.19 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 32.5 mt-10 -153.6 174.96 13.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 110.414 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CZ ' ' A' ' 88' ' ' PHE . . . -147.44 127.87 14.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD11 ' CG ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -91.61 128.52 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CZ ' ' CB ' ' A' ' 86' ' ' ALA . 56.6 m-85 -127.4 96.84 4.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.865 . . . . 0.0 109.572 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.576 ' CG ' HD11 ' A' ' 87' ' ' ILE . 3.6 mt-10 -78.55 107.16 11.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.807 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.5 t -102.27 128.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.641 HG22 ' N ' ' A' ' 92' ' ' VAL . 32.4 mt -118.06 166.15 12.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.795 . . . . 0.0 109.107 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.869 HG11 ' C ' ' A' ' 66' ' ' LYS . 7.7 t -132.8 132.08 59.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.829 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.561 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 5.8 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' LEU . 0.1 OUTLIER -44.02 132.81 4.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.5 Cg_endo -77.14 118.37 4.69 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.552 2.168 . . . . 0.0 110.491 -156.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.79 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -92.22 74.49 5.39 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.69 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.2 tt -69.59 106.33 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 122.069 0.938 . . . . 0.0 108.875 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -108.66 4.12 23.54 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.55 -0.718 . . . . 0.0 111.353 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.572 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -39.49 160.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' SER . . . -63.48 -49.12 74.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 109.802 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 35.9 t 61.83 123.0 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.515 0.674 . . . . 0.0 110.005 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER 174.54 -89.46 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.547 -0.721 . . . . 0.0 109.132 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG3' ' HB2' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -147.7 -170.6 3.61 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.608 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.894 HG23 ' NE2' ' A' ' 20' ' ' HIS . 11.8 mm -157.25 96.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -77.24 93.5 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.765 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -102.88 157.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.093 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.634 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.96 165.11 11.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.046 -1.034 . . . . 0.0 109.027 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -71.68 152.67 42.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 43.8 28.85 1.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -109.88 -176.85 3.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.217 -1.166 . . . . 0.0 110.638 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 63' ' ' PRO . 75.7 p -120.59 133.18 55.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.737 -0.602 . . . . 0.0 109.586 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.894 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.6 t60 -122.59 151.82 41.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.346 -0.846 . . . . 0.0 109.57 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.95 89.4 3.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.134 -0.979 . . . . 0.0 108.482 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.947 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -73.3 129.83 38.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.561 -0.712 . . . . 0.0 110.253 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.4 tm-20 -124.36 150.99 44.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.775 . . . . 0.0 109.811 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 16.2 t -158.09 161.73 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -152.03 142.58 22.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.994 -1.066 . . . . 0.0 110.803 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 49.1 p90 -156.61 131.36 8.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.682 . . . . 0.0 109.359 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.7 mp -82.18 78.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 109.83 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.81 146.14 18.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 173.4 169.3 0.26 Allowed Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.166 . . . . 0.0 109.614 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.873 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.52 144.78 82.07 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.137 -1.61 . . . . 0.0 110.304 0.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER 34.58 82.04 0.23 Allowed Pre-proline 0 N--CA 1.492 1.674 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.07 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.648 2.232 . . . . 0.0 110.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 m -131.62 113.59 13.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.233 -0.917 . . . . 0.0 109.291 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -108.43 118.57 37.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.405 ' HB ' ' HG3' ' A' ' 76' ' ' LYS . 88.6 m -104.69 121.0 42.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.947 ' CH2' HD21 ' A' ' 22' ' ' LEU . 31.6 m95 -86.38 98.56 11.06 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.406 1.098 . . . . 0.0 108.837 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.05 -179.73 4.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.921 -1.112 . . . . 0.0 110.648 -178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.0 p -133.71 77.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.122 0.963 . . . . 0.0 110.445 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 37.57 -152.97 0.02 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 t0 70.15 1.8 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.449 -1.03 . . . . 0.0 110.124 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 t 53.89 46.61 25.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.325 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.67 -21.16 0.91 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.83 ' O ' HG22 ' A' ' 37' ' ' THR . . . -69.43 164.89 22.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.38 -1.07 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -144.2 173.78 11.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.106 -0.996 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.803 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -139.56 144.99 38.08 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 118.105 -1.438 . . . . 0.0 110.516 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.979 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 172.57 -57.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.734 -0.603 . . . . 0.0 109.441 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.5 Cg_endo -71.58 82.05 1.21 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.309 2.006 . . . . 0.0 110.025 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 9.6 tt0 159.34 -25.4 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -142.25 -166.29 2.21 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.931 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -114.41 167.92 10.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.837 -1.164 . . . . 0.0 108.742 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.887 HG13 ' CG2' ' A' ' 60' ' ' ILE . 60.0 t -152.4 131.98 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.037 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -129.25 155.74 45.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -157.69 145.9 19.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.284 -1.51 . . . . 0.0 111.219 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -117.53 158.38 24.66 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.788 0.804 . . . . 0.0 110.048 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 5.3 t -49.88 -52.3 33.92 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 111.624 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -102.18 25.79 8.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.706 -1.246 . . . . 0.0 110.58 -178.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.0 t -177.78 -169.13 0.2 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.905 -1.122 . . . . 0.0 108.785 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.571 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.9 t 178.58 154.86 0.4 Allowed 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.94 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 52' ' ' ASP . 49.0 m -156.38 142.22 17.93 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.887 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.2 pt -128.29 159.77 39.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.472 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.912 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -106.81 157.83 17.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 2.0 m-85 -142.49 46.36 0.74 Allowed Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.352 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.931 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.4 Cg_endo -65.0 -13.45 39.83 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.865 1.71 . . . . 0.0 110.11 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.26 51.43 1.37 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -90.5 141.84 28.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.085 -1.009 . . . . 0.0 110.386 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.691 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -144.14 178.67 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.6 ttt180 -43.8 -41.63 5.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.753 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.25 85.01 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.262 -0.899 . . . . 0.0 109.964 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -45.22 -25.43 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 0.0 109.834 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.439 ' N ' HG23 ' A' ' 92' ' ' VAL . 42.4 m -50.59 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.719 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -148.84 -174.78 20.75 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.3 m-80 -103.78 99.87 9.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.19 -1.183 . . . . 0.0 108.588 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 10.8 m-85 -78.33 104.2 8.76 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.895 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -108.17 121.6 45.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -106.17 143.46 34.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 109.418 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 9.1 ptpt -138.75 107.98 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.643 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 ' CG ' ' A' ' 26' ' ' PHE . 1.4 m -108.17 123.47 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.8 mtpt -120.79 162.61 19.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 81' ' ' LEU . 4.9 t-20 -134.17 58.47 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.479 -0.763 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 50.7 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 79' ' ' ASN . 63.1 mt -74.29 0.57 13.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.11 -0.994 . . . . 0.0 110.25 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.21 175.4 20.42 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.6 pt-20 -167.35 137.94 2.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -1.211 . . . . 0.0 110.19 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.69 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -160.56 151.11 18.33 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 48.2 mt-10 -156.22 159.21 38.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.999 -1.063 . . . . 0.0 109.919 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -129.44 142.42 50.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.358 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.77 128.05 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.357 -0.839 . . . . 0.0 109.312 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.699 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 63.6 m-85 -127.37 98.8 5.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.723 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 87' ' ' ILE . 2.6 mm-40 -79.14 110.59 14.54 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 12' ' ' ILE . 48.2 t -105.46 129.96 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 0.0 110.568 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.621 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.7 mp -122.63 166.58 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.691 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.3 t -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.129 -0.982 . . . . 0.0 109.867 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.384 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 1.5 mm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -135.9 139.86 31.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.391 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 33.5 Cg_endo -75.79 144.3 27.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 110.125 -107.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.7 mttt -110.22 75.44 0.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 84' ' ' ASP . 0.9 OUTLIER -78.64 118.48 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.212 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -114.73 -5.97 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 110.463 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.651 ' CG2' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -35.12 134.51 0.26 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.512 -0.742 . . . . 0.0 110.087 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.72 -42.09 62.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.272 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.1 p 60.51 128.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.569 -0.707 . . . . 0.0 109.685 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -179.82 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.335 -0.853 . . . . 0.0 109.466 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -148.93 -170.34 3.6 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.512 -0.742 . . . . 0.0 109.894 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.87 ' HB ' HG22 ' A' ' 90' ' ' VAL . 12.9 mm -157.37 94.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -76.72 94.99 3.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 110.298 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.772 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -106.48 157.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -103.25 162.38 13.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.699 -1.25 . . . . 0.0 108.805 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.68 145.67 53.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.015 -1.053 . . . . 0.0 109.677 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 58.12 33.83 71.06 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.652 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.1 m-85 -117.16 -176.75 3.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.079 -1.248 . . . . 0.0 111.112 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.676 HG22 ' HA ' ' A' ' 63' ' ' PRO . 63.4 p -126.2 122.59 36.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.847 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.5 t60 -109.84 164.93 12.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.6 79.07 1.76 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.4 tt -63.77 137.31 58.01 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.653 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 24' ' ' VAL . 2.4 pp20? -130.24 152.73 49.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.678 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 14.0 t -159.16 154.81 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 108.724 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.63 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 67.1 t0 -133.76 139.39 46.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.213 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.824 ' CD1' HG21 ' A' ' 77' ' ' VAL . 20.4 p90 -166.37 125.58 1.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.4 mm -78.86 168.79 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 159.63 141.41 3.13 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.004 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -171.81 172.76 1.84 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.247 . . . . 0.0 109.488 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.004 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.2 Cg_endo -71.3 1.11 7.46 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.597 -1.418 . . . . 0.0 111.094 1.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 61.3 t0 -167.45 91.05 0.7 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.5 Cg_endo -78.18 174.06 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.672 2.248 . . . . 0.0 110.18 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 33.6 m -133.05 114.93 14.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.555 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -104.2 122.69 45.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.353 -0.842 . . . . 0.0 109.405 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -105.08 134.08 48.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.696 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.8 m95 -101.71 97.21 7.65 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.193 0.997 . . . . 0.0 109.181 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.618 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -105.0 174.66 5.78 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.979 -1.076 . . . . 0.0 110.601 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.2 p -128.03 63.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.873 0.844 . . . . 0.0 110.526 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.61 -154.44 0.39 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER 74.37 -1.89 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -1.053 . . . . 0.0 109.94 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 41' ' ' SER . 4.4 p 57.94 47.26 15.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.082 -1.011 . . . . 0.0 109.27 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.58 -14.55 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 37' ' ' THR . . . -79.71 160.9 26.09 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.27 -1.135 . . . . 0.0 109.099 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.607 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -140.43 172.95 12.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -140.51 146.04 37.64 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.87 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.799 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 163.97 -52.38 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.845 . . . . 0.0 110.373 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.48 -14.46 33.83 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.953 1.769 . . . . 0.0 110.897 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.859 ' HG2' HD23 ' A' ' 49' ' ' LEU . 3.3 pt-20 -100.95 14.58 31.43 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.859 HD23 ' HG2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -171.62 -164.13 0.31 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.6 HD23 ' CG ' ' A' ' 61' ' ' PHE . 11.4 tp -112.15 159.84 18.15 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 60' ' ' ILE . 66.0 t -149.95 142.67 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.8 OUTLIER -139.86 152.41 46.45 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.564 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 145.39 20.53 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.377 -1.452 . . . . 0.0 111.013 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.8 mmtt -121.44 159.34 26.43 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.715 0.769 . . . . 0.0 110.008 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 31.8 m -50.16 -52.01 38.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 111.953 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -98.33 20.04 13.29 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.644 -1.285 . . . . 0.0 111.248 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.0 t -177.46 -166.68 0.14 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.533 -1.355 . . . . 0.0 108.933 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.3 t 176.76 152.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.769 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -152.08 143.67 23.52 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.823 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.8 pt -129.86 151.38 35.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 C-N-CA 118.092 -1.443 . . . . 0.0 110.691 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.2 m-85 -98.45 157.89 15.93 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -174.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.697 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 1.5 m-85 -140.78 45.06 0.71 Allowed Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.088 177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 26.7 Cg_endo -63.0 -13.25 34.02 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.871 1.714 . . . . 0.0 109.937 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.11 48.87 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.98 140.34 29.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.969 -1.082 . . . . 0.0 110.295 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.895 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.5 mtmt -147.5 179.75 7.44 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 11.1 tpt180 -44.86 -43.03 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.173 -0.954 . . . . 0.0 109.899 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.31 83.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.907 . . . . 0.0 110.095 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.599 ' HB2' HG21 ' A' ' 92' ' ' VAL . 1.2 m-20 -45.5 -23.94 0.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.051 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 92' ' ' VAL . 74.8 p -52.99 89.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.81 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -146.38 177.25 24.84 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -97.54 93.23 6.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.145 -1.209 . . . . 0.0 108.92 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.697 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.8 m-85 -69.77 98.81 1.26 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.155 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HD3' HG23 ' A' ' 87' ' ' ILE . 7.6 mtmt -104.02 118.75 37.41 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.328 -0.857 . . . . 0.0 109.242 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.784 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.44 147.14 27.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.177 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 8.2 mttt -144.59 109.14 4.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.131 -0.981 . . . . 0.0 109.207 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.824 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.8 m -104.96 120.18 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 21.9 tttt -108.77 156.55 19.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.581 -0.699 . . . . 0.0 109.877 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.531 ' CB ' ' HA ' ' A' ' 2' ' ' LYS . 3.9 t30 -124.84 169.45 12.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.0 OUTLIER -29.25 -66.6 0.09 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.076 0.465 . . . . 0.0 111.14 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.31 38.61 4.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.801 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 2' ' ' LYS . . . -147.13 -178.96 22.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 14.6 pt-20 -166.11 139.85 4.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -1.172 . . . . 0.0 110.079 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 5' ' ' ILE . 2.7 m-20 -154.38 155.29 34.75 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -152.08 177.1 10.85 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.858 -1.152 . . . . 0.0 110.865 -178.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 7' ' ' THR . . . -149.01 134.0 18.09 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.789 HG23 ' HD3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -92.49 134.01 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 109.683 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 62.3 m-85 -133.78 93.38 3.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.031 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HD11 ' A' ' 91' ' ' ILE . 16.4 tt0 -78.58 105.65 10.01 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.87 HG22 ' HB ' ' A' ' 12' ' ' ILE . 42.9 t -99.77 129.76 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.699 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' HG2' ' A' ' 89' ' ' GLU . 3.0 mp -120.66 165.38 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 108.962 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.895 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.3 t -131.54 133.53 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.578 HD13 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -114.46 155.62 45.65 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.343 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.46 94.81 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.757 2.304 . . . . 0.0 110.381 -142.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -82.76 83.36 7.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.234 -0.916 . . . . 0.0 109.282 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.867 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -78.0 114.28 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.521 ' CD1' ' HE3' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -112.74 -2.03 14.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -33.46 139.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.638 -0.664 . . . . 0.0 110.29 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -48.09 -52.99 18.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.582 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 59.69 125.77 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.637 . . . . 0.0 109.693 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 31.8 ttm-85 178.24 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.448 -0.782 . . . . 0.0 109.104 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 8.2 mtmm -146.66 -179.0 6.47 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.538 -0.726 . . . . 0.0 109.366 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.877 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.7 mm -152.16 94.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 89.82 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 0.0 109.594 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.793 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.2 mt -97.36 157.17 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.938 . . . . 0.0 109.163 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -92.93 167.58 11.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.991 -1.068 . . . . 0.0 109.012 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -72.63 149.34 43.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.704 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 44.37 30.3 1.98 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -108.46 -177.39 3.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -1.193 . . . . 0.0 110.54 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 63' ' ' PRO . 75.3 p -116.13 143.03 46.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.736 -0.602 . . . . 0.0 109.719 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.877 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -133.57 158.78 42.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -132.14 87.95 2.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 108.566 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.887 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.5 tt -73.37 132.81 43.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.648 -0.658 . . . . 0.0 110.54 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.3 pt-20 -123.53 153.5 40.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.452 -0.78 . . . . 0.0 109.719 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.7 t -160.19 161.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.6 OUTLIER -151.63 142.68 23.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.854 -1.154 . . . . 0.0 111.172 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.558 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 51.6 p90 -157.78 128.9 6.6 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.435 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.42 86.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.513 -0.742 . . . . 0.0 110.396 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . -122.41 143.19 15.34 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.67 167.18 2.58 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.056 -1.261 . . . . 0.0 109.912 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.855 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.8 Cg_endo -75.04 140.08 65.28 Favored 'Cis proline' 0 C--N 1.31 -1.493 0 C-N-CA 123.005 -1.664 . . . . 0.0 110.4 0.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.8 t0 32.47 86.51 0.13 Allowed Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.7 Cg_endo -79.33 -166.98 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.63 2.22 . . . . 0.0 109.88 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.0 m -139.05 111.84 7.79 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.339 -0.851 . . . . 0.0 109.17 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -99.49 134.67 42.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.289 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 m -111.21 120.63 42.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.887 ' CH2' HD21 ' A' ' 22' ' ' LEU . 42.6 m95 -91.48 98.7 11.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.046 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -111.38 173.86 6.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.642 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -128.17 107.06 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . -24.55 89.46 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -168.03 43.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.0 109.149 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.5 t 72.05 54.94 0.18 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.411 -0.806 . . . . 0.0 109.94 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 75.4 4.3 73.89 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.046 ' O ' HG22 ' A' ' 37' ' ' THR . . . -44.3 146.71 0.63 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.26 -1.141 . . . . 0.0 109.297 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.99 146.34 24.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.025 HD11 ' CD2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -80.03 -172.79 3.59 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.291 -0.881 . . . . 0.0 109.901 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.734 ' N ' ' CD ' ' A' ' 47' ' ' PRO . . . 82.37 24.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.813 -0.554 . . . . 0.0 112.132 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.87 ' HD2' HD21 ' A' ' 49' ' ' LEU . 30.4 Cg_endo -67.21 87.71 0.32 Allowed 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.181 1.254 . . . . 0.0 109.968 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.0 OUTLIER 77.58 21.36 1.0 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.87 HD21 ' HD2' ' A' ' 47' ' ' PRO . 1.5 pp -138.57 -172.43 3.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.083 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 1.2 tt -115.14 169.15 9.33 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.25 -0.906 . . . . 0.0 109.816 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.853 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.3 t -148.16 148.61 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.071 -1.018 . . . . 0.0 110.148 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 59' ' ' SER . 16.1 m-20 -143.5 160.77 39.99 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -162.24 147.94 12.94 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.327 -1.483 . . . . 0.0 110.675 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -123.71 160.03 28.1 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.872 0.844 . . . . 0.0 110.586 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.536 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -44.48 -64.55 0.67 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.437 -0.79 . . . . 0.0 112.186 -179.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 p -97.66 25.64 5.66 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.622 -1.299 . . . . 0.0 110.691 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 8.3 t -172.05 -166.13 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.029 -1.044 . . . . 0.0 109.042 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.56 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.6 t 179.09 158.73 0.59 Allowed 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.13 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 52' ' ' ASP . 48.7 m -160.54 143.78 13.43 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.932 HD12 HD22 ' A' ' 45' ' ' LEU . 8.2 pt -127.81 161.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.639 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.679 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 4.0 m-85 -112.43 153.13 27.82 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.662 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.2 OUTLIER -140.79 48.59 1.37 Allowed Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' O ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -66.41 -14.54 44.55 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.056 1.838 . . . . 0.0 110.159 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.14 58.42 1.66 Allowed 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -105.35 144.56 31.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.684 ' C ' HG11 ' A' ' 92' ' ' VAL . 10.1 pttt -144.75 -172.24 3.78 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 10.1 ptm180 -41.54 -39.38 1.55 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.401 -0.812 . . . . 0.0 109.865 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.15 -49.58 73.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.216 -0.928 . . . . 0.0 109.867 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -48.87 -26.0 2.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.777 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -51.44 90.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -150.44 -170.96 18.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -102.93 105.77 16.18 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.14 -1.212 . . . . 0.0 108.421 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.025 ' CD2' HD11 ' A' ' 45' ' ' LEU . 3.1 m-85 -88.16 100.39 12.92 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.97 133.97 48.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.404 -0.81 . . . . 0.0 108.846 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -119.16 141.72 48.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.589 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.9 tttp -140.22 116.53 10.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 108.902 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.18 157.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 109.661 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 28.3 tttt -145.6 163.5 34.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.704 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 10.7 t-20 -161.77 99.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.285 -0.884 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 81' ' ' LEU . 7.0 tp10 60.86 -95.51 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -0.902 . . . . 0.0 109.916 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' N ' ' HG3' ' A' ' 80' ' ' GLU . 1.5 mt -116.55 -13.77 10.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.052 -1.03 . . . . 0.0 109.881 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.75 126.89 9.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -140.75 144.27 35.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.101 -1.235 . . . . 0.0 110.16 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.867 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -125.15 -179.98 4.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.504 -0.747 . . . . 0.0 109.142 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 8.5 tt0 -170.61 138.7 1.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -125.89 156.89 38.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.82 . . . . 0.0 109.236 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -106.29 135.69 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 109.51 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.019 ' N ' HD13 ' A' ' 87' ' ' ILE . 5.8 m-85 -136.2 97.29 3.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.3 mt-10 -79.61 120.83 24.5 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 73' ' ' TYR . 21.1 t -112.33 125.02 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.788 -1.195 . . . . 0.0 109.993 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.639 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.9 mm -118.71 167.09 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.418 -0.802 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.684 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.5 t -134.71 137.56 50.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.21 -0.931 . . . . 0.0 109.83 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 92' ' ' VAL . 29.8 mt-30 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.642 ' N ' ' HB3' ' A' ' 29' ' ' ALA . 7.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -42.13 142.15 1.25 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.455 -0.778 . . . . 0.0 109.608 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 2' ' ' LYS . 36.4 Cg_endo -79.21 110.5 2.73 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.521 2.147 . . . . 0.0 110.244 -167.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -93.63 76.64 4.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.168 -0.958 . . . . 0.0 108.966 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.838 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -75.41 114.43 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -104.83 -11.16 16.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 110.482 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.603 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -40.73 116.03 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.25 -0.906 . . . . 0.0 109.602 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -47.63 -36.21 10.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER 46.78 100.42 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -84.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 109.328 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -142.68 -177.91 5.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.924 HG23 ' NE2' ' A' ' 20' ' ' HIS . 31.0 mm -153.74 84.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.546 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.52 86.86 0.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.874 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.1 mt -86.82 148.25 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 110.375 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.738 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.4 mtmt -83.66 130.38 34.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.52 -0.738 . . . . 0.0 109.019 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -48.56 149.99 1.51 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.187 -0.946 . . . . 0.0 110.526 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' HA2' ' HG2' ' A' ' 66' ' ' LYS . . . 38.34 63.85 0.91 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.774 ' CE1' HG23 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -154.25 -171.93 4.04 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.08 -1.247 . . . . 0.0 109.896 -178.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 63' ' ' PRO . 79.1 p -116.66 131.52 56.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 111.612 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.924 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.3 t60 -118.6 161.1 20.62 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 88.47 2.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.064 -1.022 . . . . 0.0 108.978 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.962 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -73.88 132.83 42.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.747 . . . . 0.0 110.555 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 pp20? -126.57 153.94 44.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.854 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 23' ' ' GLU . 10.9 t -160.32 163.89 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 17.0 p30 -153.3 144.86 23.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.815 -1.178 . . . . 0.0 111.0 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.4 p90 -162.41 127.21 3.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.508 -0.745 . . . . 0.0 109.556 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -80.16 88.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 0.0 110.573 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -123.28 137.46 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -159.53 174.8 3.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.441 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 32.0 Cg_endo -71.99 1.2 8.59 Favored 'Cis proline' 0 C--N 1.313 -1.305 0 C-N-CA 123.759 -1.35 . . . . 0.0 111.193 1.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 11.4 t0 -178.41 89.58 0.22 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -79.28 -171.05 1.14 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.718 2.279 . . . . 0.0 110.697 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.9 m -141.0 114.19 8.59 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -103.76 102.7 12.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.5 m -87.97 124.12 33.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.39 -0.819 . . . . 0.0 109.523 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.962 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.0 m95 -86.26 100.07 12.01 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.304 1.049 . . . . 0.0 109.003 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.97 -176.89 3.25 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.933 -1.104 . . . . 0.0 110.594 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.6 p -136.95 -169.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.705 -0.622 . . . . 0.0 109.705 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.721 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -59.81 -142.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.829 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER 60.07 12.5 3.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.8 t 44.79 50.98 8.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.76 -9.79 2.09 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . -68.79 179.45 1.77 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.097 -1.237 . . . . 0.0 108.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -138.54 165.88 25.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.383 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.94 147.8 46.59 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.808 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 163.88 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.1 Cg_endo -69.3 -4.44 13.73 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.764 1.643 . . . . 0.0 110.89 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 6.8 mm-40 -108.0 22.09 16.45 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 173.98 -166.33 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HB3' ' CB ' ' A' ' 61' ' ' PHE . 28.8 tp -109.08 162.74 13.97 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 108.359 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.8 t -149.0 145.81 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.705 -1.247 . . . . 0.0 111.163 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' O ' ' O ' ' A' ' 59' ' ' SER . 44.8 m-20 -141.76 160.25 40.56 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.7 179.54 9.01 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.2 -1.563 . . . . 0.0 110.963 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -160.73 154.32 22.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.0 109.994 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.6 m -52.65 -50.15 63.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.112 -0.992 . . . . 0.0 111.166 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 74.7 m -97.94 18.21 16.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 0.0 111.01 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.2 t 179.76 -172.89 0.2 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.545 -1.347 . . . . 0.0 109.4 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.3 t -175.47 158.14 2.22 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.699 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 52' ' ' ASP . 9.4 p -160.09 141.82 12.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.86 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.4 pt -129.76 155.65 41.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.569 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.752 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -104.19 156.85 17.55 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 2.5 m-85 -138.86 47.02 1.27 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 19' ' ' THR . 26.4 Cg_endo -63.57 -13.39 36.22 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.831 1.687 . . . . 0.0 109.664 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.38 63.78 1.26 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -107.71 146.62 31.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.074 . . . . 0.0 110.604 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.737 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.8 mttt -155.71 -179.24 7.93 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.278 0.561 . . . . 0.0 109.562 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 54.0 ttt180 -44.43 -42.31 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.642 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.93 88.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.974 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.82 -20.45 56.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 109.615 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 92' ' ' VAL . 11.6 m -53.75 103.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.54 -176.4 30.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 39' ' ' GLY . 50.2 m-20 -97.75 92.69 5.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -1.132 . . . . 0.0 109.262 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.706 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.1 m-85 -70.69 103.99 2.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.126 -0.984 . . . . 0.0 108.954 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 37' ' ' THR . 3.9 ttmt -105.61 113.79 27.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.193 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.843 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.22 143.51 28.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.919 . . . . 0.0 109.588 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 ttmt -140.31 115.25 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -109.4 155.1 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.999 -1.063 . . . . 0.0 109.634 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.29 144.5 14.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 0.0 110.712 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.523 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -137.19 148.15 46.36 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.792 . . . . 0.0 109.463 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 79' ' ' ASN . 4.1 mt-10 39.38 -96.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.489 -0.757 . . . . 0.0 110.196 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 82' ' ' GLY . 2.4 pp -125.09 -9.39 7.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.025 . . . . 0.0 109.798 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.848 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -86.92 166.61 37.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 6.2 pt-20 -167.9 139.96 3.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.891 -1.358 . . . . 0.0 110.738 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.838 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.13 168.78 15.61 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' CG ' ' HG3' ' A' ' 76' ' ' LYS . 9.2 mt-10 -150.28 153.01 35.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.917 -1.114 . . . . 0.0 110.318 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' A' ' 88' ' ' PHE . . . -139.32 123.52 17.99 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.8 tt -85.1 142.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.875 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 79.0 m-85 -141.18 92.02 2.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.155 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.14 105.19 9.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.9 t -98.04 127.27 50.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.299 -0.876 . . . . 0.0 110.884 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 92' ' ' VAL . 14.1 mm -116.27 175.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.737 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.2 t -146.62 132.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.979 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.299 0.571 . . . . 0.0 109.786 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 2.0 tttt -38.89 136.15 0.96 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.776 -0.577 . . . . 0.0 110.059 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 2' ' ' LYS . 35.2 Cg_endo -77.49 89.66 1.31 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.792 2.328 . . . . 0.0 110.465 -164.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.08 81.29 3.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -0.903 . . . . 0.0 109.328 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.889 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -78.78 115.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -106.58 -11.52 15.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.852 . . . . 0.0 110.757 -178.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.592 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.5 t -37.57 114.52 0.34 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -40.69 -48.98 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.494 -0.753 . . . . 0.0 110.039 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 2.6 p 59.63 120.71 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.649 -0.657 . . . . 0.0 109.869 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -163.94 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ptmt -141.0 178.44 7.37 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.58 -0.7 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.884 HG23 ' NE2' ' A' ' 20' ' ' HIS . 24.8 mm -153.58 92.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.358 -0.839 . . . . 0.0 109.167 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.6 ptpt -74.59 90.86 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.9 mt -97.28 155.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.21 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -91.89 165.7 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.031 -1.043 . . . . 0.0 108.97 179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.41 151.54 39.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.107 -0.996 . . . . 0.0 109.618 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.73 29.56 3.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.85 -176.01 2.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.285 -1.127 . . . . 0.0 110.61 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.4 p -121.16 132.63 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.687 -0.633 . . . . 0.0 109.844 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.884 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -120.85 161.08 22.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.816 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.19 83.72 2.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.739 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -70.31 130.88 43.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.621 -0.675 . . . . 0.0 110.292 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -125.09 147.89 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.781 . . . . 0.0 109.709 179.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 19.1 t -153.62 158.28 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 38.8 t70 -146.01 140.73 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.004 -1.06 . . . . 0.0 110.804 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.566 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.1 p90 -159.74 126.93 4.6 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.67 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -78.87 82.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -112.92 145.82 18.28 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 167.58 167.44 0.12 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.034 -1.274 . . . . 0.0 109.905 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.858 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.7 Cg_endo -73.7 145.97 85.57 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 123.049 -1.646 . . . . 0.0 110.518 0.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 4.5 p-10 36.59 81.11 0.25 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 122.03 -0.419 . . . . 0.0 110.238 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.8 Cg_endo -80.12 -166.66 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.704 2.269 . . . . 0.0 110.471 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 16.9 m -131.38 148.56 52.67 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.94 101.02 2.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 109.523 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.1 m -96.08 124.99 40.31 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.931 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.2 m95 -85.13 102.22 13.09 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.241 1.019 . . . . 0.0 108.697 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.4 179.35 4.3 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.9 -1.125 . . . . 0.0 110.8 -178.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.6 p -137.5 -167.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.327 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.676 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 47.48 -142.97 6.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -156.83 27.68 0.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -1.115 . . . . 0.0 109.374 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 41' ' ' SER . 1.0 OUTLIER -141.83 6.01 1.78 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.53 -9.57 5.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 37' ' ' THR . . . -51.68 167.61 0.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.271 -1.135 . . . . 0.0 108.812 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.34 161.46 37.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.44 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.804 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.19 148.05 49.56 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.19 -1.404 . . . . 0.0 110.132 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.59 -53.88 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 110.36 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.0 Cg_endo -70.48 -3.31 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.052 1.835 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -112.92 21.44 15.45 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 45' ' ' LEU . 1.4 pp 174.33 -167.78 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD12 ' H ' ' A' ' 51' ' ' VAL . 12.7 tp -109.21 159.67 16.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.936 -1.103 . . . . 0.0 108.492 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.1 t -150.31 139.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.758 -1.214 . . . . 0.0 110.856 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -138.33 154.49 48.98 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.6 146.3 22.15 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.274 -1.516 . . . . 0.0 111.112 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB3' HG22 ' A' ' 57' ' ' THR . 1.0 OUTLIER -118.99 158.2 26.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.656 0.741 . . . . 0.0 109.911 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 92.2 p -51.57 -50.4 60.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 111.383 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 26' ' ' PHE . 37.3 m -100.92 24.25 9.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.755 -1.216 . . . . 0.0 110.623 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.7 t -177.57 -168.91 0.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.791 -1.193 . . . . 0.0 108.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.5 t 177.52 149.01 0.16 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.711 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.1 m -152.45 142.94 22.68 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -129.27 152.41 37.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 117.946 -1.502 . . . . 0.0 110.819 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.703 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.1 m-85 -99.69 155.98 17.33 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.665 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -140.12 46.12 0.94 Allowed Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.18 177.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 28.2 Cg_endo -64.45 -12.48 33.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.893 1.729 . . . . 0.0 109.652 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -123.09 51.46 1.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -91.52 142.4 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.013 -1.054 . . . . 0.0 110.506 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.851 ' C ' HG11 ' A' ' 92' ' ' VAL . 11.4 mtmt -149.16 177.98 9.14 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.32 0.581 . . . . 0.0 109.53 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -45.52 -39.45 7.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.71 89.37 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.309 -0.869 . . . . 0.0 109.795 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.5 t70 -56.94 -21.45 30.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HA ' HG23 ' A' ' 92' ' ' VAL . 38.6 p -51.96 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.519 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -151.73 -176.58 24.62 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . 55.1 t30 -94.81 100.22 12.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.238 -1.154 . . . . 0.0 109.224 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.743 ' CD1' HG23 ' A' ' 38' ' ' VAL . 3.6 m-85 -77.3 101.86 6.47 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.195 -0.941 . . . . 0.0 108.472 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' CE ' ' OE2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -106.74 119.21 38.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.366 -0.834 . . . . 0.0 109.702 -178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.859 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -100.9 140.0 35.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.453 -0.779 . . . . 0.0 109.098 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' CG ' ' HG3' ' A' ' 85' ' ' GLU . 46.0 mtpt -134.05 114.62 13.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.266 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -110.0 150.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.101 -0.999 . . . . 0.0 108.606 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 15.1 ttmt -139.91 157.91 44.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 110.469 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.518 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 2.9 t30 -145.54 165.66 27.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.94 137.98 57.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.986 -1.072 . . . . 0.0 109.941 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 49.93 22.4 0.86 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.603 -0.686 . . . . 0.0 109.713 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . -164.06 177.64 39.74 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 pt-20 172.63 140.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -1.107 . . . . 0.0 109.951 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.889 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -134.34 169.85 16.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 109.354 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 21.4 tt0 -157.18 148.28 21.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.924 -1.11 . . . . 0.0 110.065 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -130.02 130.48 45.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.219 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' SER . 2.3 tt -92.52 126.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.761 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.641 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 70.4 m-85 -129.52 93.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.1 tp10 -78.98 112.42 16.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.066 . . . . 0.0 108.343 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 73' ' ' TYR . 23.3 t -105.41 126.33 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.999 -1.063 . . . . 0.0 110.334 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 91' ' ' ILE . 3.9 mp -114.26 168.11 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.425 -0.797 . . . . 0.0 109.025 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.851 HG11 ' C ' ' A' ' 66' ' ' LYS . 15.8 t -135.01 133.6 53.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 1' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -48.74 162.72 0.35 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.289 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.2 Cg_endo -79.24 140.41 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.475 2.117 . . . . 0.0 110.237 172.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -116.83 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 1.1 tt -77.56 127.55 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 109.04 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -126.73 -7.72 6.18 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 -178.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.813 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -41.04 150.51 0.08 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.166 -0.959 . . . . 0.0 109.512 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -74.01 -30.7 62.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.972 . . . . 0.0 109.392 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.865 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 39.95 97.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.483 0.659 . . . . 0.0 110.412 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -129.56 -84.27 0.55 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.16 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -145.09 -175.39 4.67 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.879 HG22 ' CG1' ' A' ' 14' ' ' ILE . 34.4 mm -155.0 91.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.842 . . . . 0.0 109.138 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -75.45 85.72 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 109.656 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.879 ' CG1' HG22 ' A' ' 12' ' ' ILE . 4.0 mt -96.2 167.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.298 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.04 163.81 12.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.941 . . . . 0.0 109.051 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -70.09 149.16 47.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 0.0 109.556 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 29.92 4.71 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -109.85 -177.06 3.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.221 -1.164 . . . . 0.0 110.568 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 63' ' ' PRO . 71.9 p -119.45 139.33 52.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.555 -0.715 . . . . 0.0 109.891 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.861 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -133.15 162.9 30.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.802 . . . . 0.0 109.8 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 92.52 2.98 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.945 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -81.74 134.81 35.49 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.638 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.7 tt0 -127.15 153.19 46.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.742 . . . . 0.0 109.696 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 7' ' ' THR . 10.3 t -158.98 157.5 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.71 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.7 t70 -142.42 142.31 32.35 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.996 -1.065 . . . . 0.0 110.519 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.977 ' CD2' HG21 ' A' ' 77' ' ' VAL . 35.5 p90 -168.57 126.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.59 -0.694 . . . . 0.0 109.132 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.688 HG22 ' H ' ' A' ' 28' ' ' GLY . 1.7 mm -78.39 -171.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.327 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 148.9 151.81 5.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.015 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -178.88 173.46 0.57 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.318 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.015 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.52 1.29 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.221 1.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -165.46 88.81 0.95 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.157 -0.964 . . . . 0.0 109.415 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -79.04 168.32 20.77 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.749 2.299 . . . . 0.0 110.464 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -142.71 116.51 9.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.24 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -95.06 138.24 33.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.822 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.6 m -115.34 140.57 49.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 109.744 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.945 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.3 m95 -114.63 90.26 3.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 108.771 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -104.48 158.77 16.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.999 -1.063 . . . . 0.0 110.026 -179.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 38' ' ' VAL . 13.2 p -97.9 49.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 60.44 -135.63 49.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.736 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER 60.37 12.7 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.418 -1.048 . . . . 0.0 109.673 -179.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t 66.53 45.95 1.96 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.061 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 130.47 -23.62 4.51 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.736 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -45.68 144.27 1.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.002 -1.293 . . . . 0.0 109.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -99.97 149.24 23.65 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.852 HD22 ' HB3' ' A' ' 36' ' ' TRP . 2.0 mp -50.39 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 49' ' ' LEU . . . -100.27 142.55 24.84 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.967 -1.083 . . . . 0.0 110.278 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -70.17 -2.88 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.147 1.898 . . . . 0.0 109.949 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -14.58 60.04 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.363 -0.835 . . . . 0.0 109.075 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.691 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -100.58 -173.46 2.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.691 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 18.4 tp -122.71 81.49 1.87 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.906 HG13 ' CG2' ' A' ' 60' ' ' ILE . 34.5 t -79.9 123.96 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -0.828 . . . . 0.0 111.643 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.8 p30 -122.24 153.18 39.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.593 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.9 147.6 22.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.2 -1.563 . . . . 0.0 111.181 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.6 OUTLIER -121.61 158.4 28.67 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.696 0.76 . . . . 0.0 109.991 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 4.7 p -51.92 -49.97 62.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -0.991 . . . . 0.0 111.632 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' PHE . 76.0 p -97.04 17.91 15.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.728 -1.233 . . . . 0.0 111.185 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.71 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.4 t -176.76 -165.61 0.13 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.518 -1.364 . . . . 0.0 108.985 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.593 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 10.7 t 176.02 153.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.769 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 25.3 p -155.84 145.54 21.16 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.906 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.2 pt -128.48 165.89 27.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 118.081 -1.447 . . . . 0.0 109.952 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.647 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -121.24 147.56 45.46 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.924 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -132.26 47.83 3.09 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.708 ' O ' HG22 ' A' ' 19' ' ' THR . 27.9 Cg_endo -65.45 -14.14 43.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.013 1.809 . . . . 0.0 109.4 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -129.98 51.14 2.12 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.924 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.34 145.65 25.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 0.0 110.667 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' O ' HG21 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -141.8 -176.98 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.493 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -51.68 -34.07 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.54 89.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.291 -0.881 . . . . 0.0 109.853 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 65' ' ' ALA . 27.1 m-20 -67.69 -11.6 58.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 109.808 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.599 ' CA ' HG23 ' A' ' 92' ' ' VAL . 24.8 p -68.29 99.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.98 -161.08 10.41 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.8 m-80 -106.82 92.9 4.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -1.154 . . . . 0.0 108.692 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.618 ' CD2' HD21 ' A' ' 45' ' ' LEU . 4.2 m-85 -69.38 87.37 0.44 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.32 117.18 28.08 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -105.44 143.96 32.88 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 108.809 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.97 113.95 8.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.795 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.977 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.4 m -108.08 127.67 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HG2' ' CB ' ' A' ' 83' ' ' GLU . 17.3 mtpp -129.66 176.49 7.96 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.775 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' LEU . 20.7 t-20 -155.07 56.75 0.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 50.19 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.491 -0.755 . . . . 0.0 110.4 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.9 OUTLIER -71.44 -1.69 14.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.1 -1.0 . . . . 0.0 110.467 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -133.47 170.19 22.42 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.551 -1.309 . . . . 0.0 109.993 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' CB ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -167.58 138.41 2.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -1.102 . . . . 0.0 110.137 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.4 OUTLIER -160.94 150.68 17.25 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 5.4 pt-20 -156.05 172.0 19.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.737 -1.227 . . . . 0.0 110.643 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 9' ' ' SER . . . -148.87 139.41 22.6 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.767 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.55 125.38 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.898 . . . . 0.0 109.962 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' N ' HD13 ' A' ' 87' ' ' ILE . 46.1 m-85 -119.15 100.38 7.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.421 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' CD ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -79.08 108.66 12.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.972 -1.08 . . . . 0.0 108.457 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.4 t -107.06 125.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 110.238 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 92' ' ' VAL . 2.0 mp -118.29 166.69 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.411 -0.806 . . . . 0.0 109.149 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.625 ' N ' HG22 ' A' ' 91' ' ' ILE . 4.9 t -133.95 139.72 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.156 -0.965 . . . . 0.0 109.829 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.527 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.626 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -46.3 147.55 1.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 33.0 Cg_endo -77.88 124.28 6.72 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.864 2.376 . . . . 0.0 110.925 -153.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 11.9 tttt -94.25 73.6 3.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.055 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.852 HD12 ' CB ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -83.25 118.39 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.441 -0.787 . . . . 0.0 109.5 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -111.84 -15.33 13.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.921 . . . . 0.0 110.115 -179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.914 HG21 HG13 ' A' ' 24' ' ' VAL . 1.5 t -38.72 116.64 0.58 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.348 -0.845 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.17 -47.19 62.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER 64.01 144.54 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 109.88 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 11' ' ' LYS . 26.6 ttt-85 -177.02 -89.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.168 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' N ' ' HG2' ' A' ' 10' ' ' ARG . 15.5 ptmt -152.65 -173.43 4.56 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 34.0 mm -154.05 145.08 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.173 -0.955 . . . . 0.0 110.308 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.44 87.44 2.61 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.66 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.2 mt -100.54 101.51 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 110.255 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 93' ' ' GLN . 7.8 tttp -46.05 148.58 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.663 -1.273 . . . . 0.0 109.008 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.667 ' HB2' ' OXT' ' A' ' 93' ' ' GLN . . . -68.99 139.56 55.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.103 . . . . 0.0 109.725 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' ' CD1' ' A' ' 18' ' ' PHE . . . 76.31 49.15 8.58 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 17' ' ' GLY . 35.4 m-85 -144.75 -176.91 5.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 63' ' ' PRO . 82.0 p -118.85 129.0 54.97 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.66 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -114.22 161.53 17.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 0.0 110.111 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.19 87.08 2.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 108.766 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.935 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -77.49 138.46 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 110.519 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.2 tt0 -135.9 150.64 49.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.441 -0.787 . . . . 0.0 109.527 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.914 HG13 HG21 ' A' ' 7' ' ' THR . 31.8 t -153.53 129.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.862 . . . . 0.0 109.058 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -102.66 131.34 49.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.852 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.0 p90 -163.66 117.27 1.52 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 1.1 mp -77.25 168.89 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.575 -0.703 . . . . 0.0 109.447 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 27' ' ' ILE . . . 170.18 138.49 2.51 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.949 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -165.36 170.34 6.3 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.076 -1.249 . . . . 0.0 109.636 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.949 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.1 Cg_endo -71.08 0.34 7.5 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.436 -1.485 . . . . 0.0 111.192 1.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.552 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 14.7 t0 -170.52 92.19 0.48 Allowed Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.168 -0.957 . . . . 0.0 109.433 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 37.8 Cg_endo -79.67 167.47 20.65 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.768 2.312 . . . . 0.0 110.867 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 24.3 m -128.85 151.1 49.98 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -142.01 122.39 14.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.836 -1.165 . . . . 0.0 109.294 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.3 m -107.64 119.14 38.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.357 -0.84 . . . . 0.0 110.241 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.935 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -85.85 100.31 11.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.71 175.09 5.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.431 -1.418 . . . . 0.0 110.258 -179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.9 p -128.61 53.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.56 0.695 . . . . 0.0 110.223 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' LYS . . . 177.48 -115.71 0.52 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' SER . 13.1 p-10 -118.43 -19.16 8.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 2.0 t 168.84 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.249 -0.907 . . . . 0.0 109.739 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.56 -58.05 1.68 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 37' ' ' THR . . . -58.09 152.79 15.98 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.237 -1.154 . . . . 0.0 108.872 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.763 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -146.06 164.53 31.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.053 . . . . 0.0 110.163 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.074 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.4 148.48 41.3 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.409 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.01 -52.06 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.013 -1.055 . . . . 0.0 111.169 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.47 -1.8 9.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.024 1.816 . . . . 0.0 111.101 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.036 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -115.76 17.45 16.12 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.074 HD11 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -161.88 -163.92 1.02 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.655 0.74 . . . . 0.0 109.596 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -119.05 76.39 1.11 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.892 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.8 t -78.14 122.5 33.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.904 -1.122 . . . . 0.0 111.837 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.1 m-20 -123.71 143.74 50.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -143.96 146.82 33.2 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.326 -1.484 . . . . 0.0 111.047 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 57' ' ' THR . 1.5 mtmt -122.16 159.12 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.703 0.763 . . . . 0.0 110.097 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 12.7 m -53.45 -48.45 68.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.084 -1.01 . . . . 0.0 111.419 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.2 m -95.29 14.38 22.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.792 -1.193 . . . . 0.0 111.101 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -175.79 -162.02 0.09 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.432 -1.418 . . . . 0.0 109.4 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.582 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 174.24 136.19 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.384 -0.822 . . . . 0.0 109.422 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 11.4 p -140.48 141.5 35.39 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.892 ' CG2' HG13 ' A' ' 51' ' ' VAL . 10.3 pt -122.97 165.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.062 -1.455 . . . . 0.0 110.148 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -118.43 155.47 30.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -173.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -138.97 47.99 1.59 Allowed Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.1 Cg_endo -63.79 -13.29 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.009 1.806 . . . . 0.0 109.408 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 46.45 1.95 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -80.91 140.31 35.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.162 -0.961 . . . . 0.0 110.095 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.66 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -150.8 174.51 12.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 8.4 tmm_? -48.74 -45.59 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.876 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.99 74.2 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.208 -0.932 . . . . 0.0 110.058 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.18 -11.1 18.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.983 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.621 ' CA ' HG23 ' A' ' 92' ' ' VAL . 91.4 p -65.25 103.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.955 . . . . 0.0 109.732 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.99 173.92 28.76 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -92.16 95.6 9.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -1.157 . . . . 0.0 109.127 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' HG23 ' A' ' 38' ' ' VAL . 4.2 m-30 -73.89 97.14 2.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.307 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -97.44 108.91 21.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.84 . . . . 0.0 108.764 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.821 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -92.37 140.12 29.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 109.288 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.81 108.98 6.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.517 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.544 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -103.0 147.66 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.047 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 83' ' ' GLU . 7.4 ttpt -139.41 149.94 44.68 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.03 -1.044 . . . . 0.0 110.155 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 32.9 m-20 -138.39 139.55 39.01 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -44.88 136.31 4.68 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.551 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp 69.62 20.68 6.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . 174.09 177.75 43.49 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.502 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 1.4 pt-20 178.68 140.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -1.217 . . . . 0.0 110.226 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.734 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.6 163.74 28.74 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.23 149.98 30.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.779 -1.2 . . . . 0.0 110.409 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -130.03 131.12 45.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.443 -0.786 . . . . 0.0 109.048 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.499 HG23 ' HG2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -88.71 141.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 109.824 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.671 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 82.1 m-85 -143.32 91.62 2.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.363 -0.835 . . . . 0.0 109.25 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 38.8 mt-10 -79.37 105.31 10.59 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.129 -0.982 . . . . 0.0 108.432 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' HA ' ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -95.53 121.76 46.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 110.002 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.6 mm -114.63 167.13 7.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.66 HG11 ' C ' ' A' ' 66' ' ' LYS . 4.3 t -132.25 140.83 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 118.866 -1.133 . . . . 0.0 110.392 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.667 ' OXT' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.558 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.302 0.572 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -51.66 143.95 19.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 28' ' ' GLY . 35.8 Cg_endo -78.16 115.47 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.539 2.159 . . . . 0.0 110.499 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.737 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -98.56 76.67 2.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 108.736 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 HG22 ' OD2' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -70.79 107.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 122.055 0.931 . . . . 0.0 108.642 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -109.32 -0.62 19.0 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.094 -0.643 . . . . 0.0 111.348 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.602 HG21 HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -40.56 157.8 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.13 -46.64 80.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 109.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.3 p 59.58 125.73 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.432 0.634 . . . . 0.0 109.656 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 9' ' ' SER . 2.8 mtt85 178.84 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 89' ' ' GLU . 22.4 mtmm -146.91 -170.79 3.62 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.622 -0.674 . . . . 0.0 109.587 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.839 HG23 ' NE2' ' A' ' 20' ' ' HIS . 12.7 mm -156.65 95.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -77.61 96.99 4.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.78 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.7 mt -109.25 159.33 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 108.779 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -104.18 163.69 12.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.144 . . . . 0.0 108.724 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.79 146.96 51.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.022 -1.049 . . . . 0.0 109.749 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 56.41 33.38 61.88 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.51 -178.82 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.12 -1.224 . . . . 0.0 111.207 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 63' ' ' PRO . 69.4 p -123.77 122.61 38.51 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.839 ' NE2' HG23 ' A' ' 12' ' ' ILE . 3.2 t60 -109.15 163.73 13.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.168 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -130.49 85.02 2.24 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.952 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -72.96 135.9 45.07 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.549 -0.72 . . . . 0.0 110.128 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.7 pm0 -131.13 151.24 51.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 110.039 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 17.1 t -155.59 161.3 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.719 ' OD1' HD11 ' A' ' 6' ' ' LEU . 1.1 t70 -151.14 139.51 20.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.051 -1.03 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 50.7 p90 -156.95 129.52 7.55 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.281 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -80.86 82.25 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.2 -0.938 . . . . 0.0 110.021 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.612 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -118.04 150.2 18.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.37 168.15 0.19 Allowed Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.334 -1.097 . . . . 0.0 109.546 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.2 Cg_endo -74.22 143.98 79.54 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.026 -1.656 . . . . 0.0 110.364 0.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER 35.41 81.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.655 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.487 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' CG ' ' O ' ' A' ' 55' ' ' SER . 36.4 Cg_endo -78.58 -170.76 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.652 2.235 . . . . 0.0 109.909 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 52.6 m -133.75 112.22 11.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.117 -0.989 . . . . 0.0 109.758 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -107.79 117.28 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.9 m -103.85 118.19 36.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.047 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.952 ' CH2' HD21 ' A' ' 22' ' ' LEU . 34.4 m95 -83.35 102.29 11.9 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.088 0.946 . . . . 0.0 108.506 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.947 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -106.22 -176.85 3.19 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.727 -1.233 . . . . 0.0 110.045 -179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.8 p -147.69 179.98 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.639 -0.663 . . . . 0.0 109.55 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 61.5 7.11 9.63 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.384 -0.912 . . . . 0.0 110.866 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.9 t0 37.08 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.288 -1.125 . . . . 0.0 110.23 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -145.54 8.85 1.18 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.028 -1.045 . . . . 0.0 110.43 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . 123.91 -24.88 6.26 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.588 -1.291 . . . . 0.0 109.917 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.947 ' O ' HG22 ' A' ' 37' ' ' THR . . . -50.63 178.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.18 -1.188 . . . . 0.0 108.609 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.31 157.48 44.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.832 -1.168 . . . . 0.0 110.082 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.003 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -136.76 143.67 43.37 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.099 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.56 -52.48 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.891 -1.131 . . . . 0.0 111.49 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.9 Cg_endo -69.76 -1.52 8.61 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.803 . . . . 0.0 111.336 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.035 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -118.12 19.69 13.47 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -162.91 -164.53 0.99 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.735 0.779 . . . . 0.0 109.848 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 mp -118.59 76.83 1.12 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.919 HG13 ' CG2' ' A' ' 60' ' ' ILE . 39.3 t -78.63 129.65 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.917 -1.114 . . . . 0.0 112.242 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' SER . 5.1 m-20 -130.33 148.11 52.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.585 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -151.52 147.18 26.51 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.23 -1.544 . . . . 0.0 111.149 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.49 163.05 21.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.383 1.087 . . . . 0.0 110.286 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.533 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 1.1 t -50.73 -53.71 29.24 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.001 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 3.5 m -98.57 22.8 9.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 110.855 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.619 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 8.1 t -178.82 -168.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.704 -1.248 . . . . 0.0 109.385 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.585 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.6 t 177.31 145.24 0.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 52' ' ' ASP . 59.2 m -148.25 144.32 27.57 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.919 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.8 pt -128.51 165.92 26.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.55 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.746 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -117.73 154.7 31.25 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 1.8 m-85 -136.25 47.66 2.14 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.2 Cg_endo -63.04 -13.15 33.47 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.095 1.863 . . . . 0.0 109.698 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.76 48.49 1.69 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -86.87 142.01 28.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.08 . . . . 0.0 110.267 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.814 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -146.45 174.19 11.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -46.2 -44.28 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 0.0 109.71 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.93 85.26 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.02 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -49.0 -22.76 0.93 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.736 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.3 m -48.91 102.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.57 176.16 31.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' GLY . 5.0 m120 -96.71 94.81 7.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.32 -1.106 . . . . 0.0 108.878 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 4.6 m-85 -74.54 110.31 8.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' CE ' ' CD ' ' A' ' 85' ' ' GLU . 4.6 tptm -114.38 114.66 26.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.866 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -98.77 142.66 30.03 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.347 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -141.01 110.56 6.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.378 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.2 m -105.37 161.33 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.04 -1.038 . . . . 0.0 108.895 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.3 ttpt -153.42 165.17 36.65 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.056 -1.028 . . . . 0.0 110.456 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -164.68 130.53 2.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 79' ' ' ASN . 2.6 mt-10 -36.92 136.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.494 -0.754 . . . . 0.0 110.543 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 6.6 tp 74.56 12.18 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.551 -0.718 . . . . 0.0 110.826 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 79' ' ' ASN . . . -179.49 152.37 10.97 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.201 -1.476 . . . . 0.0 110.631 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp0 -148.37 142.22 25.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -1.185 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.679 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -142.85 158.6 43.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.702 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -154.44 142.11 19.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.712 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.612 ' HB3' ' HE2' ' A' ' 88' ' ' PHE . . . -122.09 137.2 54.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.0 109.152 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.645 HD12 ' H ' ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.49 148.48 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.672 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 98.9 m-85 -149.26 91.27 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.717 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 1.1 tp10 -79.27 110.12 14.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 12' ' ' ILE . 18.3 t -103.18 128.71 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 110.523 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.5 mm -121.11 165.57 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.478 -0.764 . . . . 0.0 108.993 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.814 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.7 t -131.45 141.3 46.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.252 -0.905 . . . . 0.0 110.07 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.975 HD22 ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.975 ' N ' HD22 ' A' ' 1' ' ' LEU . 7.0 mtmm -35.0 149.0 0.11 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.761 -0.587 . . . . 0.0 110.504 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 79' ' ' ASN . 35.9 Cg_endo -78.65 108.3 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.75 2.3 . . . . 0.0 110.546 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.6 OUTLIER -90.23 78.58 6.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.172 -0.955 . . . . 0.0 108.837 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -74.03 114.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.678 . . . . 0.0 109.254 -179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' THR . 2.5 mp -110.02 -4.7 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.191 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.628 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.99 137.51 0.5 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.421 -0.8 . . . . 0.0 109.942 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -51.85 -43.85 63.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.88 . . . . 0.0 109.6 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.79 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 4.5 p 49.74 102.25 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' HG3' ' A' ' 11' ' ' LYS . 3.3 tpp180 -157.45 -79.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.03 . . . . 0.0 109.505 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG3' ' HG3' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -146.99 -177.64 5.77 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.424 -0.797 . . . . 0.0 109.387 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.876 HG23 ' NE2' ' A' ' 20' ' ' HIS . 30.3 mm -154.1 89.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.416 -0.803 . . . . 0.0 109.066 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 84.65 2.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.611 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.847 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.0 mt -91.23 156.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.096 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -94.58 161.39 14.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.905 -1.122 . . . . 0.0 108.824 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -69.92 150.18 47.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.041 -1.037 . . . . 0.0 109.612 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.62 29.09 3.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.7 m-30 -110.96 -175.65 2.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -1.175 . . . . 0.0 110.6 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 63' ' ' PRO . 76.3 p -122.3 131.78 54.08 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 109.922 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.876 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -118.63 159.19 24.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.4 -0.813 . . . . 0.0 109.283 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -130.33 83.22 2.11 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -65.41 133.1 50.6 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.739 -0.601 . . . . 0.0 110.496 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.5 mt-10 -126.07 146.6 49.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.473 -0.767 . . . . 0.0 109.57 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.628 HG13 ' CG2' ' A' ' 7' ' ' THR . 7.2 t -155.69 161.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.0 t70 -152.75 145.54 24.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.903 -1.123 . . . . 0.0 111.145 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.625 ' HB3' HD12 ' A' ' 5' ' ' ILE . 46.1 p90 -159.77 127.69 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.599 -0.688 . . . . 0.0 109.458 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.68 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -81.24 84.06 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.474 -0.766 . . . . 0.0 110.357 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA3' ' HG3' ' A' ' 32' ' ' PRO . . . -115.8 140.79 16.44 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -167.22 173.8 2.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 109.293 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.964 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -72.07 2.52 7.97 Favored 'Cis proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.642 -1.399 . . . . 0.0 111.268 1.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -176.36 88.83 0.27 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.045 -1.034 . . . . 0.0 109.574 179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CA ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.28 -164.64 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 31.2 m -150.16 113.57 4.94 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.566 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -100.62 128.92 46.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.735 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 76' ' ' LYS . 12.1 t -111.49 123.11 49.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.408 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 30.8 m95 -92.06 97.6 11.03 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.37 1.081 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.987 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -101.56 160.93 14.02 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.87 -1.143 . . . . 0.0 109.924 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.73 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p -103.3 -163.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.862 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.672 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -106.71 103.82 2.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -176.78 31.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -1.11 . . . . 0.0 109.338 179.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 3.5 t 71.82 47.91 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.342 -0.849 . . . . 0.0 110.375 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.21 -2.69 37.67 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.218 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.987 ' O ' HG22 ' A' ' 37' ' ' THR . . . -56.23 164.92 1.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.031 -1.276 . . . . 0.0 108.849 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -126.54 149.69 49.24 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.229 -0.919 . . . . 0.0 108.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.915 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -115.8 147.38 41.05 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 118.108 -1.437 . . . . 0.0 109.874 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.78 -54.11 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.539 -0.726 . . . . 0.0 110.247 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.06 -3.94 13.21 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.936 1.757 . . . . 0.0 110.713 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 3.7 mm-40 -114.61 23.32 12.81 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.915 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER 171.62 -162.66 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.971 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -119.03 165.95 13.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.644 -1.285 . . . . 0.0 108.584 179.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG13 ' CG2' ' A' ' 60' ' ' ILE . 50.9 t -152.92 124.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.899 -1.126 . . . . 0.0 111.161 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 59' ' ' SER . 12.0 m-20 -121.86 152.85 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.24 146.16 22.49 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.176 -1.577 . . . . 0.0 111.237 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.2 OUTLIER -116.81 158.18 24.36 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.614 0.721 . . . . 0.0 109.921 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -51.3 -49.3 61.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.168 -0.957 . . . . 0.0 111.46 -179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' PHE . 58.0 m -102.36 24.34 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.721 -1.237 . . . . 0.0 110.784 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 54' ' ' LYS . 11.3 t -177.52 -168.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.879 -1.138 . . . . 0.0 108.863 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.93 148.97 0.13 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.071 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.4 p -150.66 142.46 23.76 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.901 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -128.37 160.04 39.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.782 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.708 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.6 m-85 -107.08 161.55 14.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -174.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 22.6 m-85 -146.21 47.11 0.59 Allowed Pre-proline 0 N--CA 1.496 1.834 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.597 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.971 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.3 Cg_endo -64.99 -14.34 44.72 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.775 1.65 . . . . 0.0 110.052 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.59 52.85 1.01 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -92.94 140.5 29.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -0.97 . . . . 0.0 110.712 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.72 ' C ' HG11 ' A' ' 92' ' ' VAL . 6.8 mtpm? -148.51 178.31 8.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.6 OUTLIER -43.03 -42.55 3.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.891 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.73 -45.08 86.3 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.212 -0.93 . . . . 0.0 110.153 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -47.48 -23.77 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 3.1 t -53.74 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.962 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.89 -176.61 22.37 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -101.31 91.47 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.384 -1.069 . . . . 0.0 108.335 179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.653 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 6.0 m-85 -74.6 111.55 9.91 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 37' ' ' THR . 13.3 ttpp -112.01 122.43 47.73 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.071 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.767 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.6 142.86 36.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 35' ' ' THR . 20.9 mtmt -141.39 111.32 6.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.823 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.566 HG12 ' CB ' ' A' ' 34' ' ' ALA . 1.5 m -108.49 125.32 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.216 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 4.3 ttpm? -117.1 165.9 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.5 -0.75 . . . . 0.0 109.791 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -155.67 100.77 2.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.2 -89.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.907 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.2 mp -115.06 -26.31 7.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.728 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 2' ' ' LYS . . . -76.21 119.88 5.72 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 17.4 pt-20 -120.46 141.61 50.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -1.182 . . . . 0.0 110.181 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.517 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.42 148.03 24.13 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 27.6 mt-10 -151.73 170.14 20.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.959 -1.088 . . . . 0.0 109.917 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -141.19 137.34 32.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.786 . . . . 0.0 109.37 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.517 ' N ' ' HB2' ' A' ' 9' ' ' SER . 6.8 tt -88.74 145.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.287 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.723 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 56.7 m-85 -143.95 89.74 2.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 3.0 tt0 -78.65 107.94 11.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 12' ' ' ILE . 3.9 t -102.51 129.01 54.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.108 -0.995 . . . . 0.0 110.912 -177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.631 HG22 ' N ' ' A' ' 92' ' ' VAL . 28.0 mm -121.07 166.41 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.72 HG11 ' C ' ' A' ' 66' ' ' LYS . 9.0 t -134.11 134.04 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.074 -1.016 . . . . 0.0 110.094 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.432 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.775 HD11 HG22 ' A' ' 27' ' ' ILE . 3.1 pp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.374 0.607 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.718 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -52.32 141.1 33.03 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.423 -0.798 . . . . 0.0 109.65 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -78.57 94.23 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.628 2.218 . . . . 0.0 110.339 -171.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.8 ttpt -76.67 81.1 3.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 108.835 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.839 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.5 tt -82.44 109.95 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 7' ' ' THR . 1.1 mp -100.6 -8.13 23.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 110.464 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.604 HG22 ' CG1' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -38.43 123.92 1.23 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -46.68 -55.53 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.888 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 0.9 OUTLIER 61.21 108.91 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.699 -0.626 . . . . 0.0 109.53 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.8 -83.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.19 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -144.37 176.36 9.42 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.638 -0.664 . . . . 0.0 109.297 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.843 HG23 ' NE2' ' A' ' 20' ' ' HIS . 27.2 mm -152.42 94.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.859 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.7 97.31 4.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 108.948 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.801 ' CG1' HG22 ' A' ' 12' ' ' ILE . 6.9 mt -104.28 129.39 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.283 -0.886 . . . . 0.0 109.891 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 8.4 mtpt -70.92 151.05 45.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.64 -1.287 . . . . 0.0 108.473 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.91 147.26 53.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.908 -1.12 . . . . 0.0 109.344 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.99 35.32 91.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 15' ' ' LYS . 4.0 m-85 -119.14 173.06 7.14 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.104 -1.233 . . . . 0.0 110.789 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 63' ' ' PRO . 67.8 p -117.1 89.19 3.06 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.498 0.666 . . . . 0.0 109.366 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.843 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.0 t60 -77.71 149.67 34.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.879 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -125.11 96.2 4.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.9 tt -79.94 141.8 35.7 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.661 -0.649 . . . . 0.0 110.822 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' VAL . 4.4 mt-10 -133.92 158.21 44.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.496 -0.753 . . . . 0.0 109.664 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 21.8 t -160.46 151.47 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.599 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 0.8 OUTLIER -136.81 137.39 39.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.096 . . . . 0.0 110.691 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 45.7 p90 -159.94 121.99 3.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 110.124 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.775 HG22 HD11 ' A' ' 1' ' ' LEU . 1.5 mp -82.86 85.31 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.539 -0.726 . . . . 0.0 110.332 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.641 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -115.47 158.98 14.04 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 168.82 170.2 0.13 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -1.115 . . . . 0.0 109.455 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.893 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.52 146.72 87.55 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 123.231 -1.57 . . . . 0.0 110.675 0.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 30' ' ' PRO . 5.1 p-10 34.55 79.4 0.29 Allowed Pre-proline 0 N--CA 1.493 1.714 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.48 -170.62 1.04 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.656 2.237 . . . . 0.0 109.97 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -147.42 112.88 5.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.164 -0.96 . . . . 0.0 109.662 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -101.21 133.63 45.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.195 -0.94 . . . . 0.0 109.127 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' LEU . 85.2 m -110.99 128.44 55.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 33.6 m95 -102.57 98.66 8.69 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -111.57 161.9 15.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.912 -1.118 . . . . 0.0 109.938 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 45' ' ' LEU . 9.5 p -109.35 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.841 . . . . 0.0 110.014 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 62.95 -143.55 48.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.697 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t70 67.18 5.21 4.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.452 -1.028 . . . . 0.0 109.735 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.97 37.17 7.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.203 -0.935 . . . . 0.0 109.785 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.54 -20.91 1.33 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 37' ' ' THR . . . -53.52 142.4 22.5 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.049 -1.265 . . . . 0.0 109.426 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -113.77 149.11 35.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.42 -0.8 . . . . 0.0 110.481 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.079 HD21 ' CD2' ' A' ' 73' ' ' TYR . 1.3 mp -78.72 142.81 36.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.609 -0.682 . . . . 0.0 109.735 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.018 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 157.24 -60.45 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 1.018 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -69.47 1.0 4.63 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.439 2.093 . . . . 0.0 111.598 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -127.07 9.89 6.86 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 108.958 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER 167.01 -162.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.96 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -118.05 167.35 11.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.051 -1.03 . . . . 0.0 109.237 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.3 t -148.48 143.37 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.857 -1.152 . . . . 0.0 111.492 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -139.09 155.75 47.68 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.572 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.35 147.98 19.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.247 -1.533 . . . . 0.0 111.151 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 57' ' ' THR . 13.7 mttt -124.82 158.58 33.06 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 110.109 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 3.5 m -49.8 -54.73 17.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.119 -0.988 . . . . 0.0 111.946 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' PHE . 3.3 m -95.52 18.02 13.56 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.693 -1.254 . . . . 0.0 111.293 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 54' ' ' LYS . 9.0 t -175.32 -163.42 0.12 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.608 -1.308 . . . . 0.0 108.811 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.572 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 176.27 154.57 0.2 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.669 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 52' ' ' ASP . 24.6 p -156.21 143.15 18.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.0 pt -129.73 154.9 40.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.344 -177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.5 m-85 -99.82 160.59 14.19 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.67 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 27.8 m-85 -144.88 41.52 0.32 Allowed Pre-proline 0 N--CA 1.496 1.854 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.699 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.96 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.4 Cg_endo -63.84 -12.5 32.05 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 110.437 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.15 49.2 1.7 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.419 ' CB ' ' OD2' ' A' ' 69' ' ' ASP . . . -88.15 140.49 29.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.954 -1.092 . . . . 0.0 109.964 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.853 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -147.69 -176.55 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 5.4 ttt-85 -46.5 -44.41 17.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.085 -1.009 . . . . 0.0 109.722 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -56.71 -39.9 74.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 110.317 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -42.61 -25.33 0.08 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.176 -0.953 . . . . 0.0 110.113 -179.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 68' ' ' ALA . 72.4 m -51.76 89.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.564 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.29 -178.77 19.4 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.9 m120 -99.76 92.14 5.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.336 -1.096 . . . . 0.0 108.794 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.079 ' CD2' HD21 ' A' ' 45' ' ' LEU . 3.9 m-85 -74.23 90.68 2.1 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 108.979 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -98.82 119.19 37.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.4 -0.813 . . . . 0.0 109.507 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -110.37 141.72 43.03 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.849 . . . . 0.0 108.848 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -139.89 117.55 11.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -0.847 . . . . 0.0 109.32 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -104.84 150.91 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.104 -0.997 . . . . 0.0 109.281 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 3.1 ttmt -145.71 162.09 38.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 18.6 p-10 -158.44 165.01 35.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -64.54 -23.47 67.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.914 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -90.51 9.75 28.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.453 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 79' ' ' ASN . . . 145.4 -139.23 8.17 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 173.22 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.129 -1.218 . . . . 0.0 110.168 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.839 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -129.36 175.89 8.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 108.921 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 75' ' ' LEU . 22.9 tt0 -163.77 144.01 8.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.899 -1.125 . . . . 0.0 110.115 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -129.67 139.93 51.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' SER . 1.2 tt -99.67 144.48 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 17.8 m-85 -139.44 97.72 3.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.825 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -79.63 109.01 13.62 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.728 HG21 ' CG ' ' A' ' 73' ' ' TYR . 3.0 t -102.36 124.32 56.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.896 -1.128 . . . . 0.0 110.385 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 92' ' ' VAL . 7.7 mt -118.25 170.56 7.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.853 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -136.15 143.99 34.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.943 -1.098 . . . . 0.0 110.466 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.445 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.295 0.569 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -116.23 137.72 23.69 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.509 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 84' ' ' ASP . 36.5 Cg_endo -78.57 110.26 2.79 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.844 2.363 . . . . 0.0 110.389 -136.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 8.7 tttp -81.04 79.75 7.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.088 -1.007 . . . . 0.0 108.902 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.913 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -80.69 114.01 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.648 . . . . 0.0 109.286 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.59 0.99 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 110.092 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -35.3 155.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 110.486 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -62.11 -66.7 0.5 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.98 115.24 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.0 109.386 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -176.26 -72.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.018 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 6.8 ptpp? -178.36 162.68 1.53 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.007 HG21 ' NE2' ' A' ' 20' ' ' HIS . 23.2 mt -153.02 153.36 9.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.951 -177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -108.99 76.1 0.99 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.784 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.9 mt -80.15 105.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 110.289 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -45.72 159.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.764 -1.21 . . . . 0.0 109.145 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -75.17 158.08 33.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.004 . . . . 0.0 109.619 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.91 28.45 3.9 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-30 -109.81 178.78 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.327 -1.102 . . . . 0.0 110.472 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 63' ' ' PRO . 74.8 p -115.89 131.96 56.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.657 -0.652 . . . . 0.0 109.475 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 1.007 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.8 t60 -121.6 153.31 38.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -122.63 82.18 1.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.938 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -64.11 132.16 49.65 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.609 -0.682 . . . . 0.0 110.208 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 24' ' ' VAL . 6.0 mt-10 -123.18 152.33 41.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.422 -0.799 . . . . 0.0 109.952 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG21 ' CH2' ' A' ' 36' ' ' TRP . 11.4 t -157.9 159.7 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.7 t70 -151.95 140.71 20.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.316 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' HB3' HD12 ' A' ' 5' ' ' ILE . 44.8 p90 -160.37 135.29 7.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.715 HG22 HD13 ' A' ' 1' ' ' LEU . 1.6 mp -90.87 84.97 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.729 . . . . 0.0 110.17 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.692 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -122.69 157.27 17.27 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.986 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 163.2 172.71 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.367 -1.078 . . . . 0.0 109.185 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.986 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 33.4 Cg_endo -72.74 153.4 98.74 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.789 1.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 30' ' ' PRO . 29.7 t0 40.77 77.46 0.42 Allowed Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.739 -0.6 . . . . 0.0 109.656 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -79.16 153.07 24.52 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.748 2.299 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 2.3 m -107.32 153.38 22.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.92 . . . . 0.0 108.594 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -154.36 101.41 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.903 -1.123 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.7 m -90.15 130.16 36.34 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.432 -0.792 . . . . 0.0 109.733 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.938 ' CH2' HD21 ' A' ' 22' ' ' LEU . 19.7 m95 -94.47 99.44 11.61 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.266 1.031 . . . . 0.0 108.756 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.803 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.03 158.37 16.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.691 -1.255 . . . . 0.0 110.394 -179.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.683 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.6 p -96.61 -160.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.635 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.661 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -111.71 101.97 1.35 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.251 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -172.5 30.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.431 -1.04 . . . . 0.0 109.091 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.469 ' O ' ' OG ' ' A' ' 41' ' ' SER . 2.5 p 68.63 47.26 0.89 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.384 -0.823 . . . . 0.0 110.51 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.65 22.32 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.133 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 37' ' ' THR . . . -60.71 157.5 14.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.048 -1.266 . . . . 0.0 108.951 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -124.7 150.26 46.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 108.895 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.42 147.69 41.42 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.066 -1.454 . . . . 0.0 110.106 179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 168.4 -54.43 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.153 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.7 Cg_endo -70.21 -3.21 11.85 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.009 1.806 . . . . 0.0 110.801 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 7.9 mp0 -118.45 23.78 11.32 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' A' ' 45' ' ' LEU . 1.0 OUTLIER 173.72 -162.8 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.029 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -121.73 160.99 23.38 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.674 -1.266 . . . . 0.0 108.699 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.917 HG13 ' CG2' ' A' ' 60' ' ' ILE . 47.6 t -148.62 119.82 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.836 -1.165 . . . . 0.0 111.337 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -117.83 156.73 27.86 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.569 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.66 147.19 18.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.279 -1.513 . . . . 0.0 111.127 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 0.0 OUTLIER -119.92 158.9 25.74 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.72 0.772 . . . . 0.0 109.969 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.517 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 2.2 m -51.56 -51.58 54.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 111.7 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.6 23.47 8.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.638 -1.289 . . . . 0.0 110.699 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.3 t -178.74 -167.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.197 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.5 t 177.16 157.61 0.33 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.717 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 52' ' ' ASP . 10.1 m -159.52 143.95 15.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.917 ' CG2' HG13 ' A' ' 51' ' ' VAL . 6.9 pt -131.27 153.26 38.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.186 -1.406 . . . . 0.0 110.568 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.715 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 3.0 m-85 -98.27 161.55 13.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.697 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 13.3 m-85 -146.75 45.89 0.48 Allowed Pre-proline 0 N--CA 1.494 1.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.229 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 1.029 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.1 Cg_endo -63.92 -12.67 33.08 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.718 1.612 . . . . 0.0 109.806 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.77 49.35 1.75 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -89.79 142.0 28.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.077 . . . . 0.0 110.256 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.694 ' C ' HG11 ' A' ' 92' ' ' VAL . 31.6 mtmt -149.19 -176.12 5.24 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -46.55 -40.25 12.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.45 -41.35 93.89 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.198 -0.939 . . . . 0.0 109.94 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' OD2' ' OH ' ' A' ' 73' ' ' TYR . 11.4 t70 -59.42 -16.97 26.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.619 ' CA ' HG23 ' A' ' 92' ' ' VAL . 1.5 m -60.57 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.62 -178.36 21.93 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.193 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.681 ' OD1' HD11 ' A' ' 87' ' ' ILE . 2.0 t-20 -95.39 89.04 5.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -1.047 . . . . 0.0 108.515 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CG ' HG21 ' A' ' 90' ' ' VAL . 7.4 m-85 -69.0 104.9 2.23 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.742 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 87' ' ' ILE . 19.4 mttt -107.79 125.95 52.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.791 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -113.28 142.9 45.28 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.003 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.5 mtmm -138.24 122.84 18.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -113.54 154.41 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 108.962 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -138.4 179.07 6.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.99 -1.069 . . . . 0.0 110.493 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 78' ' ' LYS . 32.7 m-80 -165.31 95.61 0.66 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.533 -0.73 . . . . 0.0 109.343 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 81' ' ' LEU . 5.2 tm-20 60.42 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 110.196 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' CD ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -120.62 -17.35 8.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.908 -1.12 . . . . 0.0 110.025 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -90.07 173.2 39.24 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 179.96 143.94 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.81 -1.406 . . . . 0.0 110.826 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.913 ' CG ' HG22 ' A' ' 5' ' ' ILE . 1.2 t0 -125.89 178.94 5.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 2.0 tm-20 -166.94 146.45 5.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.837 -1.165 . . . . 0.0 110.067 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 85' ' ' GLU . . . -128.36 141.04 51.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.484 -0.76 . . . . 0.0 109.206 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.031 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -100.37 137.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 0.0 109.639 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.031 ' N ' HD13 ' A' ' 87' ' ' ILE . 18.4 m-85 -133.49 101.71 5.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 21.2 tt0 -79.3 89.99 4.95 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.687 HG21 ' CG ' ' A' ' 73' ' ' TYR . 2.1 t -85.4 116.2 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.883 -1.135 . . . . 0.0 110.739 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' N ' ' A' ' 92' ' ' VAL . 25.3 mm -110.69 169.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 14' ' ' ILE . 7.9 t -134.66 148.99 29.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.822 -1.174 . . . . 0.0 110.799 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 18.5 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.458 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.76 HD12 ' CG2' ' A' ' 27' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 6.1 mttt -121.32 128.24 25.77 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 32.4 Cg_endo -74.47 130.74 14.17 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.521 2.147 . . . . 0.0 109.72 -118.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.2 tttt -99.55 78.86 2.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.878 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.3 tt -83.34 124.5 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -121.34 -4.51 9.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 110.64 -178.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.584 ' CG2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -38.29 128.79 1.36 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -45.64 -52.63 10.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.33 -0.856 . . . . 0.0 109.968 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER 60.94 121.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.62 -0.675 . . . . 0.0 109.51 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -170.8 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.132 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' O ' HG12 ' A' ' 12' ' ' ILE . 26.1 pttt -146.28 178.04 8.55 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.621 -0.674 . . . . 0.0 109.488 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.82 HG22 ' CG1' ' A' ' 14' ' ' ILE . 28.7 mm -155.46 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.479 -0.763 . . . . 0.0 108.979 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.46 82.8 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.912 . . . . 0.0 109.709 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.82 ' CG1' HG22 ' A' ' 12' ' ' ILE . 5.3 mt -85.56 164.81 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.037 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.647 ' CB ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -98.67 171.2 8.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.935 -1.103 . . . . 0.0 109.069 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -81.3 151.78 27.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.089 -1.007 . . . . 0.0 109.416 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.59 28.44 2.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' A' ' 15' ' ' LYS . 2.9 m-30 -109.2 -170.99 1.76 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.235 -1.156 . . . . 0.0 110.572 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 63' ' ' PRO . 81.1 p -125.14 141.01 52.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.771 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.7 t60 -131.07 155.87 46.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.07 91.88 3.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.2 tt -77.95 133.39 38.05 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.535 -0.728 . . . . 0.0 110.743 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -123.92 153.86 40.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 4.0 t -160.28 158.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.698 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 12.5 t70 -140.41 143.06 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.035 -1.04 . . . . 0.0 110.729 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.811 ' CZ ' ' HB2' ' A' ' 34' ' ' ALA . 26.7 p90 -169.32 123.34 0.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.76 ' CG2' HD12 ' A' ' 1' ' ' LEU . 1.1 mp -78.96 164.15 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.458 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 27' ' ' ILE . . . 167.47 147.08 5.15 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -174.1 173.76 1.13 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.208 -1.172 . . . . 0.0 109.251 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.995 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.5 Cg_endo -71.71 2.01 7.68 Favored 'Cis proline' 0 C--N 1.312 -1.39 0 C-N-CA 123.623 -1.407 . . . . 0.0 111.208 1.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 4.2 m-20 -168.47 88.73 0.65 Allowed Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.087 -1.008 . . . . 0.0 109.591 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.486 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.3 Cg_endo -78.53 172.84 14.6 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.622 2.215 . . . . 0.0 110.188 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -140.17 114.27 9.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.966 . . . . 0.0 109.523 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.811 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -101.04 121.73 42.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.253 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -107.54 118.76 37.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.991 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.939 ' CH2' HD21 ' A' ' 22' ' ' LEU . 47.4 m95 -84.88 97.38 9.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.207 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.873 ' O ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -107.3 170.18 8.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 109.168 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -127.77 83.59 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.892 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 44.67 -163.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 9.8 t0 71.8 -0.64 3.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -1.111 . . . . 0.0 110.077 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t 60.35 45.44 11.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 109.874 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' ALA . . . 146.53 -24.79 1.68 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -43.51 145.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -1.204 . . . . 0.0 109.863 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.08 147.1 27.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 73' ' ' TYR . 7.2 tt -98.28 144.89 27.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.997 -1.065 . . . . 0.0 111.659 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.702 ' N ' HD23 ' A' ' 45' ' ' LEU . . . 80.74 37.84 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -68.31 -5.71 15.65 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.608 1.539 . . . . 0.0 109.978 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' C ' HD23 ' A' ' 49' ' ' LEU . 3.9 tt0 -141.47 29.29 1.78 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -159.36 -159.65 0.77 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.17 -0.956 . . . . 0.0 110.18 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.872 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -116.57 175.05 5.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.229 -0.919 . . . . 0.0 109.811 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 60' ' ' ILE . 74.2 t -154.78 145.72 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 59' ' ' SER . 1.4 m-20 -141.28 157.98 44.5 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -161.91 146.92 13.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.347 -1.471 . . . . 0.0 111.257 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.608 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -123.55 158.02 32.34 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.676 0.751 . . . . 0.0 109.733 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -49.71 -53.14 26.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.103 -0.998 . . . . 0.0 111.955 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -97.68 18.84 14.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.746 -1.221 . . . . 0.0 111.265 -177.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.698 ' HG1' ' HA ' ' A' ' 25' ' ' ASP . 9.2 t -174.81 -164.2 0.16 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.655 -1.278 . . . . 0.0 108.631 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 7.7 t 177.08 158.3 0.34 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.07 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 p -160.33 143.41 13.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.882 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.7 pt -128.7 165.63 27.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.369 -1.333 . . . . 0.0 110.466 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.768 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -115.67 156.68 25.46 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -143.69 49.3 1.08 Allowed Pre-proline 0 N--CA 1.497 1.921 0 CA-C-N 115.455 -0.793 . . . . 0.0 108.962 177.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.872 ' HG3' HD11 ' A' ' 50' ' ' LEU . 28.7 Cg_endo -65.79 -13.16 38.52 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.905 1.737 . . . . 0.0 109.73 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.81 51.92 1.6 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -87.51 141.81 28.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.026 . . . . 0.0 110.284 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.67 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.1 mttp -145.05 178.38 8.09 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -42.04 -45.35 3.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 109.874 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' ASP . . . -56.85 -44.96 82.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 0.0 110.212 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -42.93 -26.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.932 . . . . 0.0 109.876 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 92' ' ' VAL . 49.3 m -54.16 94.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 109.435 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -145.17 179.26 22.4 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 39' ' ' GLY . 38.5 t30 -96.03 91.15 5.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -1.066 . . . . 0.0 108.71 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.966 ' CD2' HD11 ' A' ' 45' ' ' LEU . 5.0 m-85 -72.65 95.98 1.93 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 110.137 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -100.58 118.26 36.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 109.031 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -104.02 142.76 33.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.202 -0.936 . . . . 0.0 108.782 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -142.92 109.95 5.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.077 -1.014 . . . . 0.0 109.903 -179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 ' CD2' ' A' ' 26' ' ' PHE . 1.1 m -101.83 161.1 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 108.808 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -148.09 175.67 10.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.936 -1.102 . . . . 0.0 110.556 -179.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 1.7 m120 -143.68 160.62 40.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 26.5 tt0 -37.98 -36.99 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.592 -0.692 . . . . 0.0 110.359 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt -143.78 45.08 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.132 -0.98 . . . . 0.0 109.764 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 2' ' ' LYS . . . -159.58 176.07 36.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.7 pt-20 -166.88 138.71 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.443 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.878 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.09 156.2 41.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.497 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 1.2 pt-20 -153.68 165.38 36.15 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.699 -1.251 . . . . 0.0 110.674 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -141.16 135.58 30.98 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.032 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -90.8 138.56 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.625 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.032 ' N ' HD13 ' A' ' 87' ' ' ILE . 36.7 m-85 -136.9 94.39 2.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.608 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -79.63 106.38 11.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 12' ' ' ILE . 39.3 t -101.42 123.53 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.113 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 92' ' ' VAL . 3.7 mp -115.74 171.38 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.347 -0.845 . . . . 0.0 109.051 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG11 ' C ' ' A' ' 66' ' ' LYS . 5.1 t -137.78 136.75 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.48 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 17.8 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.284 0.564 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' H ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -110.81 143.73 28.84 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.922 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 35.6 Cg_endo -79.92 83.6 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.099 2.533 . . . . 0.0 110.952 -146.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -61.29 90.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.077 -1.014 . . . . 0.0 108.903 179.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -77.19 111.43 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' C ' HG23 ' A' ' 7' ' ' THR . 1.3 mp -95.84 -77.66 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.459 -0.776 . . . . 0.0 110.027 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.6 HG21 ' HB2' ' A' ' 86' ' ' ALA . 0.5 OUTLIER 43.08 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.958 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.533 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -102.03 -35.37 8.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.835 -1.166 . . . . 0.0 109.224 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER 54.54 114.05 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.594 0.711 . . . . 0.0 110.319 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER 170.89 -87.8 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.372 -0.83 . . . . 0.0 109.535 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.03 -169.02 2.06 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 109.936 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG23 ' HE2' ' A' ' 20' ' ' HIS . 23.4 mm -156.94 142.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.519 -0.738 . . . . 0.0 109.436 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pttp -110.48 81.38 1.43 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -0.899 . . . . 0.0 108.926 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.7 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.9 mt -90.67 159.16 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 109.251 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -100.65 166.6 10.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.997 -1.064 . . . . 0.0 109.357 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -73.68 151.21 40.83 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.412 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 46.08 28.98 3.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.617 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.6 m-30 -109.56 -178.09 3.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.217 -1.167 . . . . 0.0 110.693 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.759 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.5 p -121.3 130.83 53.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.658 -0.652 . . . . 0.0 109.88 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.7 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -117.75 158.21 25.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.29 -0.881 . . . . 0.0 109.799 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.43 82.73 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.926 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.8 tt -68.27 130.71 43.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.464 -0.773 . . . . 0.0 110.254 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 31.4 tt0 -126.89 151.32 48.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.423 -0.798 . . . . 0.0 109.562 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG13 ' CG2' ' A' ' 7' ' ' THR . 39.6 t -156.73 149.64 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 108.778 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.582 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.0 m-20 -141.68 118.22 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.935 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.944 ' C ' HD12 ' A' ' 27' ' ' ILE . 18.4 p90 -123.77 173.85 7.88 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.08 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.944 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.7 mp -122.12 78.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.793 -1.192 . . . . 0.0 109.846 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -120.91 152.65 16.77 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.983 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -176.94 174.24 0.69 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.243 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.983 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.9 Cg_endo -71.9 2.91 7.5 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.708 -1.372 . . . . 0.0 111.386 1.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -168.95 88.21 0.62 Allowed Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 120.982 -1.074 . . . . 0.0 109.741 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 36.2 Cg_endo -79.53 164.23 23.78 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.764 2.309 . . . . 0.0 110.461 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 24.4 m -122.55 115.19 21.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.25 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 75' ' ' LEU . . . -106.13 108.23 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.915 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.6 m -94.5 130.26 40.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.013 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.926 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.0 m95 -92.95 100.3 12.78 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.379 1.085 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.59 175.03 5.62 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.013 -1.055 . . . . 0.0 110.267 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 38' ' ' VAL . 4.8 p -128.53 67.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 122.031 0.92 . . . . 0.0 110.103 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 136.93 -161.86 25.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -121.41 -17.35 7.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -1.168 . . . . 0.0 109.525 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 t -71.74 -16.06 62.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.277 -0.889 . . . . 0.0 109.75 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.3 -8.59 7.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 37' ' ' THR . . . -48.61 165.19 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.277 -1.131 . . . . 0.0 108.59 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.745 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -143.3 168.53 19.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.845 -1.159 . . . . 0.0 110.252 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.84 146.55 37.7 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.639 -1.224 . . . . 0.0 110.032 179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.9 -53.65 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 110.3 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.838 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.6 Cg_endo -70.51 -11.11 29.34 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.004 1.802 . . . . 0.0 110.677 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.665 ' C ' HD23 ' A' ' 49' ' ' LEU . 8.8 tp10 -102.63 18.27 21.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.788 HD11 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER 179.32 -159.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . 7.7 mt -113.47 165.69 12.23 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 60' ' ' ILE . 84.2 t -156.07 140.99 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.704 -1.247 . . . . 0.0 110.644 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -142.27 159.83 41.46 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.558 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.44 147.03 15.56 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.607 -1.308 . . . . 0.0 109.857 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 5.4 mttt -125.95 164.22 21.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.792 . . . . 0.0 110.481 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' LYS . 28.3 t -16.73 -97.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 3.5 p -91.27 12.41 20.39 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.056 -1.027 . . . . 0.0 111.443 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.582 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.5 t -137.34 -171.74 3.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.354 -1.466 . . . . 0.0 108.642 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.558 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.9 t 179.14 161.04 0.73 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.494 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 52' ' ' ASP . 22.3 p -160.27 142.5 13.01 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.795 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.4 pt -127.87 161.21 36.33 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 C-N-CA 118.078 -1.449 . . . . 0.0 110.624 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.742 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -107.49 159.73 16.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.7 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 2.1 m-85 -143.27 47.13 0.76 Allowed Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.191 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.759 ' HA ' HG22 ' A' ' 19' ' ' THR . 29.2 Cg_endo -64.35 -12.21 31.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.986 1.791 . . . . 0.0 109.828 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.55 47.43 1.94 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.29 140.15 31.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 0.0 110.024 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.595 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -145.87 173.46 12.1 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HG2' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.93 -40.91 15.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.094 -1.004 . . . . 0.0 109.611 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 67' ' ' ARG . . . -62.25 -39.66 93.6 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.112 -0.993 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.07 -18.16 4.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -53.48 102.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.68 -174.8 23.52 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -102.93 95.16 5.97 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.239 -1.153 . . . . 0.0 108.933 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.717 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 3.9 m-85 -73.12 98.95 2.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 18.3 tptp -102.62 115.92 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.551 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.83 HD21 ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -101.58 145.95 28.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.503 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 5.9 mtpt -133.76 107.66 8.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.084 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.83 ' CG1' HD21 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -109.75 124.95 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 109.357 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 16.3 ptpt -126.45 -167.44 1.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.575 0.702 . . . . 0.0 110.289 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 22.1 t-20 -179.06 110.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 109.546 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 81' ' ' LEU . 11.2 tp10 57.48 -96.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD12 ' HG3' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -116.64 -16.54 10.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.997 -1.065 . . . . 0.0 109.594 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.43 122.08 5.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.97 154.22 31.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 0.0 110.011 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -155.76 164.43 38.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 63.1 mt-10 -160.59 145.36 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.066 . . . . 0.0 110.08 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 5' ' ' ILE . . . -119.69 114.4 22.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.357 -0.839 . . . . 0.0 108.811 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tt -79.72 130.85 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.647 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CZ ' ' HB1' ' A' ' 86' ' ' ALA . 72.6 m-85 -132.89 99.69 4.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.534 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 1.5 mt-10 -79.02 104.24 9.53 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 73' ' ' TYR . 12.2 t -97.19 127.11 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.982 -1.074 . . . . 0.0 110.796 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 92' ' ' VAL . 19.2 mt -120.89 164.98 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.623 ' N ' HG22 ' A' ' 91' ' ' ILE . 5.9 t -131.57 145.52 34.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.978 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.448 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 2' ' ' LYS . 2.5 pp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.341 0.591 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.755 ' O ' HD12 ' A' ' 1' ' ' LEU . 1.4 mttm -61.06 143.78 91.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.512 -0.742 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.0 Cg_endo -77.39 83.93 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.637 2.225 . . . . 0.0 110.316 -157.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 5.0 tppt? -57.48 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -82.15 115.25 24.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.743 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -116.26 2.62 13.3 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.731 -177.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 0.5 OUTLIER -37.23 -52.48 1.05 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.006 179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 7' ' ' THR . . . 83.11 -49.88 0.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.585 0.707 . . . . 0.0 109.892 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.571 ' OG ' ' CD2' ' A' ' 88' ' ' PHE . 3.3 t 39.49 -164.8 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.904 0.859 . . . . 0.0 110.781 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.94 -87.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -128.16 173.35 10.18 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.044 HG23 ' NE2' ' A' ' 20' ' ' HIS . 8.7 mm -143.4 92.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.152 -0.967 . . . . 0.0 109.742 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -76.47 110.39 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.902 ' HB ' HG22 ' A' ' 92' ' ' VAL . 6.4 mt -125.6 128.73 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.8 162.58 29.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.716 -1.24 . . . . 0.0 108.542 179.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 93' ' ' GLN . . . -66.7 149.9 49.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.996 -1.065 . . . . 0.0 109.436 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 53.82 37.18 56.92 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.5 m-85 -111.47 165.34 12.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.992 -1.299 . . . . 0.0 110.921 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 18.4 p -108.71 103.4 12.48 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 1.044 ' NE2' HG23 ' A' ' 12' ' ' ILE . 5.8 t60 -86.84 176.91 7.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 51.0 p-10 -155.12 65.91 0.65 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.978 0.894 . . . . 0.0 108.666 178.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.888 HD21 ' CH2' ' A' ' 36' ' ' TRP . 3.9 tt -47.58 140.91 5.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.325 0.583 . . . . 0.0 110.125 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -125.22 139.17 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.806 . . . . 0.0 109.299 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 ' HH2' ' A' ' 36' ' ' TRP . 5.1 t -151.12 155.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.269 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.569 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 1.2 m-20 -154.32 142.54 20.42 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.295 -0.878 . . . . 0.0 110.139 179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.925 ' C ' HD12 ' A' ' 27' ' ' ILE . 21.1 p90 -146.16 173.46 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.656 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.925 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -122.31 81.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.935 -1.103 . . . . 0.0 109.785 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' HA ' ' A' ' 3' ' ' PRO . . . -121.89 149.05 17.18 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -179.08 166.26 0.95 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.253 . . . . 0.0 110.033 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.851 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.9 Cg_endo -73.46 142.91 76.2 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.077 1.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 3.9 t70 40.21 89.52 0.08 OUTLIER Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' SER . 36.7 Cg_endo -77.86 -168.28 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.609 2.206 . . . . 0.0 110.521 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 4.4 m -138.41 133.5 32.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 108.998 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -129.26 119.83 24.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.698 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -107.14 123.11 47.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.888 ' CH2' HD21 ' A' ' 22' ' ' LEU . 40.2 m95 -89.31 102.69 15.35 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.238 1.018 . . . . 0.0 109.501 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.883 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -105.36 179.97 4.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.825 -1.172 . . . . 0.0 110.159 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.701 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 1.4 p -137.33 -169.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.627 ' H ' HG22 ' A' ' 38' ' ' VAL . . . 51.38 -134.03 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.13 25.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -1.116 . . . . 0.0 109.315 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 4.72 1.95 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.294 -0.879 . . . . 0.0 110.057 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.39 -10.08 4.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.883 ' O ' HG22 ' A' ' 37' ' ' THR . . . -50.73 167.94 0.06 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -1.146 . . . . 0.0 108.901 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -142.65 157.54 44.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.816 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -134.29 145.16 48.82 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.705 178.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.939 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 171.52 -57.06 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.132 -0.98 . . . . 0.0 110.043 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.939 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.4 Cg_endo -71.01 -5.59 17.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.16 1.907 . . . . 0.0 110.274 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -106.59 15.62 25.57 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -178.34 -165.37 0.09 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.504 -0.748 . . . . 0.0 109.172 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.911 HD23 ' HG3' ' A' ' 63' ' ' PRO . 3.5 mm? -116.53 119.4 35.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.981 HG13 ' CG2' ' A' ' 60' ' ' ILE . 85.1 t -116.69 115.53 49.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.856 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -112.82 162.55 15.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.447 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.538 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.43 147.94 16.12 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.542 -1.349 . . . . 0.0 110.097 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HB2' ' CG2' ' A' ' 57' ' ' THR . 42.7 mttt -117.84 163.27 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 110.444 -179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -15.0 -94.2 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.588 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 70.0 m -94.72 9.67 38.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 111.489 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.6 t -134.73 -169.37 2.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.607 -1.308 . . . . 0.0 108.829 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.538 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 8.0 t 179.08 167.03 0.97 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.653 -1.219 . . . . 0.0 111.283 178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 52' ' ' ASP . 1.1 m -159.02 145.16 16.66 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.981 ' CG2' HG13 ' A' ' 51' ' ' VAL . 3.7 pt -142.75 125.77 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -101.19 163.63 12.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.609 -1.307 . . . . 0.0 111.464 -178.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.791 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 1.2 m-85 -110.64 77.8 1.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.911 ' HG3' HD23 ' A' ' 50' ' ' LEU . 32.8 Cg_endo -64.61 -11.21 27.7 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.397 2.065 . . . . 0.0 110.145 -178.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -142.04 54.41 1.47 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.791 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.47 140.39 33.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.01 -1.056 . . . . 0.0 109.906 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.821 ' C ' HG11 ' A' ' 92' ' ' VAL . 2.2 mmmt -146.0 179.01 7.77 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.3 mtm180 -44.72 -45.35 9.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.49 85.44 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -47.79 -25.67 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.554 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -54.75 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.244 -0.91 . . . . 0.0 108.995 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.44 -160.63 9.83 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 21.7 m-20 -113.04 90.81 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -1.13 . . . . 0.0 109.215 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.708 ' CD1' HG21 ' A' ' 90' ' ' VAL . 9.3 m-85 -72.43 118.03 14.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.189 -0.945 . . . . 0.0 109.243 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.24 125.54 46.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.957 . . . . 0.0 109.065 -179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.682 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -110.41 146.86 35.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 -179.371 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 4.0 mttp -141.78 108.28 5.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.174 -0.954 . . . . 0.0 109.258 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.512 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.0 m -107.22 128.37 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 109.091 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 1.7 mttt -110.96 172.78 6.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.328 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 8.4 t-20 -137.77 159.57 41.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 109.387 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 79' ' ' ASN . 10.6 tm-20 -37.44 -44.98 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -137.5 45.91 2.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.942 . . . . 0.0 109.307 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 2' ' ' LYS . . . -161.12 -177.03 33.87 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.6 mt-10 -169.71 144.5 2.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 0.0 109.938 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 5.9 m-20 -160.99 160.2 30.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.594 ' O ' HG21 ' A' ' 5' ' ' ILE . 13.5 pt-20 -151.95 178.57 9.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.95 -1.094 . . . . 0.0 110.419 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.668 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -149.52 142.74 25.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.932 HD11 ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -96.26 143.16 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.444 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 27.0 m-85 -140.99 92.85 2.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.932 ' HG3' HD11 ' A' ' 87' ' ' ILE . 39.0 mt-10 -78.81 111.64 15.15 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CG2' ' A' ' 12' ' ' ILE . 2.5 t -105.23 125.99 60.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.096 HD13 ' N ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -116.6 152.14 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.096 ' N ' HD13 ' A' ' 91' ' ' ILE . 54.9 t -145.28 145.81 20.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.903 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.482 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 2.9 mp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.8 pttm -42.87 135.06 2.87 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.613 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.8 Cg_endo -77.76 103.19 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.816 2.344 . . . . 0.0 110.35 -153.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 mttm -77.47 81.3 3.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.949 -1.095 . . . . 0.0 108.922 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -77.24 115.84 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.679 0.752 . . . . 0.0 109.578 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 7' ' ' THR . 10.9 mp -78.83 -41.04 31.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.691 -0.631 . . . . 0.0 110.072 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.741 HG21 HG13 ' A' ' 24' ' ' VAL . 14.6 t -50.7 178.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.437 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CG2' ' A' ' 87' ' ' ILE . . . -170.21 -28.34 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.661 -1.274 . . . . 0.0 111.273 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.78 ' HA ' HG23 ' A' ' 87' ' ' ILE . 1.4 t -173.47 118.95 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.233 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.3 90.91 1.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.231 -0.987 . . . . 0.0 110.625 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.73 ' O ' HD13 ' A' ' 12' ' ' ILE . 18.3 mtmt -75.1 158.28 33.36 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.76 HG21 ' NE2' ' A' ' 20' ' ' HIS . 41.0 mm -141.72 114.35 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.004 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -84.26 79.1 9.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.27 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.636 ' CG1' HG22 ' A' ' 12' ' ' ILE . 8.0 mt -79.35 142.69 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.384 -178.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 3.1 tttp -76.85 142.96 40.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.651 -1.281 . . . . 0.0 109.061 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -64.06 137.23 57.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.98 -1.075 . . . . 0.0 109.862 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' ' HD2' ' A' ' 66' ' ' LYS . . . 72.42 51.18 13.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 15' ' ' LYS . 33.1 m-85 -143.23 -178.48 5.87 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.84 -1.388 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 63' ' ' PRO . 78.3 p -115.7 130.49 56.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.76 ' NE2' HG21 ' A' ' 12' ' ' ILE . 2.7 t60 -119.91 151.34 39.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.967 . . . . 0.0 110.07 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 35.5 p30 -120.7 87.39 2.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 0.0 108.868 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.4 tt -73.25 137.77 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 110.571 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' C ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -131.93 156.71 45.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.253 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.862 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 41.7 t -160.0 161.21 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.637 ' HA ' ' HG1' ' A' ' 57' ' ' THR . 5.1 t70 -141.0 142.18 34.28 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.416 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' HB3' HD12 ' A' ' 5' ' ' ILE . 15.5 p90 -167.79 123.33 1.04 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 0.0 110.128 178.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -79.39 88.09 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.503 -0.748 . . . . 0.0 110.446 -178.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -115.38 136.22 12.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -173.27 163.08 3.43 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.076 -1.25 . . . . 0.0 109.708 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.719 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.25 137.03 47.69 Favored 'Cis proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.926 -1.698 . . . . 0.0 110.312 0.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 1.3 p30 36.61 89.77 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.41 -170.25 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.654 2.236 . . . . 0.0 109.989 179.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -138.35 111.03 7.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.315 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -110.98 138.29 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.126 -0.984 . . . . 0.0 109.897 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.9 m -119.49 131.23 55.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.476 -0.765 . . . . 0.0 109.52 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.977 ' CH2' HD21 ' A' ' 22' ' ' LEU . 41.4 m95 -98.15 96.45 8.12 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.02 0.914 . . . . 0.0 108.992 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -99.65 156.17 17.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.732 -1.23 . . . . 0.0 110.918 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG22 ' H ' ' A' ' 39' ' ' GLY . 4.0 p -96.63 -170.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.772 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -57.78 -150.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 1.9 t0 71.81 -0.28 3.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -1.217 . . . . 0.0 110.115 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER 57.71 45.72 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.0 109.682 179.792 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.1 -26.66 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 37' ' ' THR . . . -52.58 156.7 1.77 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.334 -1.097 . . . . 0.0 109.396 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -120.84 150.78 40.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.663 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -111.2 -170.68 1.68 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.33 -1.748 . . . . 0.0 110.712 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 45' ' ' LEU . . . 127.62 -48.25 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.192 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 46' ' ' ALA . 31.2 Cg_endo -71.73 -2.68 11.78 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.784 1.656 . . . . 0.0 110.538 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.8 tp10 -123.45 20.58 9.57 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.7 pp 173.58 -166.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.56 -0.712 . . . . 0.0 109.214 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 49' ' ' LEU . 7.8 mt -112.82 167.93 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.816 HG13 ' CG2' ' A' ' 60' ' ' ILE . 63.3 t -157.53 140.55 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.837 -1.164 . . . . 0.0 110.825 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -140.49 156.48 46.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.567 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.87 146.39 17.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.39 -1.444 . . . . 0.0 110.757 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 57' ' ' THR . 0.5 OUTLIER -122.38 158.18 30.22 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.761 0.791 . . . . 0.0 109.895 -179.733 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PRO . 84.0 p -52.67 -47.16 67.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.087 -1.008 . . . . 0.0 111.709 -178.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' PHE . 4.9 m -98.92 18.85 16.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.669 -1.269 . . . . 0.0 111.125 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 54' ' ' LYS . 11.6 t -179.44 -165.5 0.08 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.596 -1.315 . . . . 0.0 108.712 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.567 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.2 t 179.14 153.7 0.42 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.844 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.2 p -156.3 143.55 19.07 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.816 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.09 164.7 29.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.65 -177.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.729 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.1 m-85 -111.35 159.06 18.34 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -174.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 90' ' ' VAL . 3.0 m-85 -143.8 47.56 0.79 Allowed Pre-proline 0 N--CA 1.494 1.733 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.991 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 19' ' ' THR . 27.7 Cg_endo -62.84 -12.73 30.5 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.928 1.752 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.95 46.82 2.43 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -83.27 144.24 29.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.893 -1.13 . . . . 0.0 109.405 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.887 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -160.26 178.86 9.19 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 68' ' ' ALA . 2.3 ptm180 -43.1 -42.95 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.641 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 67' ' ' ARG . . . -57.06 -46.24 82.63 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.28 -0.888 . . . . 0.0 109.809 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.618 ' CG ' ' HH ' ' A' ' 73' ' ' TYR . 3.1 t70 -57.44 -23.31 48.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 92' ' ' VAL . 58.3 p -44.91 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.496 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -160.05 -166.62 19.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.9 m-20 -114.89 104.73 12.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.346 -1.091 . . . . 0.0 108.792 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' HE2' HD21 ' A' ' 49' ' ' LEU . 26.4 m-85 -79.09 91.72 4.94 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.055 -1.028 . . . . 0.0 109.769 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -90.4 118.16 29.67 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.036 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -107.92 144.89 34.54 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.067 -1.021 . . . . 0.0 109.043 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 6.5 mttm -141.04 123.93 16.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 108.965 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -110.0 158.93 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 16.1 mtpt -144.54 163.85 32.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.039 -1.038 . . . . 0.0 110.114 -178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -148.46 49.38 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.603 179.81 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG2' HD12 ' A' ' 81' ' ' LEU . 4.4 tt0 54.54 -97.95 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.373 -0.829 . . . . 0.0 110.707 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 80' ' ' GLU . 0.3 OUTLIER -64.25 -9.83 19.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.019 -1.051 . . . . 0.0 110.498 -178.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 83' ' ' GLU . . . -136.83 -171.07 12.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 167.63 142.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.091 -1.24 . . . . 0.0 110.542 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.612 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -136.07 176.9 8.27 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 45.0 mt-10 -155.8 137.44 14.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.778 -1.202 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 7' ' ' THR . . . -124.78 149.09 47.72 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.612 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.78 HG23 ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -110.16 144.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.252 179.946 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.862 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 97.5 m-85 -146.51 112.84 5.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.963 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -89.71 149.52 22.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.004 -1.06 . . . . 0.0 108.654 179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 62' ' ' PHE . 21.5 t -143.51 84.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.856 -1.152 . . . . 0.0 109.599 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 92' ' ' VAL . 60.1 mt -83.45 165.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.887 HG11 ' C ' ' A' ' 66' ' ' LYS . 3.5 t -139.52 128.67 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.491 -178.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.374 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.953 HD22 ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.157 0.503 . . . . 0.0 110.096 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.953 ' N ' HD22 ' A' ' 1' ' ' LEU . 10.0 mttm -45.04 118.61 3.7 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.371 -0.83 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.3 Cg_endo -75.02 132.99 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.47 2.114 . . . . 0.0 110.101 -158.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.597 ' CG ' ' HB ' ' A' ' 27' ' ' ILE . 4.3 ptmt -111.78 102.99 11.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.96 -1.088 . . . . 0.0 109.955 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.5 tt -90.61 111.06 22.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD22 ' N ' ' A' ' 6' ' ' LEU . 2.8 mm? -106.68 3.13 26.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.473 -0.767 . . . . 0.0 110.633 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 86' ' ' ALA . 1.2 t -38.75 152.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 109.869 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.68 29.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER 64.93 122.68 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.659 -0.651 . . . . 0.0 109.883 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 9' ' ' SER . 1.2 mtm-85 177.58 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.489 -0.757 . . . . 0.0 109.115 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -158.23 -169.92 2.95 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.447 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.794 ' HB ' HG13 ' A' ' 90' ' ' VAL . 33.3 mm -156.05 149.52 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.412 -0.805 . . . . 0.0 109.142 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -118.39 80.49 1.54 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 108.846 179.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.681 HG23 ' ND1' ' A' ' 20' ' ' HIS . 1.6 mt -95.56 159.51 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.956 . . . . 0.0 108.884 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.67 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 6.6 tttt -107.27 158.95 16.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.943 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -67.16 144.75 55.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.951 -1.093 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.81 35.72 87.5 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.67 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.6 m-85 -119.63 -171.78 2.2 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.998 -1.295 . . . . 0.0 111.317 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 63' ' ' PRO . 72.7 p -129.06 127.62 41.91 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.5 t60 -117.57 162.31 18.21 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.23 -0.919 . . . . 0.0 109.824 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.0 82.18 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.931 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.0 tt -69.82 136.93 51.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.7 -0.625 . . . . 0.0 110.986 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -128.49 157.17 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.546 -0.722 . . . . 0.0 109.33 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 ' CZ ' ' A' ' 88' ' ' PHE . 5.6 t -160.27 136.89 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.311 -0.868 . . . . 0.0 109.123 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.521 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 14.8 m-20 -113.41 130.82 56.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.384 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.899 ' CD1' HG21 ' A' ' 77' ' ' VAL . 5.0 p90 -164.22 117.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 110.143 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -80.94 165.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 169.3 151.22 7.15 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 172.96 169.03 0.25 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.172 -1.193 . . . . 0.0 109.667 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.908 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 34.7 Cg_endo -72.9 148.8 92.92 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.589 1.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.8 OUTLIER 38.44 85.94 0.15 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.983 -0.448 . . . . 0.0 109.979 -179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.506 ' HG2' ' HA ' ' A' ' 55' ' ' SER . 36.8 Cg_endo -79.34 155.89 25.32 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.709 2.273 . . . . 0.0 110.431 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -120.31 119.31 32.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.056 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -117.51 104.68 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.844 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -90.39 135.28 33.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.255 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.943 ' CE2' HD13 ' A' ' 75' ' ' LEU . 31.1 m95 -95.41 105.75 17.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.309 1.052 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -102.38 159.25 15.58 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.018 -1.051 . . . . 0.0 110.788 -179.136 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.725 ' CG1' ' HB1' ' A' ' 43' ' ' ALA . 5.1 p -101.12 34.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.574 0.702 . . . . 0.0 110.848 -178.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 36.31 94.77 0.01 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 1.6 m-20 176.44 57.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -1.196 . . . . 0.0 109.417 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t 66.13 53.02 1.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.443 -0.785 . . . . 0.0 109.721 179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.9 -4.43 82.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.901 ' O ' HG22 ' A' ' 37' ' ' THR . . . -46.55 148.99 0.85 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.139 -1.212 . . . . 0.0 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.87 157.88 41.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.82 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -130.73 154.84 47.54 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.204 179.073 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 166.56 -54.21 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.499 -0.75 . . . . 0.0 110.207 -179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.91 -5.33 16.68 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.053 1.835 . . . . 0.0 110.674 -179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 16.9 tp10 -107.21 16.68 23.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.75 HD21 HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER 178.26 -161.33 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.049 HD13 ' N ' ' A' ' 51' ' ' VAL . 3.1 tm? -118.91 150.81 39.25 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.049 ' N ' HD13 ' A' ' 50' ' ' LEU . 59.1 t -138.24 138.9 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.599 -1.313 . . . . 0.0 110.809 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -133.61 153.88 51.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -160.64 146.74 15.07 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.573 -1.329 . . . . 0.0 110.771 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' CG ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -128.67 162.13 28.06 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.056 0.931 . . . . 0.0 110.028 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -44.43 -61.77 1.41 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.627 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.29 12.77 19.27 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.72 -1.238 . . . . 0.0 111.978 -177.077 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.551 HG22 ' CG ' ' A' ' 54' ' ' LYS . 6.0 t -170.08 -162.16 0.3 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.335 -1.478 . . . . 0.0 109.666 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.1 t 174.03 158.08 0.14 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.589 0.709 . . . . 0.0 109.907 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 52' ' ' ASP . 6.6 p -158.15 143.75 16.9 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.803 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.1 pt -130.79 143.21 41.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.045 -1.462 . . . . 0.0 110.764 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 5.7 m-85 -90.63 155.39 18.88 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.651 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -139.76 45.06 0.8 Allowed Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.062 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.8 Cg_endo -63.36 -12.92 32.96 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.954 1.769 . . . . 0.0 109.597 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -121.58 47.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -81.0 141.44 34.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.979 -1.076 . . . . 0.0 109.924 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.79 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -143.07 177.44 8.37 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 6.3 ptt180 -48.6 -41.01 29.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.625 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.44 81.55 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.313 -0.867 . . . . 0.0 109.97 -179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -46.86 -24.03 0.53 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 109.746 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p -51.33 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.686 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.44 -177.29 32.4 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' GLY . 73.9 m-20 -97.67 84.67 3.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.244 -1.151 . . . . 0.0 108.618 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.641 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 63.1 m-85 -62.96 88.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.037 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 87' ' ' ILE . 4.6 tttp -106.23 128.93 54.31 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -118.36 148.31 42.63 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 109.321 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -132.2 131.58 42.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.66 -179.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.899 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.4 m -115.46 160.62 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.93 . . . . 0.0 108.909 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -156.15 178.9 9.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.674 -1.266 . . . . 0.0 110.597 -179.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -153.39 169.66 22.57 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.453 -0.779 . . . . 0.0 109.202 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.772 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -32.8 -34.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.925 -0.484 . . . . 0.0 111.165 -179.531 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER -154.27 43.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.92 -1.112 . . . . 0.0 109.791 -179.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CD ' ' A' ' 3' ' ' PRO . . . -149.98 167.97 30.02 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 2.5 pt-20 -167.13 140.46 3.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.115 -1.226 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.59 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -149.96 168.47 23.73 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.1 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 7.1 pt-20 -156.68 165.39 36.39 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.625 -1.297 . . . . 0.0 110.941 -179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.565 ' CB ' HG21 ' A' ' 7' ' ' THR . . . -147.15 130.22 16.38 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -98.59 124.04 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.164 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.653 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 54.9 m-85 -122.23 95.95 4.85 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 5.7 tt0 -78.27 102.58 7.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 12' ' ' ILE . 14.8 t -99.12 133.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.626 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.6 mp -116.49 163.95 13.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.49 -0.756 . . . . 0.0 109.051 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.79 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.7 t -131.22 133.75 62.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.523 -0.736 . . . . 0.0 109.838 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.515 -179.967 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.608 HD11 HG22 ' A' ' 27' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.329 0.585 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.528 ' O ' HD12 ' A' ' 1' ' ' LEU . 2.0 ptpp? -43.89 144.22 1.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 0.0 109.417 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.3 Cg_endo -77.8 108.99 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.599 2.199 . . . . 0.0 110.437 -172.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.668 ' O ' HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -94.21 85.14 4.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.346 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -74.42 111.84 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.883 0.849 . . . . 0.0 108.855 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -113.36 1.4 15.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.643 -0.66 . . . . 0.0 111.616 -178.002 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.584 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -38.74 159.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.196 -0.94 . . . . 0.0 109.967 179.59 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 9' ' ' SER . . . -63.68 -67.91 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.132 -0.98 . . . . 0.0 109.496 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER 76.68 130.53 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.515 0.674 . . . . 0.0 110.354 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 172.03 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mtmt -152.8 -174.45 4.93 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 28.3 mm -154.16 143.77 13.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.065 -1.022 . . . . 0.0 110.547 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -112.18 92.95 4.21 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.052 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.831 ' O ' HG13 ' A' ' 92' ' ' VAL . 1.7 mt -107.27 96.08 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -178.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HG3' ' CG ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -44.84 159.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.026 -1.046 . . . . 0.0 108.728 179.065 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -74.29 143.38 45.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.854 -1.154 . . . . 0.0 110.027 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.61 50.84 23.46 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.601 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 61.1 m-85 -139.73 166.01 25.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.811 -1.405 . . . . 0.0 111.179 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 p -104.73 96.56 6.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.72 -0.612 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.683 ' HD1' HG23 ' A' ' 14' ' ' ILE . 4.9 t60 -77.65 177.54 8.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.234 -0.916 . . . . 0.0 110.131 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.759 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 1.5 p30 -154.36 75.01 0.98 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.278 1.037 . . . . 0.0 109.667 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.739 HD21 ' CH2' ' A' ' 36' ' ' TRP . 8.4 tt -51.57 136.7 26.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.772 -0.58 . . . . 0.0 110.097 179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -126.88 134.61 50.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.744 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 2.7 t -147.96 160.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.547 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 6.1 t70 -151.31 143.57 24.09 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.149 -0.969 . . . . 0.0 110.327 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CB ' ' HA ' ' A' ' 5' ' ' ILE . 54.6 p90 -157.24 131.94 8.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.418 -0.802 . . . . 0.0 108.968 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.5 mp -81.33 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.039 -1.038 . . . . 0.0 110.658 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -123.48 147.93 16.71 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.946 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 178.74 173.06 0.43 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.153 -1.204 . . . . 0.0 109.504 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.946 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.87 1.85 8.02 Favored 'Cis proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.109 1.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -172.04 87.35 0.44 Allowed Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.279 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.513 ' CG ' ' O ' ' A' ' 55' ' ' SER . 37.9 Cg_endo -80.35 -171.39 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.766 2.31 . . . . 0.0 110.721 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 94.9 m -134.5 147.61 50.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -143.7 123.47 13.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.887 -1.133 . . . . 0.0 109.778 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -111.35 122.31 47.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.356 -0.84 . . . . 0.0 109.275 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.739 ' CH2' HD21 ' A' ' 22' ' ' LEU . 37.6 m95 -88.73 105.75 17.9 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.96 0.886 . . . . 0.0 109.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -100.92 176.78 5.16 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.951 -1.093 . . . . 0.0 110.038 -179.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -129.61 51.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.294 -178.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 40' ' ' ASP . . . 39.89 -143.42 0.5 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 2.1 t0 78.51 -73.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.676 -0.896 . . . . 0.0 109.751 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 174.76 39.33 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.22 -0.925 . . . . 0.0 108.872 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.99 25.56 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' THR . . . -65.58 162.61 17.85 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 109.149 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -129.05 155.64 45.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.216 -0.927 . . . . 0.0 108.899 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -128.49 143.46 50.98 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.39 179.545 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 172.0 -57.2 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.62 -0.675 . . . . 0.0 109.507 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.7 Cg_endo -71.66 80.98 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.309 2.006 . . . . 0.0 109.814 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' CB ' ' O ' ' A' ' 47' ' ' PRO . 1.4 mm-40 160.25 -25.17 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -134.59 -167.49 1.98 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.2 mt -115.2 115.4 26.65 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 108.744 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.986 HG13 ' CG2' ' A' ' 60' ' ' ILE . 93.0 t -115.1 103.37 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.315 -0.866 . . . . 0.0 110.894 -178.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 11.8 m-20 -100.86 156.77 17.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.35 145.2 20.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.378 -1.451 . . . . 0.0 111.127 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -118.72 157.64 27.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.515 0.674 . . . . 0.0 109.725 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 72.9 m -56.61 -36.59 69.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.15 -0.969 . . . . 0.0 111.124 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 57' ' ' THR . 82.0 p -106.08 19.42 20.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.726 -1.234 . . . . 0.0 110.504 -178.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 11.7 t 179.6 -167.58 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.795 -1.19 . . . . 0.0 108.745 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 13.3 t 176.32 149.74 0.13 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.002 178.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 44.0 m -148.63 149.18 31.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.986 ' CG2' HG13 ' A' ' 51' ' ' VAL . 4.7 pt -145.05 113.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.145 -0.972 . . . . 0.0 109.105 -178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.759 ' HB3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -91.71 166.97 12.51 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.334 1.064 . . . . 0.0 111.287 -178.226 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CE2' ' CZ ' ' A' ' 73' ' ' TYR . 1.7 m-85 -113.72 82.09 6.2 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 31.3 Cg_endo -64.21 -11.79 29.52 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.115 1.877 . . . . 0.0 109.642 -178.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.09 55.55 1.55 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -79.85 141.68 35.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.022 -1.049 . . . . 0.0 109.853 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.773 ' C ' HG11 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -153.29 175.26 13.29 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.377 0.608 . . . . 0.0 109.882 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.9 OUTLIER -46.62 -47.72 19.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.82 . . . . 0.0 110.285 -179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.26 -34.89 74.36 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 110.453 -179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' OD1' ' CD2' ' A' ' 62' ' ' PHE . 6.5 t70 -57.97 -15.45 9.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.048 -1.033 . . . . 0.0 110.135 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.439 ' CA ' HG23 ' A' ' 92' ' ' VAL . 32.2 p -56.7 105.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.962 . . . . 0.0 109.805 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.5 -169.25 18.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . 28.7 m-20 -104.01 94.18 5.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -1.185 . . . . 0.0 108.773 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.696 ' CZ ' ' CE2' ' A' ' 62' ' ' PHE . 22.0 m-85 -75.59 102.91 5.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.997 -1.065 . . . . 0.0 109.391 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -104.46 170.27 7.99 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.469 -0.769 . . . . 0.0 108.958 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.733 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -152.43 144.14 23.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 108.98 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 12.8 mtmt -141.19 108.08 5.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.051 -1.03 . . . . 0.0 109.407 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' THR . 1.1 m -108.35 144.66 16.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 3.3 mtmt -137.56 -178.16 5.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 36.3 t30 -170.11 161.92 8.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -61.85 -21.17 64.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.214 -0.929 . . . . 0.0 110.148 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -96.56 19.21 12.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.382 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . 134.93 -145.68 17.77 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 1.5 pt-20 177.26 141.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.163 -1.198 . . . . 0.0 110.222 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.615 ' OD1' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -126.08 170.56 11.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.539 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 79.1 mt-10 -158.89 165.76 33.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 0.0 109.852 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.37 41.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.451 -0.78 . . . . 0.0 109.406 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -118.88 136.36 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 109.453 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.999 ' N ' HD13 ' A' ' 87' ' ' ILE . 55.0 m-85 -135.22 105.02 6.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 109.671 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER -79.49 105.68 10.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.334 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 73' ' ' TYR . 42.8 t -97.79 126.62 50.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.654 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 92' ' ' VAL . 52.5 mt -120.31 170.63 9.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 14' ' ' ILE . 15.0 t -130.19 148.52 33.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.764 -1.21 . . . . 0.0 110.529 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.466 ' OXT' ' HA ' ' A' ' 15' ' ' LYS . 48.7 mt-30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -45.27 159.67 0.27 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.692 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 35.1 Cg_endo -77.82 148.24 25.18 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.821 2.348 . . . . 0.0 110.351 -145.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.1 mmtt -122.17 79.36 1.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.467 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.676 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -82.03 118.52 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -114.72 -8.43 12.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 110.199 -179.407 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 7' ' ' THR . 5.9 t -36.1 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 0.0 110.248 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.516 ' O ' ' C ' ' A' ' 9' ' ' SER . . . -57.88 -20.75 39.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.383 -0.823 . . . . 0.0 109.593 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.606 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -23.88 141.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -135.76 -41.34 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.406 -0.809 . . . . 0.0 109.202 179.556 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 12' ' ' ILE . 12.6 mtpp -141.9 -169.64 2.96 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.636 -0.665 . . . . 0.0 109.473 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.854 ' HB ' HG22 ' A' ' 90' ' ' VAL . 13.8 mm -158.08 94.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 94.58 5.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.795 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.5 mt -104.79 160.29 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 108.801 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.671 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -101.69 167.09 10.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.919 -1.113 . . . . 0.0 108.849 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -74.27 145.23 44.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.074 . . . . 0.0 109.428 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 56.32 33.5 61.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 2.8 m-85 -116.11 -174.33 2.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.109 -1.23 . . . . 0.0 110.903 -179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 63' ' ' PRO . 66.8 p -126.25 129.55 49.15 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.849 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.8 t60 -116.82 162.07 18.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.54 89.13 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.924 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.3 tt -77.18 132.95 39.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.59 -0.694 . . . . 0.0 110.702 -178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 27.5 tt0 -127.99 152.05 48.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.126 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG13 ' HB ' ' A' ' 7' ' ' THR . 19.6 t -157.84 138.49 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.132 -0.98 . . . . 0.0 109.227 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.1 OUTLIER -113.67 133.28 55.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 110.006 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CB ' HD12 ' A' ' 5' ' ' ILE . 6.5 p90 -161.87 120.47 2.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.862 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 28' ' ' GLY . 2.6 mm -78.62 -173.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.806 . . . . 0.0 109.587 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.707 ' H ' HG22 ' A' ' 27' ' ' ILE . . . 153.15 140.98 3.19 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -164.96 170.88 5.95 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 120.918 -1.342 . . . . 0.0 109.821 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.948 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.3 Cg_endo -70.89 -0.69 7.74 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.417 -1.493 . . . . 0.0 111.065 1.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 8.1 t0 -169.29 92.8 0.55 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.338 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.2 Cg_endo -79.33 176.07 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.694 2.262 . . . . 0.0 110.948 -179.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 89.9 m -142.32 146.41 34.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -131.98 120.43 22.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.703 -1.248 . . . . 0.0 109.686 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.8 m -104.38 125.6 50.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.348 -0.845 . . . . 0.0 109.49 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.924 ' CH2' HD21 ' A' ' 22' ' ' LEU . 46.4 m95 -88.9 103.92 16.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.278 1.037 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -108.11 178.82 4.39 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.746 -1.221 . . . . 0.0 110.433 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 44' ' ' ALA . 1.2 p -140.42 -179.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 75.49 -7.7 23.69 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 76.49 -11.02 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -1.234 . . . . 0.0 110.505 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' ASP . 1.7 t 163.79 80.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.026 -1.046 . . . . 0.0 109.615 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.05 31.76 0.43 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' VAL . . . -169.57 176.14 5.11 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.212 -1.169 . . . . 0.0 108.885 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -147.72 165.99 28.83 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.066 -1.021 . . . . 0.0 109.479 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.101 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.96 150.98 47.5 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.649 179.108 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.91 -53.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 111.233 -179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 29.8 Cg_endo -70.37 -1.39 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.165 1.91 . . . . 0.0 111.394 -178.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.033 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -116.61 15.93 15.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.325 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.101 ' CD1' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -164.17 -164.67 0.88 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.603 0.716 . . . . 0.0 109.397 -179.638 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.821 HD23 ' C ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -122.84 83.0 2.06 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.08 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.931 HG13 ' CG2' ' A' ' 60' ' ' ILE . 44.3 t -78.91 128.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.869 0.842 . . . . 0.0 111.937 -177.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -127.21 156.23 42.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.586 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.25 147.51 22.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.19 -1.568 . . . . 0.0 111.171 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.3 OUTLIER -118.19 158.71 24.6 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.679 0.752 . . . . 0.0 110.071 -179.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 97.7 p -50.62 -56.59 11.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 111.323 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 26' ' ' PHE . 4.1 m -93.58 17.54 11.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.854 -1.154 . . . . 0.0 110.997 -178.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 54' ' ' LYS . 6.3 t -172.49 -163.21 0.22 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.52 -1.363 . . . . 0.0 109.341 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.586 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.7 t 175.46 156.06 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.596 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASP . 68.7 m -158.61 144.68 16.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.931 ' CG2' HG13 ' A' ' 51' ' ' VAL . 8.5 pt -128.58 165.67 27.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 C-N-CA 118.21 -1.396 . . . . 0.0 110.097 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.655 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -117.93 150.85 38.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.605 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -135.31 47.91 2.53 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HG3' HD11 ' A' ' 50' ' ' LEU . 27.5 Cg_endo -64.42 -13.31 37.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.898 1.732 . . . . 0.0 109.493 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.52 49.25 1.38 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.86 141.11 29.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.163 -0.96 . . . . 0.0 110.257 -178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.811 ' C ' HG11 ' A' ' 92' ' ' VAL . 4.2 ttmt -152.97 176.51 11.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.4 OUTLIER -43.55 -41.65 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.219 -0.926 . . . . 0.0 109.913 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.3 m-20 -51.95 -23.36 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.481 ' CA ' HG23 ' A' ' 92' ' ' VAL . 14.9 m -52.37 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -147.33 178.18 25.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . 1.8 m120 -94.65 96.46 9.43 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.265 -1.138 . . . . 0.0 108.739 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.676 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 8.1 m-85 -77.45 107.64 10.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -112.08 125.1 53.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.408 -0.807 . . . . 0.0 109.058 -179.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.747 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -107.28 141.74 38.14 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.28 -0.888 . . . . 0.0 109.543 -179.49 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.517 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -139.08 115.07 10.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.588 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -106.03 145.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.939 . . . . 0.0 108.807 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 5.1 tttp -134.0 165.96 23.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 110.009 -179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.547 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 46.9 t-20 -173.8 129.5 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 11.0 pt-20 44.65 -144.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.186 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -81.92 11.44 5.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.931 -1.106 . . . . 0.0 110.824 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -123.61 151.13 16.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 2.0 mt-10 -152.57 141.92 21.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.283 . . . . 0.0 110.179 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.643 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -117.25 168.72 10.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.259 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 86' ' ' ALA . 1.1 tm-20 -161.85 141.61 10.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.115 . . . . 0.0 110.109 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -122.44 153.35 39.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.081 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -109.23 143.5 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.745 -179.551 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.081 ' N ' HD13 ' A' ' 87' ' ' ILE . 10.2 m-85 -145.95 91.83 2.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 11' ' ' LYS . 10.8 mt-10 -79.15 108.21 12.48 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' HB ' ' A' ' 12' ' ' ILE . 43.6 t -100.47 122.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.549 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 92' ' ' VAL . 66.8 mt -112.87 165.82 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.437 -0.789 . . . . 0.0 108.961 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.811 HG11 ' C ' ' A' ' 66' ' ' LYS . 6.0 t -134.26 131.52 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' OXT' ' HD2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.497 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.574 ' H1 ' ' HB3' ' A' ' 29' ' ' ALA . 1.2 mp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.375 0.607 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' HG3' ' CD ' ' A' ' 3' ' ' PRO . 8.3 ttpp -103.08 122.65 44.71 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.585 -0.697 . . . . 0.0 109.128 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 31.7 Cg_endo -75.35 137.36 20.88 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.636 2.224 . . . . 0.0 109.837 -129.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -107.04 83.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.264 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 5' ' ' ILE . 3.0 tt -88.3 112.71 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.1 OUTLIER -111.11 1.3 17.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 110.685 -178.661 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -37.52 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.282 -0.886 . . . . 0.0 109.971 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -56.2 -48.53 76.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.914 . . . . 0.0 109.855 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.599 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . 14.8 t 59.92 118.36 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 11' ' ' LYS . 3.6 ttt180 177.97 -87.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.781 0.8 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HG2' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -160.7 -169.24 2.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.602 -0.687 . . . . 0.0 109.361 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 HG23 ' HE2' ' A' ' 20' ' ' HIS . 31.1 mm -156.33 144.17 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.389 -0.819 . . . . 0.0 109.613 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -113.34 79.97 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.164 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.695 HG23 ' ND1' ' A' ' 20' ' ' HIS . 2.1 mt -92.23 161.68 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 108.889 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HB2' ' CG ' ' A' ' 18' ' ' PHE . 5.0 mmtt -106.96 166.22 10.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.76 -1.213 . . . . 0.0 108.963 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -68.82 147.99 50.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.26 33.44 38.7 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CG ' ' HB2' ' A' ' 15' ' ' LYS . 2.5 m-85 -112.48 -177.7 3.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.112 -1.228 . . . . 0.0 110.958 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 63' ' ' PRO . 64.4 p -124.84 122.93 38.81 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.695 ' ND1' HG23 ' A' ' 14' ' ' ILE . 2.4 t60 -112.35 161.47 16.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.043 -179.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.465 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 5.7 p-10 -130.86 81.75 2.01 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.946 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.7 tt -69.55 135.52 50.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.651 -0.656 . . . . 0.0 110.539 -178.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 24' ' ' VAL . 24.6 mt-10 -130.85 153.31 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.525 -0.735 . . . . 0.0 109.512 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 7' ' ' THR . 23.5 t -158.06 144.53 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 0.0 108.861 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 2.5 m-20 -119.99 134.06 55.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 77' ' ' VAL . 16.0 p90 -164.81 118.81 1.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.304 179.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.812 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.1 mm -81.32 165.1 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.503 -0.748 . . . . 0.0 110.005 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 32' ' ' PRO . . . 167.62 149.95 6.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.059 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -166.51 175.38 2.24 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.475 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.059 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.8 Cg_endo -71.92 0.18 9.07 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.956 1.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 12.3 t0 -170.8 89.23 0.48 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -78.01 155.18 29.88 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.727 2.284 . . . . 0.0 110.749 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 15.6 m -122.79 118.97 29.23 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -105.0 107.68 18.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.535 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.2 m -88.04 133.87 33.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.694 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.946 ' CH2' HD21 ' A' ' 22' ' ' LEU . 45.9 m95 -98.8 99.8 10.93 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.06 0.934 . . . . 0.0 108.962 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.6 178.18 4.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.751 -1.218 . . . . 0.0 111.019 -178.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -132.76 51.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.673 -0.642 . . . . 0.0 110.429 -177.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 156.59 -31.41 0.57 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' HB2' ' CG ' ' A' ' 74' ' ' LYS . 6.2 t0 62.28 30.78 17.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -1.14 . . . . 0.0 109.531 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.6 t -160.45 20.35 0.15 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.202 -0.936 . . . . 0.0 109.924 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.75 40.93 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.675 ' HB1' ' CG1' ' A' ' 38' ' ' VAL . . . -168.09 148.97 5.05 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.119 -1.224 . . . . 0.0 109.84 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -141.08 171.49 13.98 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.794 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -138.99 149.89 45.22 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.229 179.251 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 165.13 -53.17 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.326 -179.01 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.2 Cg_endo -70.61 -12.95 32.08 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.966 1.777 . . . . 0.0 110.827 -179.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.429 ' C ' HD23 ' A' ' 49' ' ' LEU . 1.3 mt-10 -99.04 14.32 29.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -174.66 -163.09 0.13 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 51' ' ' VAL . 16.0 tp -113.9 161.66 17.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG13 ' CG2' ' A' ' 60' ' ' ILE . 64.6 t -150.44 143.84 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.605 -1.31 . . . . 0.0 110.985 -178.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 59' ' ' SER . 2.2 m-20 -139.08 152.49 47.58 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -156.7 146.06 20.52 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.346 -1.472 . . . . 0.0 110.987 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HB2' HG22 ' A' ' 57' ' ' THR . 20.8 mtmm -124.75 160.0 29.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.844 0.83 . . . . 0.0 110.065 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 35.0 p -49.21 -57.16 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -178.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.451 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -93.2 17.5 10.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.622 -1.299 . . . . 0.0 111.368 -177.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 54' ' ' LYS . 7.8 t -174.69 -165.53 0.21 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.517 -1.365 . . . . 0.0 109.398 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.552 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 14.1 t 176.4 151.18 0.15 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.686 178.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASP . 15.2 m -151.22 140.98 21.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.828 ' CG2' HG13 ' A' ' 51' ' ' VAL . 5.7 pt -126.7 152.63 34.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 C-N-CA 118.222 -1.391 . . . . 0.0 110.726 -177.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.812 ' O ' HD12 ' A' ' 49' ' ' LEU . 3.0 m-85 -100.65 157.23 16.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.704 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.61 45.24 0.76 Allowed Pre-proline 0 N--CA 1.493 1.716 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.328 177.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 61' ' ' PHE . 27.5 Cg_endo -63.66 -12.87 33.42 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.967 1.778 . . . . 0.0 109.59 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.52 46.47 2.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -82.88 141.1 32.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.902 -1.124 . . . . 0.0 109.929 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.685 ' O ' HG21 ' A' ' 92' ' ' VAL . 3.5 mtmp? -146.63 174.03 11.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -43.29 -46.55 6.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.799 -179.846 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.09 -42.44 80.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -44.38 -25.27 0.23 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.017 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.6 t -49.24 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.965 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -143.52 167.31 26.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 3.7 m-20 -89.03 88.26 7.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -1.115 . . . . 0.0 108.922 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.704 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 3.5 m-30 -65.66 92.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.424 -0.797 . . . . 0.0 109.081 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -96.43 112.63 24.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.84 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -97.69 143.53 28.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 tttt -143.09 116.77 9.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.137 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.969 HG22 ' OD1' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -106.16 150.45 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 109.704 -179.628 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' CB ' ' HB3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -142.91 179.52 6.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.178 -179.308 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 8.2 p30 178.54 115.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.264 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 81' ' ' LEU . 1.6 tp10 63.33 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.887 . . . . 0.0 110.299 179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -138.29 4.25 2.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.26 -179.763 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 81' ' ' LEU . . . -114.93 150.44 18.72 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HA ' ' HG3' ' A' ' 3' ' ' PRO . 4.6 pt-20 -164.86 139.04 5.06 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.984 -1.303 . . . . 0.0 110.584 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.969 ' OD1' HG22 ' A' ' 77' ' ' VAL . 3.8 p30 -124.6 -173.23 2.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 10.7 pt-20 -167.36 147.99 5.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.918 -1.114 . . . . 0.0 110.288 -179.386 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.731 ' HB3' ' CE2' ' A' ' 88' ' ' PHE . . . -121.46 127.58 51.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.436 -0.79 . . . . 0.0 109.035 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -83.32 118.38 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 109.607 -179.707 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.732 ' N ' HD13 ' A' ' 87' ' ' ILE . 73.2 m-85 -121.05 94.3 4.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.462 -0.774 . . . . 0.0 109.151 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 9.2 tt0 -79.4 100.51 7.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 73' ' ' TYR . 31.0 t -91.0 122.25 42.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.114 -0.991 . . . . 0.0 110.089 -178.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 92' ' ' VAL . 21.2 mt -116.96 163.61 13.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 66' ' ' LYS . 4.5 t -130.74 144.81 36.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.568 -0.707 . . . . 0.0 109.739 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.467 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 1' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -42.68 158.14 0.22 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 109.667 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' HA ' ' A' ' 83' ' ' GLU . 36.2 Cg_endo -79.5 74.46 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.705 2.27 . . . . 0.0 110.152 160.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -53.43 104.84 0.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.231 179.834 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -100.32 122.56 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' THR . 5.6 mp -121.72 9.82 10.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.99 -1.068 . . . . 0.0 110.571 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.58 ' CG2' HG13 ' A' ' 24' ' ' VAL . 1.4 t -42.94 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.082 -1.012 . . . . 0.0 109.431 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -65.19 -51.39 61.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 1.9 p 59.11 121.99 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.453 0.644 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.51 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.828 . . . . 0.0 109.194 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 12' ' ' ILE . 11.8 mttp -147.27 -175.7 4.94 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 109.485 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.878 HG23 ' NE2' ' A' ' 20' ' ' HIS . 33.2 mm -155.46 90.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.342 -0.849 . . . . 0.0 109.233 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -75.24 90.06 2.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 -179.629 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.789 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -98.55 153.42 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.21 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 3.2 tptp -96.71 155.9 16.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.089 . . . . 0.0 108.474 179.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -65.07 145.74 55.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.862 -1.149 . . . . 0.0 109.664 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 66' ' ' LYS . . . 60.1 35.62 88.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 3.4 m-85 -118.26 175.99 5.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.992 -1.299 . . . . 0.0 111.147 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.787 HG22 ' HA ' ' A' ' 63' ' ' PRO . 80.6 p -119.48 104.49 10.37 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.878 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.7 t60 -92.74 153.17 19.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.413 -0.804 . . . . 0.0 110.03 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.56 87.37 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 108.822 179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.974 HD21 ' CH2' ' A' ' 36' ' ' TRP . 9.6 tt -72.7 138.9 46.9 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.681 -0.637 . . . . 0.0 110.871 -178.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 1.6 tt0 -134.6 152.1 51.54 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.479 -0.763 . . . . 0.0 109.531 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 11.7 t -154.73 122.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.198 -0.939 . . . . 0.0 109.268 -179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 0.5 OUTLIER -90.67 136.83 32.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.158 -0.964 . . . . 0.0 110.287 -179.748 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.814 ' CB ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -175.39 120.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.103 -0.998 . . . . 0.0 109.138 179.291 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -127.83 155.27 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.539 -179.087 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 179.47 -158.46 22.36 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.877 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 170.41 168.63 0.19 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.266 . . . . 0.0 109.721 179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.877 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.7 Cg_endo -74.91 143.51 78.03 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.158 -1.601 . . . . 0.0 110.778 0.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER 32.61 86.5 0.13 Allowed Pre-proline 0 N--CA 1.494 1.734 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 35.7 Cg_endo -78.83 135.9 12.99 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 110.067 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 77' ' ' VAL . 61.6 m -93.32 159.75 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.686 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -147.25 107.95 4.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.085 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -96.17 131.5 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.844 -179.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.974 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.2 m95 -93.91 101.01 13.07 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.219 1.009 . . . . 0.0 109.216 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -103.25 -177.6 3.42 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.955 -1.09 . . . . 0.0 110.651 -179.071 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 39' ' ' GLY . 2.1 p -135.99 -165.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.737 -0.602 . . . . 0.0 109.629 -178.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.727 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -58.86 -145.36 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.246 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.784 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 t0 59.05 12.6 2.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 109.84 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 40' ' ' ASP . 10.5 p 43.33 48.22 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.502 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.55 -17.46 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 37' ' ' THR . . . -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.259 -1.142 . . . . 0.0 108.968 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' THR . . . -136.14 157.68 46.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.118 -0.989 . . . . 0.0 109.301 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.822 ' C ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -130.94 149.98 52.31 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.353 -1.339 . . . . 0.0 109.989 179.342 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 164.12 -52.71 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 110.534 -178.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.1 Cg_endo -70.58 -12.33 31.17 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.979 1.786 . . . . 0.0 110.748 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -100.17 15.12 28.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.201 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -176.4 -160.96 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.443 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.2 mt -115.16 168.15 10.19 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.82 HG13 ' CG2' ' A' ' 60' ' ' ILE . 61.2 t -153.3 145.92 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.587 -1.321 . . . . 0.0 111.234 -178.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -142.99 143.09 31.78 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -148.39 146.72 28.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.372 -1.455 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -130.1 156.89 43.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.432 0.634 . . . . 0.0 109.647 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 51.6 p -60.66 -24.43 65.57 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.971 -1.081 . . . . 0.0 111.164 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.674 ' CA ' HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -105.29 3.22 29.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.702 -1.249 . . . . 0.0 110.23 -179.187 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 10.4 t -176.37 -157.52 0.05 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.697 -1.252 . . . . 0.0 108.257 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' ALA . 10.4 t 174.08 130.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.319 178.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 14.7 p -135.23 139.62 44.62 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.82 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -122.76 153.97 27.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 C-N-CA 118.479 -1.288 . . . . 0.0 109.993 -177.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.808 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.4 m-85 -98.11 160.74 14.1 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.652 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 21.2 m-85 -143.55 43.37 0.44 Allowed Pre-proline 0 N--CA 1.494 1.739 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.47 178.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.787 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.9 Cg_endo -62.26 -12.44 27.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.004 1.803 . . . . 0.0 110.282 -179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.27 46.32 2.22 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -85.01 139.43 31.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.845 -1.159 . . . . 0.0 109.78 -179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.952 ' C ' HG11 ' A' ' 92' ' ' VAL . 1.5 mmtp -144.35 -173.07 3.92 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 4.2 mtt-85 -54.68 -44.85 73.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.38 67.74 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 110.061 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.02 -7.53 23.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.16 -0.963 . . . . 0.0 109.815 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.486 ' CA ' HG23 ' A' ' 92' ' ' VAL . 13.4 t -69.99 103.45 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.45 -176.48 24.29 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 39' ' ' GLY . 10.3 t-20 -97.36 89.43 4.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -1.122 . . . . 0.0 108.497 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.652 ' CD2' ' HG ' ' A' ' 45' ' ' LEU . 18.1 m-85 -68.03 113.61 5.86 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -118.36 123.42 45.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.105 -179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -108.77 142.21 39.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.452 -179.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 112.87 8.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.454 -0.779 . . . . 0.0 109.215 -179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.1 m -107.07 149.27 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.98 . . . . 0.0 109.175 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -138.7 -174.31 3.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.014 -179.371 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 30' ' ' PRO . 6.8 t-20 -179.26 121.63 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.431 -0.793 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.9 mm-40 41.48 -94.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' ASN . 1.1 mm? -116.96 -19.7 9.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.088 -1.007 . . . . 0.0 109.863 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 2' ' ' LYS . . . -89.11 162.38 31.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -175.29 141.96 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.214 . . . . 0.0 110.095 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -129.71 177.75 7.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 0.0 108.932 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -157.71 155.72 30.43 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.011 -1.056 . . . . 0.0 110.323 -179.351 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.643 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -135.33 140.85 45.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.435 -0.791 . . . . 0.0 109.109 179.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.071 HD13 ' N ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -94.25 147.5 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.315 -0.866 . . . . 0.0 109.811 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 1.071 ' N ' HD13 ' A' ' 87' ' ' ILE . 44.9 m-85 -148.09 88.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.761 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -78.74 105.48 10.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.906 -1.121 . . . . 0.0 108.001 179.152 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.689 HG13 ' CG2' ' A' ' 12' ' ' ILE . 12.9 t -101.58 130.03 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.975 . . . . 0.0 110.642 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.627 HG22 ' N ' ' A' ' 92' ' ' VAL . 3.3 mp -120.48 165.99 15.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.952 HG11 ' C ' ' A' ' 66' ' ' LYS . 12.5 t -132.23 135.59 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.126 -0.984 . . . . 0.0 109.847 -179.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.472 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 3.4 pt20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.512 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 0.0 109.511 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -69.39 143.96 94.0 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.438 179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 35.4 Cg_endo -77.22 106.76 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.672 2.248 . . . . 0.0 110.358 -159.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -87.15 76.82 9.2 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.184 -0.948 . . . . 0.0 109.238 179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.837 HG22 ' CG ' ' A' ' 84' ' ' ASP . 1.2 tt -76.18 114.11 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -114.75 0.36 13.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.903 -178.536 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -35.25 131.69 0.42 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.387 -0.821 . . . . 0.0 110.134 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' SER . . . -42.59 -51.0 5.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -0.872 . . . . 0.0 109.897 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 88' ' ' PHE . 1.3 p 60.32 127.57 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.493 0.663 . . . . 0.0 109.738 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 5.2 ttp-105 177.68 -88.9 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.473 -0.767 . . . . 0.0 109.115 -179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG3' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -144.82 -176.36 5.04 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.608 179.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.865 HG23 ' NE2' ' A' ' 20' ' ' HIS . 32.3 mm -155.19 84.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.085 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.934 ' HA ' HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -69.9 94.18 0.82 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.46 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.777 ' CG1' HG22 ' A' ' 12' ' ' ILE . 2.4 mt -103.7 166.41 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 0.0 108.65 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' CD ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -107.17 162.84 13.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.593 -1.317 . . . . 0.0 108.633 179.619 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -66.52 146.62 54.32 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.057 -1.027 . . . . 0.0 110.031 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 52.25 35.69 43.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE2' ' CD ' ' A' ' 15' ' ' LYS . 2.5 m-85 -113.21 179.88 3.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.001 -1.293 . . . . 0.0 111.009 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 63' ' ' PRO . 58.5 p -120.62 119.85 34.05 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.865 ' NE2' HG23 ' A' ' 12' ' ' ILE . 2.9 t60 -110.17 157.94 18.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.258 -0.901 . . . . 0.0 109.846 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.5 82.12 2.04 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.92 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.3 tt -67.27 132.92 48.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.617 -0.677 . . . . 0.0 110.393 -179.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.5 tt0 -125.38 152.34 44.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 0.0 109.951 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 23' ' ' GLU . 8.1 t -160.07 162.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 11.8 t0 -153.49 145.18 23.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.897 -1.127 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 46.3 p90 -159.51 139.65 11.89 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.927 179.277 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB2' ' A' ' 4' ' ' LYS . 3.6 mm -91.75 75.52 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.375 -0.828 . . . . 0.0 109.69 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.588 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . -111.95 151.95 17.85 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 171.31 170.38 0.2 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.277 -1.131 . . . . 0.0 109.538 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 36.0 Cg_endo -74.81 146.14 85.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.287 -1.547 . . . . 0.0 110.559 0.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 33.48 80.44 0.26 Allowed Pre-proline 0 N--CA 1.494 1.758 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 55' ' ' SER . 37.1 Cg_endo -79.38 -168.27 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.652 2.235 . . . . 0.0 110.216 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 34.3 m -139.39 113.76 9.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . . . -105.53 112.99 26.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.675 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.7 m -92.48 135.8 33.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.558 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.92 ' CH2' HD21 ' A' ' 22' ' ' LEU . 29.4 m95 -103.39 100.69 10.57 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.206 1.003 . . . . 0.0 109.355 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -104.04 177.14 4.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.728 -1.233 . . . . 0.0 110.817 -179.196 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 38' ' ' VAL . 3.8 p -132.48 56.94 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.82 0.819 . . . . 0.0 110.08 -178.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 133.15 133.56 3.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -12.35 41.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -1.19 . . . . 0.0 109.549 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.12 -7.4 22.93 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.6 -7.21 28.08 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.862 ' O ' HG22 ' A' ' 37' ' ' THR . . . -59.83 164.54 3.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.401 -1.058 . . . . 0.0 108.845 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' N ' HG12 ' A' ' 38' ' ' VAL . . . -144.56 168.85 19.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 109.442 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.903 HD23 HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -138.81 146.48 41.37 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.096 -1.442 . . . . 0.0 110.537 179.291 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 47' ' ' PRO . . . 169.23 -56.73 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.566 -0.709 . . . . 0.0 109.978 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 30.3 Cg_endo -70.58 -4.41 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.251 1.967 . . . . 0.0 110.625 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HG3' HD23 ' A' ' 49' ' ' LEU . 9.0 pt-20 -113.22 21.67 15.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.903 HD11 HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER 175.36 -165.43 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' CB ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 mt -111.27 164.4 12.93 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.961 -1.087 . . . . 0.0 108.414 179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.9 t -154.79 136.1 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.715 -1.24 . . . . 0.0 110.974 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -135.26 156.25 49.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.78 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -158.36 146.03 18.17 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.313 -1.492 . . . . 0.0 111.097 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HB3' HG22 ' A' ' 57' ' ' THR . 0.8 OUTLIER -118.78 158.08 26.3 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.639 0.733 . . . . 0.0 109.938 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -52.32 -47.7 65.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 111.514 -179.19 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -101.81 23.13 11.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.611 -1.306 . . . . 0.0 110.729 -178.569 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 12.5 t -178.95 -168.23 0.13 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.763 -1.21 . . . . 0.0 108.788 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 11.4 t 178.5 155.02 0.4 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.73 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 52' ' ' ASP . 21.7 p -157.42 143.01 17.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.821 ' CG2' HG13 ' A' ' 51' ' ' VAL . 7.3 pt -128.25 158.53 40.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 117.818 -1.553 . . . . 0.0 110.93 -177.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.74 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.4 m-85 -103.4 159.77 15.29 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 6.8 m-85 -142.73 45.38 0.62 Allowed Pre-proline 0 N--CA 1.494 1.726 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.253 177.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.4 Cg_endo -62.72 -12.21 27.58 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.093 1.862 . . . . 0.0 110.063 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.96 47.08 2.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . . . -84.81 142.45 29.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.838 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.876 ' C ' HG11 ' A' ' 92' ' ' VAL . 30.2 mtpt -145.7 -174.91 4.53 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.243 0.544 . . . . 0.0 109.539 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.43 -41.93 61.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.88 74.46 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.873 . . . . 0.0 109.786 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 92' ' ' VAL . 8.9 t70 -63.44 -11.63 24.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.0 109.765 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 67' ' ' ARG . 1.6 t -70.24 107.67 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.68 18.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . 72.3 m-20 -99.35 91.69 5.07 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.254 -1.145 . . . . 0.0 108.678 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.716 ' HB2' HG23 ' A' ' 90' ' ' VAL . 9.5 m-85 -73.64 100.73 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 108.862 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 166.92 10.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.416 -0.802 . . . . 0.0 109.194 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.79 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -149.42 144.16 26.18 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.29 110.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.448 -179.719 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 1.3 m -102.87 153.23 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.23 -0.919 . . . . 0.0 109.022 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -160.81 154.97 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.034 . . . . 0.0 109.815 -179.086 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -152.04 144.12 23.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.496 -179.959 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.4 mp0 39.06 -94.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 0.0 110.166 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.872 HD12 ' N ' ' A' ' 82' ' ' GLY . 1.4 pp -125.29 -11.02 6.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.872 ' N ' HD12 ' A' ' 81' ' ' LEU . . . -82.71 166.16 44.87 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' C ' ' HG2' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.17 139.04 1.03 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.356 . . . . 0.0 110.723 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.837 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.27 163.55 32.65 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.305 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' CB ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 pt-20 -148.17 164.27 34.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.751 -1.218 . . . . 0.0 110.755 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -143.24 141.43 31.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.754 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -108.61 140.34 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.58 -179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 37.1 m-85 -140.18 99.43 3.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.5 tt0 -78.74 109.19 12.75 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' HB2' ' A' ' 73' ' ' TYR . 10.7 t -102.72 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.136 -0.978 . . . . 0.0 111.023 -178.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.934 HG22 ' HA ' ' A' ' 13' ' ' LYS . 5.0 tp -111.61 171.36 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.876 HG11 ' C ' ' A' ' 66' ' ' LYS . 95.8 t -154.79 123.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.969 -1.082 . . . . 0.0 110.558 178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 28' ' ' GLY . 6.6 mp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 1.7 ptpt -63.68 135.14 96.15 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.37 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' CG ' ' OD1' ' A' ' 79' ' ' ASN . 35.3 Cg_endo -77.78 135.53 14.38 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.828 2.352 . . . . 0.0 110.369 -147.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 26' ' ' PHE . 3.3 mttt -101.42 79.28 1.95 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 108.929 179.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.773 HG22 ' HB3' ' A' ' 84' ' ' ASP . 1.2 tt -85.44 114.42 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.805 . . . . 0.0 109.723 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -104.36 -74.33 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.148 179.843 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.712 HG21 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER 42.33 -172.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.108 179.002 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' N ' ' OG1' ' A' ' 7' ' ' THR . . . -111.05 -28.28 8.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.767 -1.208 . . . . 0.0 109.226 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 1.012 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 14.5 p 39.94 62.35 1.27 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.792 -0.567 . . . . 0.0 110.107 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HD3' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mtm180 -114.54 -76.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.089 -1.007 . . . . 0.0 109.184 179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -157.2 -175.63 5.52 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.543 179.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.911 ' HB ' HG13 ' A' ' 90' ' ' VAL . 26.8 mm -154.57 83.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.295 -0.878 . . . . 0.0 109.626 -179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -66.5 92.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.841 ' CG1' HG22 ' A' ' 12' ' ' ILE . 3.6 mt -90.13 138.34 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.342 -0.849 . . . . 0.0 110.914 -178.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . 2.9 mtmm -68.11 123.33 20.38 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . . . -45.33 144.41 1.44 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.819 -178.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 66' ' ' LYS . . . 42.61 69.86 0.56 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -160.09 -171.66 3.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.294 . . . . 0.0 110.234 -178.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.814 HG22 ' HA ' ' A' ' 63' ' ' PRO . 53.1 p -110.97 122.14 47.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 111.144 -178.67 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.905 ' NE2' HG23 ' A' ' 12' ' ' ILE . 4.8 t60 -111.18 147.95 33.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.429 -0.795 . . . . 0.0 108.888 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.38 95.94 5.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.912 . . . . 0.0 108.62 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.859 HD21 ' CH2' ' A' ' 36' ' ' TRP . 10.2 tt -79.28 143.41 35.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.52 -0.738 . . . . 0.0 110.295 -178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 24' ' ' VAL . 12.4 pt-20 -138.56 156.13 47.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG21 ' A' ' 7' ' ' THR . 23.1 t -160.38 141.58 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.049 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 3.6 m-20 -113.05 133.06 55.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.864 . . . . 0.0 109.683 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.963 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.5 p90 -164.67 116.8 1.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.013 -1.054 . . . . 0.0 110.114 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.805 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -79.61 170.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.241 -179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' ALA . . . 155.93 151.11 5.81 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.962 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . 176.66 171.16 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.156 -1.203 . . . . 0.0 109.526 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.962 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 35.0 Cg_endo -74.01 148.4 91.87 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.35 -1.521 . . . . 0.0 110.465 1.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 30' ' ' PRO . 2.7 m-20 36.29 85.55 0.16 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 122.024 -0.423 . . . . 0.0 109.955 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 36.6 Cg_endo -78.29 163.22 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.478 2.118 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 54.4 m -121.96 113.6 19.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.699 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -101.68 137.54 39.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.005 179.587 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.682 HG21 ' NZ ' ' A' ' 76' ' ' LYS . 46.5 m -114.99 131.3 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 110.111 -179.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.859 ' CH2' HD21 ' A' ' 22' ' ' LEU . 32.0 m95 -105.16 86.08 2.37 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.71 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -103.0 160.99 14.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 110.348 -178.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.768 HG22 ' H ' ' A' ' 39' ' ' GLY . 4.7 p -100.92 -174.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.768 ' H ' HG22 ' A' ' 38' ' ' VAL . . . -60.67 -139.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t0 66.71 4.87 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -1.221 . . . . 0.0 110.214 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.27 46.52 23.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.111 -0.993 . . . . 0.0 110.096 179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.28 -17.92 2.09 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . . . -58.21 154.45 13.16 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.235 -1.156 . . . . 0.0 109.184 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -100.15 149.21 23.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.926 . . . . 0.0 108.817 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.759 HD21 ' HD2' ' A' ' 73' ' ' TYR . 0.7 OUTLIER -44.99 148.11 0.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.009 -1.057 . . . . 0.0 109.754 -179.622 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -52.56 125.48 36.7 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.356 -0.84 . . . . 0.0 110.027 -179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -2.55 11.25 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.035 1.823 . . . . 0.0 110.28 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HG2' ' HB1' ' A' ' 46' ' ' ALA . 2.4 pt-20 -83.06 -12.08 57.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 46' ' ' ALA . 1.1 pp -102.45 -169.88 1.73 Allowed 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.226 -0.922 . . . . 0.0 110.036 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.868 ' O ' HD12 ' A' ' 49' ' ' LEU . 6.5 mt -116.96 169.06 9.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' CG2' ' A' ' 60' ' ' ILE . 59.1 t -156.85 136.62 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.855 -1.153 . . . . 0.0 110.723 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 59' ' ' SER . 88.3 m-20 -135.4 153.78 51.69 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' CB ' ' OG1' ' A' ' 58' ' ' THR . . . -155.48 145.93 21.96 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.313 -1.492 . . . . 0.0 111.072 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HB2' HG22 ' A' ' 57' ' ' THR . 73.3 mttt -120.48 158.99 26.08 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 19.6 m -50.19 -55.26 15.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.07 -1.019 . . . . 0.0 111.639 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -94.31 16.85 13.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.703 -1.248 . . . . 0.0 111.156 -178.106 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 54' ' ' LYS . 6.1 t -174.16 -162.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.444 -1.41 . . . . 0.0 109.322 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.562 ' OG1' ' CB ' ' A' ' 53' ' ' ALA . 12.4 t 177.27 150.57 0.18 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.765 178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 52' ' ' ASP . 2.4 p -150.81 143.09 24.22 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.852 ' CG2' HG13 ' A' ' 51' ' ' VAL . 22.0 pt -128.31 168.81 20.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 117.935 -1.506 . . . . 0.0 110.842 -177.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.692 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 1.9 m-85 -114.67 158.8 21.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 23.3 m-85 -143.27 45.68 0.62 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.332 178.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.814 ' HA ' HG22 ' A' ' 19' ' ' THR . 28.3 Cg_endo -62.47 -12.59 28.53 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.047 1.832 . . . . 0.0 110.44 -179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.1 m -130.82 59.69 1.66 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 17' ' ' GLY . . . -95.2 139.71 31.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.884 -1.135 . . . . 0.0 109.685 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 31.2 mttt -124.41 176.06 6.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -51.54 -46.28 63.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.988 . . . . 0.0 109.285 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' SER . . . -57.63 -33.09 67.9 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.271 -0.893 . . . . 0.0 109.905 -179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 11.0 t70 -42.92 -26.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 109.512 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.1 t -56.14 104.23 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.32 -175.08 22.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . 2.4 m-80 -96.49 86.72 4.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.36 -1.082 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.759 ' HD2' HD21 ' A' ' 45' ' ' LEU . 5.7 m-85 -71.94 89.2 1.08 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -93.96 127.33 39.67 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.432 -0.792 . . . . 0.0 108.958 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -116.55 143.95 44.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.928 . . . . 0.0 108.895 -179.78 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' NZ ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -141.89 119.67 11.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.063 -1.023 . . . . 0.0 109.675 -179.823 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 26' ' ' PHE . 2.2 m -109.18 124.91 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.765 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 19.1 mtmt -116.58 168.3 10.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 110.124 -179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m120 -145.13 164.54 30.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 79' ' ' ASN . 1.8 tt0 -29.41 -38.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 120.918 0.39 . . . . 0.0 111.181 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -153.44 47.51 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.999 -1.063 . . . . 0.0 110.108 -179.808 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 2' ' ' LYS . . . -165.58 117.92 0.78 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 1.6 mp0 -119.31 139.95 51.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.95 -1.324 . . . . 0.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.773 ' HB3' HG22 ' A' ' 5' ' ' ILE . 1.4 m-20 -150.34 163.22 38.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -162.03 -178.38 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.566 -1.334 . . . . 0.0 111.161 -178.86 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 9' ' ' SER . . . -158.11 138.52 12.67 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.752 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.93 130.87 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.476 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 24' ' ' VAL . 55.5 m-85 -118.57 107.33 13.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.258 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -81.57 94.07 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.406 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.911 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.3 t -87.56 128.29 40.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.127 -0.983 . . . . 0.0 110.604 -178.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 92' ' ' VAL . 4.8 mm -120.47 -172.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.715 ' H ' HG22 ' A' ' 91' ' ' ILE . 6.0 t -154.24 131.95 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.007 -1.058 . . . . 0.0 109.934 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.912 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.808 HD13 ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.348 0.594 . . . . 0.0 109.575 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' O ' HD23 ' A' ' 1' ' ' LEU . 34.0 mtpt -48.65 137.65 12.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.95 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 36.4 Cg_endo -78.99 93.11 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.545 2.163 . . . . 0.0 110.529 -170.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 6' ' ' LEU . 3.4 mttt -76.62 93.12 3.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.374 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.659 HG22 ' OD2' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -81.83 116.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.731 179.617 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.774 HD13 ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -118.76 5.61 11.53 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.595 -0.691 . . . . 0.0 111.462 -178.139 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.566 ' N ' HD22 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -35.46 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.392 -0.817 . . . . 0.0 110.307 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' H ' HG23 ' A' ' 7' ' ' THR . . . -173.6 -49.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.291 -0.88 . . . . 0.0 109.204 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.706 ' CB ' ' HB1' ' A' ' 86' ' ' ALA . 1.0 OUTLIER 59.34 127.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.57 0.7 . . . . 0.0 109.986 179.65 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 9' ' ' SER . 1.6 mtt180 174.99 -90.24 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.467 -0.771 . . . . 0.0 109.128 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -162.62 -171.49 2.76 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.556 -0.715 . . . . 0.0 109.429 179.717 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' HB ' HG13 ' A' ' 90' ' ' VAL . 34.9 mm -157.22 143.06 9.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.372 -179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.73 78.74 1.14 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.781 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.705 HG23 ' HD1' ' A' ' 20' ' ' HIS . 2.0 mt -90.16 162.23 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 0.0 109.134 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HB3' ' CG ' ' A' ' 18' ' ' PHE . 1.6 tptp -103.88 176.42 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.9 -1.125 . . . . 0.0 109.41 -179.567 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . . . -79.81 152.23 29.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.249 -179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . 45.35 29.56 2.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CG ' ' HB3' ' A' ' 15' ' ' LYS . 2.8 m-30 -108.09 -178.41 3.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.235 -1.156 . . . . 0.0 110.741 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.696 HG22 ' HA ' ' A' ' 63' ' ' PRO . 60.8 p -122.75 131.48 53.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.648 -0.658 . . . . 0.0 109.851 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.705 ' HD1' HG23 ' A' ' 14' ' ' ILE . 2.9 t60 -119.84 154.99 33.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.273 -0.892 . . . . 0.0 109.965 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.32 86.26 2.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.902 HD21 ' CH2' ' A' ' 36' ' ' TRP . 7.7 tt -69.73 133.36 47.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.487 -0.758 . . . . 0.0 110.779 -178.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 59' ' ' SER . 4.1 pt-20 -122.5 140.19 53.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG21 ' HH2' ' A' ' 36' ' ' TRP . 3.7 t -153.13 164.38 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 57' ' ' THR . 4.3 t70 -160.38 143.01 13.2 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.03 -1.044 . . . . 0.0 110.666 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.884 ' C ' HD12 ' A' ' 27' ' ' ILE . 16.8 p90 -147.28 171.9 14.7 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 26' ' ' PHE . 1.6 mp -120.42 84.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 110.184 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 1' ' ' LEU . . . -123.12 150.12 16.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.998 ' HB1' ' HA ' ' A' ' 30' ' ' PRO . . . -168.41 173.15 2.76 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.299 . . . . 0.0 109.561 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -71.47 0.84 7.89 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.624 -1.407 . . . . 0.0 111.146 1.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' N ' ' HA ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -170.34 90.65 0.5 Allowed Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.286 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 37.3 Cg_endo -79.22 159.64 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.66 2.24 . . . . 0.0 110.724 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 28.8 m -116.98 114.26 23.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.356 -0.84 . . . . 0.0 108.909 179.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' CB ' HG12 ' A' ' 77' ' ' VAL . . . -99.21 124.16 44.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.33 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 m -108.08 121.49 44.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.851 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.902 ' CH2' HD21 ' A' ' 22' ' ' LEU . 50.5 m95 -91.86 95.54 9.89 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' O ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -103.5 160.22 14.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.934 -1.104 . . . . 0.0 110.383 -179.062 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -105.76 51.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.445 -0.784 . . . . 0.0 109.62 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 72' ' ' ASN . . . 144.07 154.54 6.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -81.27 -13.85 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.354 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 p -67.0 -8.35 29.31 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.04 25.23 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' THR . . . -48.15 143.85 4.19 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.256 -1.143 . . . . 0.0 109.656 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 37' ' ' THR . . . -102.29 148.39 25.52 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.383 -0.823 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.039 HD23 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -45.33 161.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.135 -0.978 . . . . 0.0 109.598 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -84.46 136.8 39.57 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.0 110.411 -178.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.02 -10.89 28.39 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.186 1.924 . . . . 0.0 109.669 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.48 -19.62 64.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.039 HD11 HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -110.16 -167.92 1.25 Allowed 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.492 -0.755 . . . . 0.0 109.016 179.416 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.98 HD11 ' HG3' ' A' ' 63' ' ' PRO . 0.1 OUTLIER -124.32 169.32 11.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.139 -0.976 . . . . 0.0 109.12 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.903 HG13 ' CG2' ' A' ' 60' ' ' ILE . 57.6 t -157.1 128.16 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.104 -0.998 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -128.91 141.17 51.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.081 179.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB2' ' OG1' ' A' ' 58' ' ' THR . . . -152.29 148.82 27.99 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 108.665 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER -161.89 174.98 12.37 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.597 -178.891 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' LYS . 8.0 t 34.88 -96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.226 178.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.615 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 52.6 m -134.79 3.62 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.182 -0.949 . . . . 0.0 109.865 -178.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 25' ' ' ASP . 14.3 t -125.11 -170.26 2.14 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 53' ' ' ALA . 7.8 t 176.32 156.43 0.24 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.526 -1.269 . . . . 0.0 111.255 178.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 52' ' ' ASP . 3.1 p -148.03 150.95 34.89 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.903 ' CG2' HG13 ' A' ' 51' ' ' VAL . 14.2 pt -130.76 166.72 27.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.016 -1.474 . . . . 0.0 110.466 -178.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.709 ' HB3' ' HD3' ' A' ' 63' ' ' PRO . 2.3 m-85 -114.77 156.79 24.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.659 ' CE2' ' CE2' ' A' ' 73' ' ' TYR . 0.3 OUTLIER -143.16 48.46 0.98 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.98 ' HG3' HD11 ' A' ' 50' ' ' LEU . 29.0 Cg_endo -65.49 -13.27 38.93 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.349 2.033 . . . . 0.0 110.194 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.43 46.42 2.3 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . . . -81.38 140.16 34.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.05 -1.031 . . . . 0.0 109.921 -179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' O ' HG21 ' A' ' 92' ' ' VAL . 42.6 tttt -140.55 174.55 10.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -44.33 -47.13 9.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.688 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.35 80.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.907 . . . . 0.0 110.446 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' A' ' 92' ' ' VAL . 0.5 OUTLIER -45.69 -24.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -179.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . 7.8 m -49.71 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 109.363 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' ASP . . . -139.99 176.91 20.97 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.13 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.634 ' ND2' HD11 ' A' ' 87' ' ' ILE . 10.5 t-20 -97.6 89.67 4.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -1.016 . . . . 0.0 109.123 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.659 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 4.5 m-85 -68.74 86.24 0.32 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 1.2 ttpm? -89.26 118.99 29.35 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.241 -0.912 . . . . 0.0 108.573 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD13 ' CE2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -105.41 134.29 48.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.738 -179.295 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 85' ' ' GLU . 8.0 tttt -130.15 110.95 11.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.624 HG12 ' CB ' ' A' ' 34' ' ' ALA . 2.5 m -108.47 120.14 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.04 -1.037 . . . . 0.0 109.606 -179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -108.18 -178.17 3.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.171 -179.212 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 1.8 t30 -174.3 112.46 0.17 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 109.929 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.705 ' HB3' HD13 ' A' ' 81' ' ' LEU . 6.6 tt0 55.86 -87.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.084 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -130.7 -9.09 4.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.446 -1.409 . . . . 0.0 110.312 179.781 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.815 ' N ' HD22 ' A' ' 81' ' ' LEU . . . -99.69 162.13 19.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 7.6 pt-20 -155.93 174.88 14.69 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.913 -1.345 . . . . 0.0 110.709 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -160.11 168.8 24.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB2' ' CG ' ' A' ' 76' ' ' LYS . 1.3 tm-20 -168.58 140.76 2.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.866 -1.146 . . . . 0.0 110.151 -179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . . . -123.51 131.96 53.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.212 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.728 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.95 109.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.539 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.991 ' CE1' ' HB3' ' A' ' 86' ' ' ALA . 7.7 m-85 -105.91 95.57 5.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.168 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 tt0 -79.0 100.28 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 12' ' ' ILE . 2.6 t -96.06 123.92 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -178.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 92' ' ' VAL . 31.8 mt -118.7 164.82 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 66' ' ' LYS . 7.8 t -129.58 147.06 33.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 109.914 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 stop_ save_